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“A man is like a fraction whose numerator is what he is and whose
denominator is what he thinks of himself. The larger the
denominator, the smaller the fraction”
— Leo Tolstoy
Abstract
Pulse oximeters rely on the technique of photoplethysmography (PPG) to estimate arterial
oxygen saturation (SpO2). In conditions of poor peripheral perfusion such as hypotension,
hypothermia, and vasoconstriction, the PPG signals detected are often small and noisy,
or in some cases unobtainable. Hence, pulse oximeters produce erroneous SpO2 readings
in these circumstances. The problem arises as most commercial pulse oximeter probes
are designed to be attached to peripheral sites such as the finger or toes, which are easily
affected by vasoconstriction. In order to overcome this problem, the ear canal was investi-
gated as an alternative site for measuring reliable SpO2 on the hypothesis that blood flow
to this central site is preferentially preserved. Novel miniature ear canal PPG sensors were
developed along with a state of the art PPG processing unit and a data acquisition system
to allow for PPG measurements from different depths and surfaces of the ear canal. A pre-
liminary in vivo investigation on seven healthy volunteers has revealed that good quality
PPG signals with high amplitude can be obtained from the posterior surface of the outer
ear canal. Based on these observations, a second prototype probe suitable for acquisition
of PPGs from the posterior surface of the outer ear canal was developed. A pilot study was
then carried out on 15 healthy volunteers to validate the feasibility of measuring PPGs
and SpO2 from the ear canal in conditions of induced local peripheral vasoconstriction
(right hand immersion in ice water). The PPG signals acquired from the ear canal probe
were compared with those obtained simultaneously from finger probes attached to the left
and the right index fingers. Significant drop (p< 0.05) in amplitude was observed in the
PPG signals acquired from the left (> 45%) and right (> 50%) index fingers during the
ice water immersion, while good quality PPG signals with relatively constant amplitude
were obtained from the ear canal. Also, the SpO2 values showed that the ear canal pulse
oximeter performed better than the two finger pulse oximeters (mean failure rate 30%). A
second in vivo investigation was carried out in 15 healthy volunteers, where hypoperfusion
was induced more naturally by exposing the volunteer to cold temperatures of 10◦C for 10
min. Normalised Pulse Amplitude (NPA) and SpO2 was calculated from the PPG signals
acquired from the ear canal, the finger and the earlobe. By the end of the cold exposure, a
mean drop of > 80% was found in the NPA of finger PPGs. The % drop in the NPA of red
and infrared earlobe PPG signals was 20% and 26% respectively. Contrarily to both these
sites, the NPA of the ear canal PPGs had only dropped by 0.2% and 13% respectively.
The SpO2 estimated from the finger sensor was below 90% in 5 volunteers (failure) by the
end of the cold exposure. The earlobe pulse oximeter failed in 3 volunteers. The ear canal
sensor on the other hand had only failed in 1 volunteer. These results strongly suggest
that the ear canal may be used as a suitable alternative site for reliable monitoring of
PPGs and SpO2 in cases of compromised peripheral perfusion.
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A pulse oximeter is a non-invasive optical device used to provide a continuous and robust
measure of arterial oxygen saturation (SpO2). The device measures SpO2 by shining light
at two different wavelengths into the vascular tissue (such as the finger or the ear lobe) and
sensing the changes in light absorption of the oxygenated and deoxygenated haemoglobin
produced during arterial pulsations [1]. The device has since its invention in the 1980’s
revolutionised anaesthesia and critical care. Pulse oximeters are now one of the most
commonly used medical devices in health care; in fact they are now a standard of practice
for the administration of general anaesthesia. The oximetry measurements provided by
the instrument are often referred to as the “fifth vital sign” [2].
The popularity of the device and its increased clinical use in recent years has driven the
manufacturers and researchers to consistently develop its hardware, software and signal
processing algorithms. However, there still remain a few unsolved problems that limit its
performance. Possibly, the most important limitation of the device in its current state is
the inability to estimate accurate SpO2 in conditions of poor peripheral perfusion. Poor
perfusion can result from various clinical conditions such as hypotension, hypothermia,
vasoconstriction, low cardiac output, hypovolemia, and peripheral vascular disease [3–15].
These clinical situations, can occur in patients undergoing major surgical procedures such
as cardiopulmonary bypass surgery or in patients with chronic cardiovascular complications
and renal failure [16]. The SpO2 readings in these conditions become very inaccurate or
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cease altogether. The failure of the device in these circumstances is directly associated
with the inability of the pulse oximeter probe, placed at the periphery, to detect adequate
photoplethysmographic signals which are necessary for the estimation of SpO2 by pulse
oximetry. Most commercial probes are attached to the extremities such as the finger,
earlobe or toe, where the pulsatile flow is very easily withdrawn and diverted to more vital
organs. Many attempts were made previously to minimise or eliminate this limitation by
the application of vasodilation creams [11], administration of intra-arterial vasodilators
[17], digital nerve blockers [18–20], and applications of sensors on better perfused areas
such as the forehead [13], nose [21], and oesophagus [22]. However, these attempts were
either impractical for use in critically ill patients or gave no improvement in poorly perfused
states. Thus, SpO2 readings are still unobtainable or inaccurate at just the time when
they will be most necessary.
In an effort to address this limitation of pulse oximeters, the outer auditory canal was
proposed as an alternative site for monitoring photoplethysmograms (PPG) and SpO2.
The hypothesis underlying the proposal was that the ear canal being closer to the trunk,
and being supplied by the arteries that supply blood to the brain, would remain adequately
perfused during low perfusion states. This thesis describes in detail the incremental design,
and development of a novel ear canal electro-optic PPG sensor and a state of the art PPG
processing system used to acquire PPGs from the ear canal. The in vivo investigations
carried out to test the hypothesis are also described in this thesis.
A brief summary of each of the chapters contained in this thesis is as follows:
Chapter 2 describes the anatomy and physiology of the respiratory and cardiovascular
system of the human body with emphasis on the method of oxygen transport from sur-
rounding air to each cell in the body. An overview on the significance of adequate oxygen
supply and the pathologies resulting from deficient oxygen supply are also discussed.
Chapter 3 lists the chemical, optical and calorimetric techniques used to measure oxy-
genation in both blood and tissue. The chapter provides a brief review on the principle
of operation and the physiological basis through which oxygenation is measured by some
of the modalities currently being used in clinical practice. The basic principles of spec-
trophotometry and oximetry such as the Beer-Lambert law for the absorption of light in
a solution are also described in this chapter.
Chapter 4 describes the principle of photoplethysmography and the way in which it is
applied in pulse oximetry. The chapter provides a brief history of pulse oximetry and
the choice of wavelengths commonly used in the device. Following this, the equations re-
quired (manipulation of Beer-Lambert law) for converting the measured light transmission
through tissue to values of haemoglobin oxygen saturation are developed. The modern
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methods for calibrating pulse oximeters are also briefly pointed out. The two probe con-
figurations commonly used in pulse oximetry and the instrumentation used to detect the
PPG signals and estimate SpO2 are then discussed.
Chapter 5 provides an in-depth review of the technological and physiological limitations
of pulse oximeters. Following the limitations, the recent advancements in the field of pulse
oximetry and photoplethysmography, and the need for further development of pulse oxime-
ters to improve their performance, especially in conditions of poor peripheral perfusion are
discussed. A possible solution i.e., the ear canal as a site for uninterrupted monitoring of
PPGs and SpO2 in such circumstances is also proposed.
Chapter 6 describes the anatomy and the physiology of the human ear. A detailed
description of the blood supply to the ear canal and its surrounding tissue is provided
in this chapter since the ear canal is the main area of investigation in this project. The
chapter then focuses on the physiological advantages of the ear canal over other sensor
locations for monitoring PPGs. Finally, the chapter presents previous work carried out
by other researchers in developing an in-ear PPG sensor, the drawbacks associated with
their developments, further gaps in knowledge, and how the proposed technology aims to
achieve this new knowledge.
Chapter 7 details the incremental design and development of the reflectance ear canal
PPG (RECAP) probe. The design considerations, components used in the fabrication
of the probe, their specifications and the manufacturing procedures are reported in this
chapter. In addition, the preliminary tests carried out to find the optimal depth and
surface within the ear canal from which high quality PPGs are obtained are presented in
this chapter. The design and development of two optically identical finger PPG probes
are also described.
Chapter 8 covers the development of a modular dual channel, dual wavelength PPG
processing system. The chapter begins with the design brief and specifications of the
system, followed by the top-level and circuit level design architecture. The system is
used to drive the emitters, and precondition the acquired PPG signals (the ear canal and
finger PPGs). The last sections of the chapter provide a comprehensive description of the
manufacturing process and the system’s performance.
Chapter 9 presents the developed virtual instrument (VI) which is used in conjunction
with the developed sensors, Lead I ECG and the PPG instrumentation system. The
chapter describes the various algorithms used in the VI to acquire, display and analyse
the acquired PPG signals.
Chapter 10 describes the first in vivo investigation of PPG signals and SpO2 values in
healthy volunteers undergoing induced local hypoperfusion by means of a cold pressor
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test (CPT). The motivation for the investigation is first presented here followed by the
materials and methods of the study. The data acquired and the statistical analysis that
was undertaken are presented, and the reasons for any particular trends in the data was
discussed. Preliminary estimates of the ear canal SpO2 were compared to those obtained
from the peripheral finger probe during CPT.
Chapter 11 details the second in vivo investigation of PPG signals acquired from the
ear canal and the finger of healthy volunteers undergoing peripheral vasoconstriction by
hypothermia. The aims and objects of the investigation, the measurement setup, the
protocol, the data analysis and materials used are described. Data and statistical analysis
of all acquired PPG signals undertaken are presented and discussed. Comparisons are
made of the AC and DC PPG amplitudes measured from the ear canal and the finger.
The reliability of measuring accurate SpO2 by the ear canal and the finger pulse oximeters
under conditions of cold stress is assessed.
Chapter 12 presents the conclusions along with suggestions for future work.
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—Oxygen is addicting and toxic. It
rusts a person in a century or less.
With oxygen came the danger, and
the blessing, of fire. If introduced
today, this gas might have difficulty
getting approved by the Food and
Drug Administration.
John W. Severinghaus - J Clin
Monit 1986; 270-288
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Tissue perfusion - Anatomy, physiology and
pathology
The human body is composed of trillions (approx - 75) of cells. Each of these cells requires
continuous oxygen (O2) supply and excretion of carbon dioxide (CO2) for metabolism.
Metabolism is a set of diverse chemical reactions continuously proceeding in every living
cell [23]. Oxygen starvation leads to improper metabolism, which in turn may lead to
cell death. Thus, oxygen is known to be the most vital element for life [24]. Oxygen is
delivered to each cell in the body with the help of the respiratory and circulatory systems.
The respiratory system provides gaseous exchange i.e. intake of oxygen and removal of
carbon dioxide, and the cardiovascular system transports blood containing gases from
the lungs to every cell in the body [25]. The percentage level of oxygen present in the
bloodstream indicates how well the cells are perfused and is called oxygen saturation
[26]. Failure to either system upsets metabolism and allows waste product build-up. This
may contribute to the development of multiple organ failures and increase chances of
mortality. Thus, oxygen saturation measure is an important indicator of patients health.
Several invasive and non-invasive techniques are used for measuring oxygen saturation in
clinical environments with pulse oximetry being the most commonly used non-invasive
technique [26]. This thesis proposes a new application of pulse oximetry which estimates
arterial blood oxygen saturation from the external auditory canal. Before continuing, it is
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essential to understand the mechanism of oxygen transport and underlying physiology of
the respiratory and cardiovascular systems, which is the content of this chapter.
2.1 Respiratory system
A respiratory system is a group of organs that includes the lungs and the air passages
(nose, pharynx, larynx, trachea and bronchi). Together these organs are responsible for
carrying O2 from the atmosphere into the bloodstream and for expelling the waste product
CO2. This process of gaseous exchange is known as respiration. The respiratory cycle in
the human body is split into three main steps: pulmonary ventilation, external respiration
and internal respiration.
2.1.1 Pulmonary ventilation
Pulmonary ventilation is the mechanical process by which gases are exchanged between
the atmosphere and the lungs alveoli [28]. This process is controlled by the respiratory
and motor neurones in the brain and spinal cord. The respiratory neurones in the brain
are controlled by chemoreceptors (provide feedback on O2, CO2, and hydrogen ions in
the blood) and mechanoreceptors (provide feedback on mechanical aspects of breathing)
[29]. Depending on the feedback given by these receptors, the respiratory neurones excite
the motor neurone in the spinal cord which causes the contraction of the diaphragm, the
pectoral muscles and the external intercostal muscles [26]. This contraction results in the
enlargement of the anteroposterior and lateral diameter of the chest cavity. The expansion
of the chest cavity lowers pressure within the lungs triggering a pressure difference between
the air inside the body and air outside the body. Thus, allowing air to flow into the lungs
Figure 2.1: The inspiratory and expiratory stages of pulmonary ventilation [27].
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known as inspiration [30]. The inspired air flows from the nose into the pharynx, larynx,
trachea, bronchi and finally, into the lungs alveoli, where the gases exchange. This gas
exchange occurs through the process of diffusion (Section 2.1.2).
During normal breathing, the elastic recoil of the external intercostal muscles and the
diaphragm causes a decrease in the diameter of the chest cavity and an increase in alveolar
pressure. This creates a pressure gradient resulting in the flow of air out of the lungs [24].
However during forced breathing, the respiratory neurones cyclically excite the motor
neurones in the spinal cord, resulting in contraction of the abdominal muscles and the
internal intercostal muscles [26], causing a reduction in the diameter of the chest cavity
and increasing the pressure inside the lungs as shown in Figure 2.1. This creates a pressure
gradient resulting in the flow of air out of the lungs and is known as expiration.
2.1.2 External respiration
External respiration is the exchange of gases between the air in the alveoli and the blood
in the pulmonary capillaries surrounding the walls of alveoli [24]. Alveoli are microscopic
balloon-like structures made up of collagen and elastic fibres [31]. The elastic fibres help
alveoli to stretch as they are filled with air during inhalation. Each alveolus is surrounded
by a network of pulmonary capillaries as shown in Figure 2.2. The capillaries are made of
simple squamous epithelium, so there are only two cells between the air in the alveoli and
the blood in the pulmonary capillaries, which permits the efficient exchange of gases [32].
The gas exchange takes place by the process of passive diffusion.
Diffusion through tissue is described by Fick’s law, which states that the rate of transfer
of gas through a sheet of tissue is proportional to the tissue area and the difference in gas
Figure 2.2: Gas exchange occurs between alveoli and capillaries surrounding alveoli [33].
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partial pressure between both sides, and inversely proportional to the tissue thickness [32].
Air in the alveoli has a higher partial pressure of oxygen (PO2) and lower partial pressure
of carbon dioxide (PCO2). Blood being carried by the capillary network has higher PCO2
and lower PO2 [24]. This pressure gradient causes diffusion of O2 from alveoli into blood
and CO2 from the blood into alveoli. However, external respiration cannot be carried out
by diffusion in blood plasma alone, as gases are not particularly soluble in blood, which
is composed mostly of water. Thus, for efficient oxygen transport, a secondary transport
mechanism is required [34].
The compound “haemoglobin” (Hb) present in the red blood cells provides the necessary
binding mechanism that allows oxygen to be transported through the blood. Haemoglobin
(Heme = blood, Globin = polypeptide chain) molecules have a tetrahedral structure. Each
haemoglobin molecule consists of four iron (heme) atoms which can bind with four atoms
of oxygen accordingly [34]. In the oxygenated state, the molecule is called oxyhaemoglobin
(HbO2) and is bright red in colour, and in the reduced state, it is purplish blue and referred
to as deoxyhaemoglobin. Haemoglobins that are unable to bind to oxygen or interfere
with the ability of oxyhaemoglobin to release oxygen to the tissue are called dysfunctional
haemoglobins. The three most common dysfunctional haemoglobins are methaemoglobin,
carboxyhaemoglobin, and sulfhaemoglobin [26]
2.1.3 Internal respiration
Internal respiration refers to the exchange of gases between the blood in the systemic
capillaries and the tissue cells. The oxygenated blood from the lungs returns to the heart
via the pulmonary vein during external respiration. The heart pumps the oxygenated blood
to the rest of the body through systemic capillaries. The tissue surrounding the systemic
capillaries usually has lower PO2 and higher PCO2 , when compared to the oxygenated
blood [31]. Hence, oxygen diffuses into the surrounding tissue and carbon dioxide diffuses
into the blood. Once inside the cell, the oxygen is used for producing energy in the form
of adenosine triphosphate (ATP).
2.2 The Oxyhaemoglobin dissociation curve
The oxyhaemoglobin dissociation curve as shown in Figure 2.3 is an important tool for
understanding how readily haemoglobin acquires and releases oxygen molecules to the sur-
rounding tissue. The oxyhaemoglobin dissociation curve illustrates the equilibrium of oxy-
haemoglobin and deoxyhaemoglobin at various partial pressures [35]. The sigmoid shape
of the curve is due to the cooperative binding nature of haemoglobin. When haemoglobin
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Figure 2.3: Oxyhaemoglobin disassociation curve [37].
binds with one oxygen molecule, it has a greater affinity to bind with another oxygen
molecule. Consequently, when oxyhaemoglobin releases one oxygen molecule in the tis-
sue, it has higher propensity to lose another oxygen molecule. Hence, at high partial
pressures of oxygen, usually in the lungs, the red blood cells are saturated with oxygen
(oxyhaemoglobin). At areas of low partial pressures of oxygen such as tissue the oxy-
haemoglobin releases oxygen and becomes haemoglobin [26]. Factors such as decreased
carbon dioxide concentration, increased pH and decreased temperature will shift the curve
to the left. The left shifted curve indicates that haemoglobin molecules will be highly
saturated at a lower partial pressure of oxygen. A right shifted curve means there is a
reduced affinity between the haemoglobin and the oxygen [36].
2.3 Circulatory system
The circulatory system is a vast network of organs and vessels that is responsible for,
(1) efficient delivery of oxygen and vital nutrients required by the cells, (2) removal of
carbon dioxide and other waste products produced by the cells during cellular respiration.
For efficient delivery of oxygen, blood must travel through a series of vessels with enough
pressure. This is facilitated by the heart which acts as a pump [26]. Together, the heart
and the blood vessels form circulatory routes through which blood is carried around the
body. These routes are parallel and in most cases a portion of the cardiac output flows
separately to each tissue of the body so that each organ receives it’s own supply of freshly
oxygenated blood. The two main circulatory routes are the systemic circulation and the
pulmonary circulation [24].
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2.3.1 Heart
The heart is a dual muscular pump which supplies oxygen-rich blood to the whole body
and returns the deoxygenated blood to the lungs [38]. The heart consists of four hollow
chambers; the upper two chambers are called atria and the lower two are ventricles. In-
ternal valves present between the chambers help blood flow in one direction, preventing
backwards flow of blood. The closing and the opening of these valves make a thumping
sound - the ‘heart beat’ [23]. The sequence of events that occur when the heart beats
is known as a cardiac cycle as shown in Figure 2.4(b). This sequence is initiated by a
series of electrical impulses, originating from the sinoatrial node triggering the atria to
contract. This contraction causes the opening of atrioventricular (AV) valves and rushing
of blood into ventricles. These electrical impulses then pass through the atrioventricular
node into ventricular walls, stimulating ventricular contraction [31]. As the ventricular
contraction increases, the ventricular pressure causes the AV valves to close and opens the
semi-lunar valves. The closing of AV valves at this stage results in producing the first
heart sound ‘LUB’. The opening of the semi-lunar valves allows the blood to flow into the
pulmonary artery and the aorta. Once the ventricles start to relax the ventricular pressure
falls causing the semilunar valves to shut. This produces the second heart sound ‘DUB’.
Figure 2.4: (a) Stages in cardiac cycle. 1: relaxed heart, 2: atrial contraction, 3:
ventricular contraction, [39] (b) Circulatory routes that deliver blood to tissues of the
body [40].
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2.3.2 Blood circulation
When the heart contracts during the cardiac cycle, the blood from the heart flows to the
rest of the body through a network of blood vessels arranged in specific circulatory routes.
The two main circulatory routes are the systemic circulation and pulmonary circulation
[24]. The pulmonary circulation is the part of the circulatory system that transports
blood to and from the lungs for the uptake of oxygen and removal of carbon dioxide.
Deoxygenated blood from the right atrium is pumped into the right ventricle during atrial
contraction. From the right ventricle of the heart, the blood is then pumped out into
the pulmonary artery. The blood from the pulmonary artery travels through smaller
arterioles and eventually into arterial capillaries in the lungs, where the gas exchange
takes place between the alveoli and the capillaries [38]. The oxygenated blood from the
lungs is then returned to the left atrium, and to the body through the systemic circulation
(Figure 2.4(a)).
In the systemic circulation, the oxygenated blood from the left atrium is pumped into
the left ventricle during atrial contraction. The blood from the left ventricle then enters
the aorta during ventricular contraction. The aorta is the single systemic artery emerging
from the heart. By successive branching, the aorta gives rise to hundreds of arteries taking
oxygenated blood to all regions of the body [30]. Following the branching, the arteries
divide into numerous arterioles. In the target organs, they produce many capillaries. A
similar number of venules converge into each other forming veins of increasingly larger
size. Finally, only the two veins, the superior and the inferior vena cava return the blood
to the right atrium [30]. This unimpeded flow of blood to the body via the circulatory
networks is referred as perfusion, and the volume of blood that flows through a target
tissue is known as Tissue perfusion.
2.4 Significance of oxygen in human body
Oxygen is the key element for the survival of cells in the human body. Cells obtain
energy by oxidation of glucose to carbon dioxide and water in cellular respiration. This
energy is used in the regulation of tissue repair, growth, immune functions, and hormone
synthesis [41]. In the absence of oxygen, cells cease to function and eventually die leading
to malfunctioning of organs. At times when dead and degenerative cells cannot be replaced
with new cells, the toxins from dead cells poison surrounding cells [42]. This causes them
to mutate forming abnormal growths and increased susceptibility to infectious diseases.
Restriction of oxygen supply in the blood is known as hypoxemia [1]. This condition can be
caused by blockage of airways, intake of narcotics, stress, high altitudes, and diseases such
as anaemia, pulmonary oedema, sleep apnoea, and pneumonia. The primary symptoms
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of hypoxemia include shortness of breath, fatigue, confusion, pain in muscles and joints,
short term memory loss, etc., [43]. Also, chronic restriction of oxygen transport in the body
caused by a build-up of plaque in the arteries can lead to stroke and heart failure. With
increased amount of oxygen consumption, our bodies can reverse degeneration, stimulate
the immune system and promote healing. Thus, oxygen is essential for healthy function
of living organisms.
2.5 Pathologies due to impaired perfusion
Adequate perfusion is required for life. If an organ is not adequately perfused with sufficient
oxygenated blood, it cannot create enough energy to maintain its health and function. This
section describes some of the pathologies resulting from inadequate perfusion.
2.5.1 Circulatory shock
Circulatory shock represents a state of collapse and failure of the cardiovascular system
in which blood circulation decreases and eventually ceases [44]. Shock results from the
inadequate cardiac output. Therefore, any condition that reduces the cardiac output
far below normal will likely lead to circulatory shock. The two factors that severely
reduce cardiac output are (1) decreased ability of the heart to pump blood due to cardiac
abnormalities and (2) decreased venous return. The circulatory shock that results from
diminished cardiac pumping ability is called cardiogenic shock. Shock resulting from heavy
loss (20% or 1/5th) of the body’s blood is called hypovolemic shock or haemorrhagic shock
[45]. One of the key dangers of shock is that it progresses by a positive feedback mechanism.
Once shock begins, it tends to make itself worse, so immediate treatment of shock is critical
to the survival of the sufferer [46]. Almost 70% of the people who develop cardiogenic shock
do not survive.
2.5.2 Ischaemia
Ischaemia can also be described as an inadequate flow of blood to a part of the body, caused
by constriction or blockage of the blood vessels supplying it. It is an absolute or relative
shortage of the blood supply to an organ that can be caused due to conditions such as
tachycardia, atherosclerosis, hypotension, thromboembolism and foreign body embolism
[47]. Ischaemia may result in irreversible damage to highly aerobic tissues of the heart and
brain, in as little as 3-4 minutes at body temperature. Tissues with slower metabolic rates
may undergo irreversible damage after 20 minutes [48]. Without immediate intervention,
ischaemia may progress quickly to tissue necrosis and gangrene within a few hours.
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Restoration of blood supply to ischaemic tissues causes the production of free radicals and
reactive oxygen species that cause additional damage to the cells known as reperfusion
injury. This can be more damaging than the initial ischaemia. The restored blood flow
also exaggerates the inflammation response of damaged tissues, causing white blood cells
to destroy damaged cells that may otherwise still be viable [49].
2.5.3 Hypoxia
Hypoxia is defined as the deficiency in the amount of oxygen reaching body tissues. Hy-
poxia can be caused due to inadequate transport and delivery of oxygen, inadequate tissue
capabilities of using oxygen, venous to arterial shunts and hypoventilation [50]. Hypoxia,
if severe enough, can cause the death of the cells, but in less severe degrees it results
principally in depressed mental activity, sometimes culminating in a coma, and reduced
work capacity of the muscles [51].
2.6 Summary
The ability of the body to utilise oxygen has a direct impact on health. Oxygen present
in the air is inspired into the lungs during breathing. The inspired oxygen is diffused into
the blood with the help of haemoglobin. The blood then supplies oxygen to every cell in
the body with the help of the cardiovascular system. The cells receive oxygen and convert
it into the energy required to carry on processes essential for living. Failure in any of
these processes can lead to cell death and may eventually cause organ failure and death.
Oxygen saturation levels in the human body is a direct indicator of good health. Oxygen
starvation in the human body leads to build up of acids in muscles, poor digestion, and
dizziness. Hence, it is imperative to measure oxygen levels in critically ill patients with
low blood flow states. There are several techniques for measuring oxygen levels in the
body and these are discussed in the next chapter.
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— For life, nothing is more impor-
tant than oxygen supply. Thus,
one might argue that nothing is
more important to monitor the care
of the unconscious or disabled pa-
tient than the colour of the arterial
blood.
John W. Severinghaus, and Poul
B. Astrup - J Clin Monit 1986;
270-288
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A review of oxygen measurement technologies
Adequate oxygen supply to the body’s tissues is required for normal body function. Knowl-
edge of oxygen level in the blood could help assess a person’s health and overall well-being.
Blood oxygenation is the measure of oxygen present in arterial or venous blood. Tissue
oxygenation is the measure of oxygen present in the vascular tissue (i.e. measuring O2 in
microvascular bed). Blood oxygenation assesses how well oxygen binds to haemoglobin,
indicating adequacy of pulmonary gas exchange. Tissue oxygenation indicates adequacy
of tissue perfusion and is primarily determined by local oxygen delivery, particularly blood
flow.
Oxygen levels in the blood or tissue can be measured using chemical, optical or colori-
metric techniques. Some methods determine blood oxygenation by measuring the partial
pressure of oxygen (PO2) in blood and others by measuring oxygen saturation (SO2) [26].
‘Oximetry’ is the general term used to refer to optical methods of measuring oxygen levels,
and is most often used in clinical environments. In oximetry, the level of oxygen in arterial
and venous blood is indirectly determined by measuring the arterial oxygen saturation
(SaO2) and the venous oxygen saturation (SvO2) [43]. Oxygen levels measured in tissue
are determined by measuring the tissue oxygen saturation (StO2) or the tissue oxygenation
index (TOI). Figure 3.1 shows the taxonomy of oxygenation measurement in blood and
tissue. It is not within the scope of the thesis to explain all the methods used to measure
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Galvanic electrode Polanyi and Hehir (1962)
CO Oximeter
Spectrophotometers Millikan ear Oximeter
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Catheter Oximeter
HP 8λ ear oximeter
Pulse oximeter
Near infrared spectroscopy
Figure 3.1: Taxonomy of the field of oxygenation measurement (Redrawn from [52]).
oxygen in the body. Hence, a few key methods that are commonly used in clinical envi-
ronments are described in the chapter. The first section of the chapter describes one of the
most commonly used chemical methods of determining tissue oxygenation, and the rest of
the chapter discusses, optical techniques used to determine blood and tissue oxygenation.
3.1 Clark’s electrode
Clark’s electrode is an electrochemical oxygen sensor most commonly used to determine
the partial pressure of oxygen in arterial blood. It is widely used in blood gas analysers,
which use a variety of electrodes to measure pH, PO2 and PCO2 in small samples of blood
[26]. Clark’s electrode uses the basic principles of oxidation and reduction to measure
PO2 in a solution. This sensor is categorised as an amperometric sensor and requires an
external polarising bias voltage source of about 0.6 V. As shown in Figure 3.2, the sensor
consists of silver (anode) and platinum (cathode) electrodes connected to the positive and
negative side of a voltage source, immersed in potassium chloride electrolyte. The cathode
is made from noble metals such as platinum or gold so that the electrode surface does not
participate in the chemical reactions. When oxygen is dissolved in the potassium chloride
15














Figure 3.2: Principle of operation of Clark electrode (inspired from [56]).
solution and exposed to the bias voltage, the following reaction occurs,
At the cathode : O2 + 2H2O + 4e
− = 4OH− (3.1)
At the anode : Ag + Cl− = AgCl + e− (3.2)
In the electrolyte : NaCl +OH− = NaOH + Cl− (3.3)
Electrons are taken up at the cathode and the current generated is directly proportional
to the O2 molecules reduced at the surface of the cathode (i.e., the amount of PO2 in the
solution) [53],[54],[55]. The actual sensor is arranged in a cylindrical fashion, and is used
to measure PO2 of blood solutions in vitro, and when miniaturised, can be attached to the
end of the catheter and placed inside an artery to provide in vivo measurement [55].
3.2 Spectrophotometry
Spectrophotometry is an optical technique used to measure the concentration of any trans-
parent substance in a solution. It is the basis for all oximetry techniques. A spectropho-
tometer usually consists of a light source, a monochromator, a cuvette, a photodetector
and an amplifier as shown in Figure 3.3. Wide bandwidth incandescent light is passed
through the monochromator to produce a single-wavelength beam of choice [57]. The
monochromator can consist of either a prism, a diffraction grating, or a narrow-bandwidth
filter. Monochromatic light is then passed through a cuvette of known path length con-
taining the substance under test. A portion of this light is transmitted through the sample
and the rest is absorbed by the sample. The transmitted light is detected by the photode-
tector on the other end of the cuvette [1]. The photodetector converts detected light into
an electrical current proportional to the intensity of the light detected. The concentration
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Figure 3.3: Block diagram of a single beam spectrophotometer [58].
of a light-absorbing substance in a solution is then determined by the spectrophotome-
ter using the Beer-Lambert law [57]. According to Beers’s law, when a monochromatic
light of intensity I0 enters a sample, a part of the light is transmitted through the sample
while another part is absorbed. The intensity I of light transmitting through the medium
decreases exponentially with distance. This relationship is given as
I = I0 e
−ε(λ).c.d (3.4)
Where ‘ε(λ)’ is the extinction coefficient of the absorbing substance at a specific wave-
length, ‘c’ is the concentration of the absorbing substance which is constant in the medium,
and d is the optical path length through the medium. The transmittance of light travelling
through the medium is defined as the ratio of transmitted light (I ) to incident light (I0)
[1].




As each molecule in the solution absorbs light equally, the absorbance of the substance
is linearly related to the concentration of substance in the sample and is defined as the
negative logarithm of transmittance
Absorbance (A) = − ln(T ) = ε(λ).c.d (3.6)
Beer’s law can be applied to a medium containing more than one absorbing substance.
The total absorbance of the sample is given by the sum of n independent absorbances.
At = ε1(λ).c1.d1 + ε2(λ).c2.d2 + ......+ εn(λ).cn.dn (3.7)
As mentioned earlier, spectrophotometers are used for determining the concentration of
any transparent substance in a solution. However, in a clinical setting, they are used
to measure the concentration of oxygen in the blood. The concentration of oxygen in
the blood can only be measured if the chemical and light absorbance properties of blood
are known [26]. The chemical and light absorbance characteristics of blood depend on
haemoglobin present in red blood cells. The absorbance properties of haemoglobin change
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with its chemical binding and the wavelength of the incident light. The following subsec-
tions describe how haemoglobin binds with different chemicals in blood and also explains
how each of these different haemoglobins absorb incident light at different wavelengths.
3.2.1 Chemical binding of haemoglobin
As described in Section 2.1.2, haemoglobin binds with oxygen in the alveoli during external
respiration. In the oxygenated state the molecule is called oxyhaemoglobin (HbO2) and is
bright red in colour. In the reduced state (i.e., when the oxygen in the blood is diffused to
the cells) the molecule is referred to as deoxyhaemoglobin (Hb). These haemoglobins that
can bind reversibly with molecular oxygen are called functional haemoglobins. Although
oxygenated and reduced haemoglobin make up most of the blood content in the body, they
do not represent the only haemoglobin species present in human blood [59]. Haemoglobin
may also combine with other substances such as carbon monoxide or hydrogen sulphide
as well. Haemoglobins that are unable to bind to oxygen or interfere with the ability of
oxyhaemoglobin to release oxygen to the tissue are called Dysfunctional haemoglobins [1].
The two most common dysfunctional haemoglobins are:
• Methaemoglobin (MetHb): Methaemoglobin is oxidised haemoglobin and is the
result of oxidation of a free heme ion (Fe2+). MetHb levels may be high congenitally
or as a result of exposure to a number of agents, most notably anaesthetics, sulpha
drugs, and nitrites. In healthy individuals, the amount of methaemoglobin remains
under 0.6% [1].
• Carboxyhaemoglobin (COHb): This is formed when haemoglobin combines with
carbon monoxide (CO). The affinity of Hb binding with CO is approximately 210
times larger than that of oxygen [60]. Therefore, the presence of a high level of CO
will reduce the amount of oxygenated Hb significantly. Smoking increases the level
of COHb, but normal levels are below 2%. Inhalation of CO from fires can cause a
dangerous or fatal rise in COHb concentration [61].
3.2.2 Haemoglobin absorption spectra
Haemoglobin and its variants have specific characteristics for light absorption. Each has its
own pattern of absorption over a range of wavelengths. This is due to different chemical
bonding characteristics of haemoglobin. Figure 3.4 shows the extinction coefficients of
oxyhaemoglobin, reduced haemoglobin, methaemoglobin and carboxyhaemoglobin in the
red and near-infrared region. The absorbance of light in the red region of the spectrum is
much higher for reduced haemoglobin than for oxyhaemoglobin. The extinction coefficients
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Figure 3.4: Extinction coefficients of the four most common haemoglobin species -
oxyhaemoglobin, deoxyhaemoglobin, carboxyhaemoglobin and methaemoglobin - in the
visible and near-infrared regions [26].
of both haemoglobin species are equal at the isobestic point (805 nm) [62]. The reduced
haemoglobin is more transparent to light in the infrared region of the spectrum than the
oxyhaemoglobin. The extinction coefficient of carboxyhaemoglobin is about the same as
that of oxyhaemoglobin in the red region while it is almost transparent in the infrared
band. Methaemoglobin absorbs much light in the red region of the spectrum and its
extinction coefficient remains higher than that of oxyhaemoglobin in the infrared region
[63]. Using these optical properties of blood, the concentration of all the haemoglobin
species in a sample of blood can be determined using a spectrophotometer. If the absolute
concentrations of different haemoglobin species in a sample of blood are known then, the
functional and fractional oxygen saturation of the sample can be calculated easily. The
functional oxygen saturation is measured as a percentage and is defined as the ratio of
oxyhaemoglobin (CHbO2) concentration to the sum of concentrations of oxygenated and





The fractional oxygen saturation is the measured as a ratio of the concentration of oxy-
genated haemoglobin to the concentration of total haemoglobin [1].
Fractional SO2 =
CHbO2
CHb + CHbO2 + CCOHb + CMetHb
× 100% (3.9)
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3.3 CO-Oximeters
CO-oximeters are spectrophotometers specially designed to analyse the concentrations
of four most common species of haemoglobin in blood; oxyhaemoglobin, reduced
haemoglobin, carboxyhaemoglobin, and methaemoglobin. CO-oximeters are very accu-
rate and are considered the “gold standard” method for measuring haemoglobin species
[1]. A CO-oximeter analyse small samples of arterial blood collected in a heparinized sy-
ringe. Samples are collected in a heparinized syringe to prevent clotting of the blood. The
blood sample is inserted into the sample port of a CO-oximeter and then transported into
a cuvette which is regulated at 37◦ C. The blood sample is then haemolysed (red blood
cell membranes removed) to reduce the amount of light scattering. This is to increase
the accuracy of the measurement [26]. Scattering is reduced in a haemolysed sample as
the haemoglobin molecules are distributed evenly throughout the blood sample instead of
being localised in red blood cells.
Light from a halogen lamp is transmitted by two different pathways within the instru-
ment, and two measurements sensors are used. One pathway is the transmission of light
directly from the source to the detector. This measurement provides a reference value for
the intensity of light transmitted. The second light pathway is from the source, through
the blood sample, and into the sensor. This pathway is used to measure the intensity of
unabsorbed light by the sample. In modern CO-oximeters, the unabsorbed light before
reaching the photodiode is split into 128 different wavelengths using a concave diffrac-
tion grating [65]. However, in the most basic mode, the instrument uses data from four
wavelengths to calculate the concentrations of the four most common Hb species:
CHb = K[εHb(λ1)A1 + εHb(λ2)A2 + εHb(λ3)A3 + εHb(λ4)A4] (3.10)
CHbO2 = K[εHbO2(λ1)A1 + εHbO2(λ2)A2 + εHbO2(λ3)A3 + εHbO2(λ4)A4] (3.11)
CCOHb = K[εCOHb(λ1)A1 + εCOHb(λ2)A2 + εCOHb(λ3)A3 + εCOHb(λ4)A4] (3.12)
CMetHb = K[εMetHb(λ1)A1 + εMetHb(λ2)A2 + εMetHb(λ3)A3 + εMetHb(λ4)A4]
(3.13)
Where Cx is the concentration of Hb species ‘x’. εx(λ1) is the extinction coefficient of
haemoglobin type x at the first wavelength, A1 is the absorbance value of blood at the
first wavelength and K is a constant set by the calibration procedure. Total haemoglobin
concentration, fractional oxygen saturation and functional oxygen saturation of blood
sample are measured by the instrument using the measured haemoglobin concentration
values [1]. Although CO-oximeters provide a very accurate in vitro measurement, they
have the disadvantage that every time a measurement is required, a blood sample must
be taken and the readings obtained apply only to the instant in time in which the blood
is withdrawn.
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3.4 Optical fibre venous oximetry
Fibre optic venous oximetry is an in vivo, catheter-based oximetry technique used to mea-
sure continuous blood oxygen saturation in critically ill patients. This technique measures
oxygen levels in venous blood instead of arterial blood. Oxygen saturation measured from
the arterial blood indicates how well the body is perfused with oxygenated blood. While
oxygen saturation measured from mixed venous blood reflects the amount of O2 left over
in the blood, after the uptake of O2 by tissue [66]. Hence by measuring venous oxygen
saturation (SvO2) of a hemodynamically unstable patient in ICU, the balance between
oxygen delivery and consumption at the tissue level, can be monitored. The normal range
for SvO2 is 60 - 80 %. If the SvO2 value is normal, there is sufficient oxygen supply avail-
able to the tissues. However, if the SvO2 value is low, then either the oxygen supply is
insufficient or the oxygen demand is elevated. Regardless of the cause, a decrease in SvO2
indicates that the body has called upon its last line of defence to preserve oxygen balance
and in these cases therapeutic interventions may be appropriate [67].
SvO2 = Oxygen Delivery (SaO2)−Oxygen Consumed (vO2) (3.14)
SvO2 values are usually only measured in the pulmonary artery. This is to allow for
adequate mixing of venous blood returning to the right side of the heart from the superior
and inferior vena cavae and the coronary sinus [68].
SvO2 is measured by a multi-lumen tube (catheter), made of flexible plastic with a number
of channels. The distal end of the catheter consists of a small inflatable balloon and a
thermistor, used to measure cardiac output. Running along the distal end of the catheter
(a) Catheter in the pulmonary artery of the heart (b) Venous oxygen saturation measurement system
Figure 3.5: Venous oxygen saturation is measured from the pulmonary artery of the
heart using reflection spectroscopy [68].
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is a pair of optical fibres, used for venous oxygen saturation measurements (Figure 3.5(a)).
The technology used to measure SvO2 is based on reflection spectrophotometry [69]. This
involves transmitting light of selected wavelength through one of the fiber-optic filaments
to the blood flowing past the catheter tip and detecting the reflected light back using the
other fiber-optic filament. The detected light is converted into an electrical signal using
the photodetector located in the optical module (Figure 3.5(b)). Since haemoglobin and
oxyhaemoglobin absorb light differently at the selected wavelengths, the reflected light can
be analysed to determine the percent SvO2. Although continuous oxygen measurement
is possible using optical fibre venous oximetry, it requires the placement of a pulmonary
artery catheter, which is an invasive procedure with the possibility of numerous complica-
tions [68].
3.5 Pulse Oximetry
Pulse oximetry is a non-invasive optical technique used to monitor continuous arterial oxy-
gen saturation in human vascular tissue. There is no doubt that pulse oximetry represents
the greatest advancement in patient monitoring in recent years. By virtue of its ability to
quickly detect hypoxaemia, it has become the standard of care during anaesthesia as well
as in the recovery room and intensive care units. It was invented by Takuo Aoyagi in 1974
[26]. Pulse oximeters determine the oxygen saturation of arterial blood by measuring the
light absorbance of living tissue at two different wavelengths and use the arterial pulsation
to differentiate between the absorbance of arterial blood and other absorbers such as skin,
melanin, venous blood, etc., [70]. The two wavelengths typically used are 660 nm and
940 nm, but other wavelengths could be used. The absorbance of light by tissue at both
wavelengths is recorded as a voltage signal known as the photoplethysmograph (PPG) [71].
The photoplethysmograph consists of two main components, an AC pulsating component
Figure 3.6: A portable fingertip pulse oximeter [26].
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(refers to absorption during arterial pulsation) and a DC component (refers to the ab-
sorption of venous blood and other absorbers). The saturation values obtained in-vivo by
the pulse oximeter is often abbreviated SpO2 to differentiate it from the saturation value
obtained in-vitro from haemolysed arterial blood by a CO-oximeter (SaO2). SpO2 values
in healthy individuals are between 95% and 100% [72]. Pulse oximeters are empirically
calibrated by the manufacturers using data obtained from a large group of healthy human
volunteers. Pulse oximeters possess many advantages over previous technologies. They
are non-invasive, continuous, does not require calibration, are accurate, relatively mobile
and convenient to use [73]. A detailed description of the technology and its application is
described in Chapter 4.
3.6 Near infrared spectroscopy
Diverse optical systems used for measuring blood oxygenation have been discussed in this
chapter so far, this section depicts a non-invasive method for measuring tissue oxygenation
in the body. Near-infrared spectroscopy (NIRS) is one of the commonly used optical
techniques to provide a regional quantification of tissue oxygenation in the body. NIRS
was first invented by F.F Jobsis in 1977 and since then many groups around the world have
refined and amended the technique [74]. NIRS systems can be connected to any vascular
part of the body for instance on the muscles to gauge the oxygen uptake. However, the
technique is predominantly utilised in quantifying the oxygenation status of the brain
tissue [75].
The basis of NIRS relies upon two main principles: (1) that tissue is relatively transparent
to light in the near infrared region (i.e., 700 - 1100nm) and (2) that there are compounds
in the tissues whose absorption of light varies with oxygenation (e.g. HbO2, Hb, CytOx)
and have characteristic absorption spectra (Figure 3.4). The concentrations of these com-
pounds are likely to change rapidly during alterations in tissue perfusion and oxygenation
[76].
3.6.1 Modified Beer-Lambert law as used in NIRS
NIRS provides tissue oxygenation measure by monitoring in-vivo changes of the oxygen
saturation of haemoglobin molecules in the body, based on the absorbance of near-infrared
light by haemoglobin [77]. The concentrations of haemoglobin variants are then determined
using the Beer-Lambert law (Equation 3.6). However attenuation of light energy in tissue
due to absorption (20%) is relatively low compared to the scattering of light (80%), and
it is the scattering effect which causes the light to travel further than the straight line
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DPF = 1 DPF > 1
Figure 3.7: Illustration showing the path length of light photons in a clear and scattering
medium. The actual light path of photons increases due to scattering (inspired from [76]).
between the source and the detector as shown in Figure 3.7 [78]. Besides being the major
cause of light attenuation in tissues, Beer’s law does not take into account scattering
while deriving the concentration of different chromophores. The increase in the distance
travelled by each photon because of scattering introduces an additional factor known as
differential pathlength factor (DPF) to Beer’s law [79].
A = ε(λ).c.d.DPF +G
(
DPF =




Where DPF is the ratio of mean optical path length to the straight line distance between
the source and the detector, and G expresses the attenuation due to scattering. DPF is
generally derived from studies in healthy adults and is assumed to be constant. In reality,
the value varies from individual to individual. Values for DPF in different tissues and
patient age groups are in the public domain [80–82].
3.6.2 Deriving tissue oxygenation using NIRS
The algorithms used by NIRS systems to derive tissue oxygenation vary from manufacturer
to manufacturer but the essential features and the physical principles are common across
all commercially available NIRS systems [74]. Near infrared light generated at two or
more wavelengths by laser diodes is directed into vascular tissue and the attenuated light
is detected by a silicon photodiode placed several cm away from the light source. The
wavelengths used are a mix of wavelengths around the isobestic point of the haemoglobin
absorption spectrum (Figure 3.4), such as 770/830, 760/840 and 690/900 nm [83]. The
changes in light attenuation are converted into chromophore concentrations by an inbuilt
computer. Two distinct methods are commonly used in handling the data conversion. The
two methods are the relative quantification method or continuous wave method and the
absolute concentration quantification method.





















(b) Frequency domain NIRS
Figure 3.8: Schematic presentation of the two main categories of quantitative NIRS
(inspired from [76]).
Continuous wave (CW) NIRS instruments are the earliest and the most common com-
mercial NIRS devices. In the continuous wave method, the absolute concentrations of
haemoglobin are not measured, as the loss of light due to tissue scattering (G) is not
known [79]. The scattering factor ‘G’ is dependent upon the measurement geometry and
the scattering coefficient of the tissue. Therefore, CW-NIRS assumes that G does not
change during the measurement period and determines the change in concentration of a
chromophore (∆c) from the change in attenuation (∆A) [78]. The change in absorption
of haemoglobin variants is given by
(∆A) = (∆c).ε(λ).d.DPF +∆G; where ∆G = 0 (3.16)
A ratio of light absorption by oxyhaemoglobin and haemoglobin is then used to calculate
the mean tissue oxygen saturation. Thus avoiding quantification of change in haemoglobin
concentrations. CW-NIRS is only fit to do oxygenation trend monitoring. However, over
the years several methods to quantify the changes in concentrations of chromophores were
investigated. One such method regularly used by commercial NIRS devices is spatially
resolved spectroscopy (SRS) [84].
The second category of NIRS equipment allows full quantification of changes in chro-
mophore concentration and maximises the potential of tissue spectroscopy. The NIRS
devices using the absolute quantification technique can be classified into two main groups
- (1) Time domain NIRS instruments, (2) Frequency domain NIRS devices. In time-
domain NIRS measurements, the tissue is illuminated with ultrashort light pulses (2ps),
and variations in received light intensity are measured with respect to time (as shown in
Figure 3.8) [79]. From these variations, the actual distance travelled by the light photons
is calculated. Since the absorption of the light, the distance and the extinction coefficient
are known, the concentration of oxyhaemoglobin and haemoglobin can be calculated. For
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known concentrations of HbO2 and Hb, the tissue oxygenation index TOI is given by




In frequency domain NIRS measurements, the light source is modulated to a frequency of
100-200 MHz, and the relationship between the amplitude and the phase of the incident
and the detected light (the optical frequency response of the tissue) is measured [85]. Using
the measured phase shift, the actual path length is calculated. From these measurements,
the concentration of haemoglobin variants and the tissue oxygenation is measured.
3.7 Summary
Oxygen levels in the human body can be measured using chemical, optical and calorimetric
techniques. Oximetry is the general term used to refer to optical measurement techniques.
Spectrophotometry is the basis of all the oximetry techniques. CO-oximeters are spe-
cially designed spectrophotometers used to determine the concentrations of Hb species in
blood. Tissue oxygenation can be measured by near infrared spectroscopy. Other optical
techniques for monitoring blood oxygen level include optical fibre venous oximetry, pulse
oximetry, etc. Pulse oximetry is the safest, efficient, and reasonably accurate method for
measuring arterial oxygen saturation. A detailed description of this technique is given in
next chapter.
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— The clinical applications of pulse
oximetry in medicine are as impor-
tant as oxygen is to life. This may
seem an overstatement, but as more
and more pulse-oximeters are com-
ing into use, more and more hypox-
aemic events are being seen as pre-
cursors of pathological events
John TB Moyle - Pulse oximetry,
1994
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Theory of Pulse Oximetry
Blood oxygenation is determined by measuring the partial pressure of oxygen (PO2) in
blood or by measuring oxygen saturation (SaO2). There are various methods for measur-
ing oxygen levels in the body as discussed in Chapter 3. Pulse oximetry is one of the most
convenient non-invasive and accurate techniques for measuring arterial oxygen saturation.
The fact that this non-invasive technology measures SpO2 continuously without the need
for calibration has made it a standard for monitoring blood oxygenation status in critical
care. Takuo Aoyagi first developed the pulse oximeter in 1974 using a combination of
transmission oximetry and photoplethysmography [86]. Pulse oximeters provide a robust
measure of SpO2 by shining light into the vascular tissue, and measuring the changes in
light absorbance produced during arterial pulsations. These changes in light absorbance
during arterial pulsations are measured as a voltage signal known as a photoplethysmo-
graph.
This chapter describes the theoretical background of the principle of pulse oximetry. The
principle of photoplethysmography and its application in pulse oximetry are also discussed
in this chapter to highlight how the pulsatile arterial blood can be differentiated from
venous blood and miscellaneous tissue. The light absorbance properties of blood and the
modified Beer-Lambert law as used in pulse oximetry are also explained in this chapter,
before discussing how current commercial pulse oximeters are calibrated for estimating
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SpO2. Finally, a brief review of the type of optical components used in modern pulse
oximeter sensors, and the sensor design configurations are discussed in the chapter.
4.1 Photoplethysmography
Photoplethysmography is a non-invasive optical technique widely used in the study and
monitoring of pulsations associated with changes in blood volume in the peripheral vas-
cular bed [87]. It has a widespread clinical application, with the technology being utilised
in commercially available medical devices, for example in pulse oximeters, vascular di-
agnostics and digital beat-to-beat blood pressure measurement systems [88]. Although
this technique has been used for many years, there are still disagreements about how
the information collected arises in the photoplethysmographic signal and there are some
doubts and fundamental misconceptions associated with the method [87]. It is generally
accepted, however, that PPGs can provide valuable information about the cardiovascular
system [89].
4.1.1 Principle of photoplethysmography
When light transilluminates vascular tissue, the emitted light is reflected, scattered and
absorbed in the tissue and blood. The intensity of light absorbed or reflected varies
with arterial pulsations (heart’s pulsations). These variations are due to the transmitted
light intensity corresponding directly to the cardiac cycle and can be detected using a
photodetector. This is the principle on which photoplethysmography is based [90].
It is possible for the tissue to directly transilluminate vascular tissue by placing the light
source on one side of the skin and the photodiode on the other. This mode known as
the transmission mode is limited to areas such as the finger, the ear lobe or the toe
[26]. However, when the light is directed down into the skin, a proportion of the light is
backscattered so that it emerges from the skin adjacent to the light source. This reflected
light can be detected by placing the photodetector next to the light source. This mode
is called the reflection mode which, allows measurements on virtually any vascular tissue
[64], [90]. The intensity of the reflected and backscattered light which reaches the pho-
todetector in either reflection or transmission mode is measured and the variations in the
photodetector current are assumed to be related to blood volume changes underneath the
probe. These variations are electrically amplified and recorded as a voltage signal called
the photoplethysmograph (PPG) (Figure 4.1) [91].
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Figure 4.1: Absorbed and transmitted light in living tissue. The amount of absorbed
light correlates with the pulsation of arterial blood (illustration inspired from [92])
4.1.2 Photoplethysmographic waveform
The photoplethysmographic waveform is divided into two components. A pulsatile AC
component synchronous with the cardiac cycle and a slowly varying DC component with
a magnitude that is determined by the nature of the material through which the light
passes (skin, cartilage, venous blood, etc.) (Figure 4.1). The amplitude of the pulsatile
component varies with the pumping action of the heart. As the volume of blood in ar-
teries and the arterioles starts to increase during systole, the proportion of incident light
absorbed also increases. Conversely during diastole, the light absorption decreases with
a decrease in blood volume, creating a rapidly alternating signal. These excursions in
light absorption typically account for 1-2% of the total light absorption [93]. However,
this is not entirely due to the increase in blood volume during systole, if it were, then the
variation in absorption during the cardiac cycle would be very much less [1].
Examination of fluid mechanics of blood by D’Agrosa and Hertzmen in 1967 has shown
that the orientation of red blood cells in blood changes during the cardiac cycle, thereby
Tissue surface
Tissue surface




Figure 4.2: Erythrocytes changing their axis during cardiac cycle (inspired from [52])
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presenting a greater absorption path length [94]. As shown in Figure 4.2, during diastole,
the cells are less densely grouped and are rotated such that their long axes are parallel to
the direction of flow. At systole, the cells are packed tightly together and are orientated
such that their long axes are perpendicular to the direction of flow, hence increasing the
optical path length and thereby absorption [95]. The AC PPG signal can be extracted
using a band-pass filter (typical bandwidth 0.5 Hz to 20 Hz) [87]. The AC PPG pulse
shapes are indicative of vessel compliance and cardiac performance. The DC component
includes the absorption due to still arterial blood, venous blood, and other tissues and
constitutes up to 99% of the total light absorption. The DC component varies slowly due
to respiration, vasomotor activity and vasoconstrictor waves, and thermoregulation. This
DC component may be extracted using a low pass filter (typical bandwidth DC 0.5 Hz)
[70].
4.1.3 Photoplethysmography in pulse oximetry
Pulse oximetry is the most recognised application of photoplethysmography. Pulse oxime-
ters measure SpO2 using PPG signals obtained at two different wavelengths in living tissue
[96]. The two wavelengths typically used are 660 nm (in the red part of the visible spec-
trum) and 940 nm (in the infrared part of the spectrum) but other wavelengths could be
used. The light absorbance of oxygenated haemoglobin and deoxygenated haemoglobin at
these two wavelengths is different. Therefore, the amplitudes of the red and infrared AC
PPG signals are different and are sensitive to changes in arterial oxygen saturation. From
the ratios of these amplitudes and the corresponding DC photoplethysmographic compo-
nents, SpO2 is estimated. Hence, the technique of pulse oximetry relies on the presence of
adequate peripheral pulsations, which are detected as photoplethysmographic signals [93].
Therefore, for pulse oximeters to accurately estimate SpO2, PPG signals of high quality
and high signal to noise ratio (SNR) are required.
4.2 Pulse oximetry
Pulse oximeters can measure arterial oxygen saturation from any vascular tissue in the
body. It is based on two physical principles:
• The light absorbance of oxygenated haemoglobin is different from that of reduced
haemoglobin, at the two wavelengths used in pulse oximetry.
• The pulsatile nature of arterial blood results in a waveform in the transmitted signal
that allows the absorbance effects of arterial blood to be identified from those of
non-pulsatile venous blood and other body tissue.
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Figure 4.3: The Nihon Kohden OLV-5100, the first commercially available pulse oxime-
ter, with ear-probe [68].
4.2.1 Evolution of Pulse oximetry
The oxygen-carrying blood pigment - ‘haemoglobin’ (Hb), was first discovered by a Ger-
man chemist known as Friedrich Ludwig Hu¨nefeld in the early nineteenth century. The
evolution of pulse oximetry has begun when this pigment was first reported to change
colour when mixed with oxygen by Hoppe-Seyler and George Gabriel Stokes. This discov-
ery led to the development of the first tissue oximeter. Ludwig Nicolai and Kurt Kramer
made the first steps towards modern oxygen saturation measurement in 1931 [97]. Using
an incandescent light and a barrier photocell they made the first report of precise oxy-
gen saturation measurement of blood both in cuvettes and flowing blood in 1934. Using
Kramers work, a German physician known as Karl Matthes produced the first oximeter
to measure continuous oxygen saturation in humans, by transillumination of the ear [86].
The next significant development came during the Second World War in 1939 when Glenn
Millikan a British scientist designed the first lightweight and practical aviation ear oximeter
for aircraft pilots and incidentally coined the term ‘Oximeter’ [98]. Building on the work
done by Millikan, a surgeon and inventor Robert Shaw developed an eight wavelength
ear oximeter in 1964. Eight wavelengths of light were passed through tissue and the
oxygen content was calculated from the differential absorption of the various wavelengths
during the experiment conducted by him. It was later observed that there was a pulsatile
change in light absorption in tissues during each cardiac cycle, attributable to the arrival
of arterial blood in the capillaries. This marked the evolution from tissue oximetry to
pulse oximetry. However due to its expense and the large size of the ear piece, it was
seldom used for clinical monitoring [99].
Aoyagi and co-workers achieved the next breakthrough in 1974 with the development of
the non-invasive pulse oximeter (Figure 4.3). Aoyagi found that arterial oxygen saturation,
rather than tissue oxygen saturation, could now be obtained by measuring light absorption
at the peak and trough of a pulse and cancelling that which was common to both, leaving
the pulsatile arterial component [100]. This new device developed by Nihon Kohden
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used filtered light sources similar to Millikans ear oximeter. The device was evaluated
clinically in the mid-1970s and marketed with little success. A competing pulse oximeter
was introduced by the Minolta Co, marketed in the United States as the Oximet MET-
1471 in 1977 with a fingertip probe which was connected to the instrument using optical
fibres. This device was found to overestimate oxygen saturation during clinical testing
[99].
The first clinically approved pulse oximeter was developed by Biox Corporation of Boul-
der, Colorado [100]. Their device used light emitting diodes (LEDs) as light sources and
photodiodes as photodetector instead of optical fibres. The saturation estimates were also
improved by using a digital microprocessor to store a complex calibration algorithm based
on human volunteer data. This device immediately became popular with neonatologists
and anaesthetists achieving widespread use in these fields by the 1980s. Non-invasive pulse
oximetry is now an indispensable and mandatory tool for the monitoring of patients in
these clinical areas, as practitioners may be considered negligent if they fail to use it, by
the American Society of Anesthesiologists [101].
4.2.2 Choice of wavelengths in pulse oximetry
Pulse oximeters determine arterial oxygen saturation from the ratio of the absorption
(ROS) of the light energy at two wavelengths. The two most commonly used wavelengths
are 660 nm and 940 nm [103]. The choice of wavelengths is based on three main criteria.
First, at chosen wavelengths (λ1 and λ2) the difference in absorption between Hb and
HbO2 should be the greatest. Second, one of the chosen wavelengths should mostly be










































Figure 4.4: Absorption spectra of Hb and HbO2 at the wavelengths of interest in pulse
oximetry (plotted using data acquired from [102])
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absorbed by HbO2 and the other by Hb. Finally, the absorption spectra around the chosen
wavelengths should be relatively flat [104].
Figure 4.4 depicts the absorption of Hb and HbO2 across a portion of the visible and near
infrared electromagnetic spectrum. It can be seen in Figure 4.4 that Hb and HbO2 have
different absorption across the entire portion of the spectrum except at 805 nm, termed the
isobestic point. Below the isobestic point, absorption is principally due to Hb, while above
the isobestic point most absorption is due to HbO2 [105]. The absorption between Hb and
HbO2 is greatest at 660 nm below the isobestic point, thus, absorption measured at this
wavelength will be largely proportional to the concentration of Hb. At any wavelengths
below 600nm, skin pigment melanin absorbs light sharply. Above the isobestic point, the
difference is greatest above 970 nm, however from 950nm and upwards the water in the
tissue absorbs light, making use of these wavelengths unviable. At 940 nm, absorption
by water is sufficiently low, and both the Hb and HbO2 absorption curves are relatively
flat [106]. Another compelling reason for the choice of 660nm and 940nm is the common
availability of LEDs at these wavelengths.
4.2.3 Manipulating Beer-Lamberts law for use in pulse oximetry
As mentioned in Section 3.2, the absorption of light at any given wavelength in tissue can
be determined by using Beer-Lambert Law. According to Beers Law, the absorbance of
a substance in a medium is linearly proportional to the concentration of the substance,
extinction coefficient and the optical path length. For the absorbance to be linearly related
to the concentration, optical distance and absorptivity, the medium must be homogeneous.
However, when determining the absorption of blood using pulse oximetry, this is not a
good assumption, as blood is not homogeneous [107]. Recalling Equation 3.6 and 3.7, the
relation between absorption, transmittance and the original intensity (I0) is given by




Where absorbance of the tissue can only be determined if the intensity of the detected
light and the original intensities of transmitted light are known. But the intensity of the
original incident light is very difficult to determine accurately as not all the LEDs in a single
batch from a factory emit the same intensity. Moreover, LEDs are not monochromatic
as their intensity is spread over a spectrum of wavelengths. Hence to make ‘I0’ become
irrelevant in the estimation of arterial oxygen saturation, pulse oximeters take advantage
of the pulsating properties of arteries. The arteries contain more blood during systole
(contraction of the heart) than diastole (relaxation of the heart). Their diameter, therefore,
increases due to increased pressure (the walls of the arteries are fairly elastic). This effect
occurs in the arteries and arterioles (small arteries that feed the capillaries) but not in
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the veins (or the capillaries themselves). This can be seen as a change in the optical
path distance (d) in the Beer-Lamberts Law [108]. Beer’s Law can be modified to provide
the intensity of absorption during systole (IP ) and diastole (IB) (Figure 4.1). Baseline
intensity (IB) can be written as,
IB = I0 e
−εB(λ).cB .d = I0 e
−αB(λ).d (4.2)
Where αB is the absorptivity of baseline absorption and is equivalent to εB(λ).cB and d is
the optical path length. The light emerging from the pulsatile component can be written
as
IP = IB e
−αP (λ)∆d = I0 e
−αB(λ)d −αP (λ)∆d (4.3)
Where αP is the absorptivity of the pulsatile arterial blood. A change in transmittance








= ∆T = e−αP (λ)∆d (4.4)
The I0 terms cancel out leaving the arterial transmittance as a function of the pulsatile
components absorptivity and path length only [109]. The unscattered absorbance of light
at each wavelength can be calculated by taking the natural log of Equation 4.4.





= − ln(e−αP (λ)∆d) = αP (λ)∆d (4.5)
Now by comparing the ratio of the unscattered absorbance measured at two wavelengths









Note that the change in optical path length (∆d) is, however, impossible to measure [109].
By assuming that the geometrical distance between the source and the detector is the same
at each wavelength, and number of scattering events per millimetre of tissue is similar,
variable distance ∆d (the optical path length over which arterial absorption takes place)








This ratio is used in calculating the oxygen saturation level of the patients’ blood. Before
describing the conventional way of measuring SpO2, it is important to understand what
is physically being measured here in Equation 4.7
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4.2.4 Ratio of ratios
In pulse oximetry, two diodes emit red and infrared signals that are transmitted through
a spot in the body and detected in their attenuated form by a photodetector. Figure 4.5
shows the red and infrared PPG signal obtained by monitoring the intensity of light
emerging from the tissue by the photodetector. Note that the PPG signals appear inverted
compared to the absorption-derived waveform depicted in Figure 4.1. The change in












Where, Id(λR) and Id(λIR) represent the baseline transmittance at the R and IR wave-
lengths, and Is(λR) and Is(λIR) represent the pulsatile transmittance at respective wave-
lengths. The difference between Id(λR) and Is(λR), represents the reduction in transmit-
tance due to the pulsation of the arterial blood. This variation in transmitted signal is
referred to as the AC component of the PPG signal, where ACR = Id(λR) - Is(λR). Since


































Another consequence of AC being small is that the slowly varying (DC) component of the


































Figure 4.5: Received light intensity from the red (R) and infrared (IR) LEDs over time
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4.2.5 Deriving arterial oxygen saturation using the ratio of ratios
As mentioned in Section 3.2.2, arterial oxygen saturation (SaO2) is defined as the percent-
age concentration of the oxygenated haemoglobin divided by the sum of concentrations of





As the optical path is assumed to be the same for each medium in pulse oximetry, the
concentrations for HbO2 and Hb can be related to the functional oxygen saturation
CHbO2 = SaO2(CHbO2 + CHb) (4.13)
CHb = (1− SaO2)(CHbO2 + CHb)
Going back to Beer-Lamberts Law for multiple media in Equation 3.7 and combining it
with Equation 4.13, the total absorbance at red and infrared wavelengths can be written
as
At(λR) = [εHb(λR) + SaO2(εHbO2(λR)− εHb(λR))]× (CHbO2 + CHb)d (4.14)
At(λIR) = [εHb(λIR) + SaO2(εHbO2(λIR)− εHb(λIR))]× (CHbO2 + CHb)d
Just as in computing the Ratio of Ratios in Equation 4.7, the ratio of absorbance at the





[εHb(λR) + SaO2(εHbO2(λR)− εHb(λR))]× (CHbO2 + CHb)d
[εHb(λIR) + SaO2(εHbO2(λIR)− εHb(λIR))]× (CHbO2 + CHb)d
(4.15)
ROS =
εHb(λR) + SaO2(εHbO2(λR)− εHb(λR))
εHb(λIR) + SaO2(εHbO2(λIR)− εHb(λIR))
The above equation can now be simplified to the form where functional oxygen saturation
is a function of the ratio of ratios. Note that SaO2 is referred as SpO2; indicating arterial
blood oxygen saturation measured by pulse oximetry
SpO2 =
ROS . εHb(λIR)− εHb(λR)
ROS [εHb(λIR)− εHbO2(λIR)] + εHbO2(λR)− εHb(λR)
× 100% (4.16)
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Note that Equation 4.16 is composed of all measurable and known values. The value of
ROS is calculated from the four parameters derived in Equation 4.11 and the values of
the molar extinction coefficients of oxygenated and de-oxygenated haemoglobin are known
and given as a function of wavelength in Figure 4.4 [112]. By substituting these values
from Figure 4.4 into Equation 4.16, produces the following equation
SpO2 =
ROS × 693− 3227





and approximating Equation 4.17 with a linear function produces the following equation
SpO2 = 116− 41(ROS) (4.18)
However, a more accurate empirically derived linear equation that is commonly used by
those who had any experience with pulse oximetry technology is
SpO2 = 110− 25(ROS) (4.19)
4.2.6 Calibration of pulse oximeters
Since, SpO2 is calculated using a ration (ROS) rather than absolute value, there is no need
for any calibration. However, most modern pulse oximetry manufactures build experimen-
tal calibration curves instead of relying on the theoretically obtained equations such as


















Figure 4.6: Calibration curves for pulse oximeters: Functions plotted in green and blue
are theoretically obtained curves using Equation 4.17 and 4.18, red line is the experimen-
tally obtained calibration curve used in commercial Pulse Oximeter
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Equation 4.17 and 4.18. One of such calibration curves is plotted together with functions
from Equation 4.17 and 4.18 in Figure 4.6.
Manufacturers calibrate pulse oximeters empirically by correlating the measured ratio
of AC/DC PPG signals to SaO2 values measured from in-vitro oximeters such as CO-
oximeters [101]. The calibration procedure involves desaturating the subjects by asking
them to breathe hypoxic gas mixtures and collecting optical measurements of blood sam-
ples at different steady-state oxygenation levels. At each oxygenation level, the measured
SaO2 value is correlated to the ROS value measured by the pulse oximeter. In most studies
the volunteers are desaturated to a SaO2 of up to 80%. As a result, the accuracy of pulse
oximetry deteriorates when SaO2 falls to 80% or less. The calibration curve programmed
into the software also varies from manufacturer to manufacturer and can be different in
various pulse oximeters of the same manufacturer [1]. For these reasons, the same pulse
oximeter and probe should be used for all saturation determination in a given patient.
One of the limitations of this calibration method is the limited range of oxygen saturation
that can be acquired. Ethical issues prevent intentional desaturation of healthy subjects
below a certain point due to the risk of hypoxic brain damage.
4.3 Pulse Oximetry Probes
The pulse oximeter probes are widely used in clinical settings for the monitoring of ar-
terial blood oxygen saturation. A conventional pulse oximetry sensor consists of a pair
of light emitters and a highly sensitive photodetector, mounted inside a reusable spring
loaded clip. The most commonly used light sources are the Light Emitting Diodes (LED).
LEDs are ideal for pulse oximeters as they are cheap, compact and possess excellent drive
characteristics, along with large light output over a narrow bandwidth [113]. The photode-
tectors usually used in pulse oximetry probes are silicon photodiodes, but other devices
such as photocells and phototransistors are also used. Silicon photodiodes are a good
choice for light detection, as they possess good linearity to detected light and produce
minimum noise. The two main configurations used in the design of pulse oximetry probes
are discussed below:
4.3.1 Transmittance probes
As the name suggests, in transmittance probes, light emitters transmit light through one
side of the vascular tissue to the photodiode on the other side, as shown in Figure 4.7.
Transmittance probes were the first pulse oximetry probes to be developed and remain
the most commonly used probes in clinical environments [57]. The probe consists of
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Figure 4.7: Transmission pulse oximetry configuration - illustrating the relative posi-
tions of the emitters and photodetector (drawing inspired from [116])
two emitters, with wavelengths at 660nm in the red region and at 940 nm in the near
infrared region. LEDs are mounted on the pulse oximeter probe so their output is directed
perpendicularly through the finger to the photodetector, which is located opposite the
LEDs. The intensity of light emerging from the tissue is attenuated by the blood present
in the tissue. This varies with the arterial pulse and is used to measure SpO2 and heart
rate [70]. The probe is designed to fit comfortably on the finger and is spring loaded,
applying constant light pressure on the tissues. The whole assembly is shielded to prevent
ambient light from entering the detector. Normally transmission probes are placed on the
patients finger, earlobe or toe and are available in different reusable packaging [114]. A
disadvantage of transmission-mode pulse oximetry is the limited measurement sites. For
this sensor to be effective, it must be placed somewhere on the body where transmitted
light can be readily detected. Placement of the sensor on the ear or fingertip may result
in inaccuracies when peripheral circulation is impaired [115].
4.3.2 Reflectance pulse oximetry probe
Incident light from the emitters is known to be absorbed, transmitted and reflected when












Figure 4.8: Reflectance pulse oximetry configuration - illustrating the relative positions
of the emitters and photodetector
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of light to acquire arterial oxygen saturation. Reflectance probes consist of two LEDs, with
wavelengths at 660nm in the red region and at 940 nm in the near infrared region and
a photodiode aligned next to the emitters. The light from the emitters transilluminates
the tissue and the backscattered light is detected as a pulsating photoplethysmograph by
the photodiode next to the emitters (Figure 4.8). These signals are then analysed by the
pulse oximeters to estimate arterial oxygen saturation [93].
As the emitters and photodetectors are placed adjacent to each other, reflection pulse
oximetry probes can be used to measure arterial oxygen saturation at virtually any place
on the skin. This solves the sensor placement problems associated with transmission-mode
pulse oximetry. It has been found that the separation between the emitters and photode-
tector affects the quality of the photoplethysmographic signals received in reflection pulse
oximetry. A separation of 4 to 5 mm between the emitter and the photodetector is usually
recommended [117]. The most common surfaces for monitoring oxygen saturation with a
reflectance pulse oximetry probe are the forehead and temple [115].
4.4 Instrumentation used in pulse oximetry
This section describes briefly the main electronic blocks comprising the pulse oximeter
system (Figure 4.9)
Emitter driver - In the pulse oximeter, the red and infrared emitters are driven by
a current driver circuit consisting of a current source and a multiplexer. Emitter drive
currents may vary between 60 mA to 120 mA. As there is only one photodiode to take
samples of light at both wavelengths, the signals need to be multiplexed. Therefore,

































Figure 4.9: Block diagram of a commercial pulse oximetry showing the major electronics
components (Drawing inspired from [1])
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generated by the microprocessor, turns the red and infrared emitters on and off at a rate
of approximately 500 Hz in sequence.
Transimpedance amplifier - The transimpedance amplifier converts and amplifies the
photocurrents generated by the photodetector into a mixed voltage signal. The strength of
the signal from the amplifier depends on the intensity of light detected by the photodiode
and the gain resistor of the transimpedance amplifier.
Demodulator and filtering - The inputs to this circuit are the mixed PPG signal
output of the transimpedance amplifier and the timing signal from the microprocessor.
The microprocessor along with the information stored in the EPROM calculates the time
period each signal component is present in the photodetector output [118]. Switching at
the right time results in the two PPG components (red and infrared) getting separated.
Analogue-to-Digital Converter (ADC) - This is the point in the system where digital
electronics take over. The PPG signals are converted by an analogue-to-digital converter
to a form suitable for manipulation by the microprocessor. In most of the commercial
pulse oximeters, the analogue-to-digital conversion is accomplished by using a sample and
hold circuit, which holds a voltage until it is sampled by the ADC controlled by a routine
written in the memory of the microprocessor [105].
Microprocessor - The most important component of the pulse oximeter system is the
microprocessor. The digitised information at the output of the ADC is processed by the
microprocessor to compute the blood oxygen saturation from the ratio (ROS) derived from
the signal at the red wavelength compared with the signal at the infrared wavelength.
Displays and Status Messages - Apart from displays of blood oxygen saturation, heart
rate, and photoplethysmograph, most pulse oximeters also display messages such as: no
probe connected, battery low, noisy signal, probe off the patient, searching for a pulse,
insufficient signal [119].
Alarms - All pulse oximeters must have alarms for low oxygen saturation and for low and
high heart rate. These alarms have to be both in audio and visual form. Comparators,
power amplifiers, drivers and speakers constitute the audio alarm section. LCD bar graphs
and blinkers are used for the visual section [108].
Power supply - The internal power supply requirements of the pulse oximeter may be
considered in three sections: the light emitting diodes; the electronics; and the display.
The power supply present in most pulse oximetry boards is switched mode power supply
with an optically isolated power transformer, isolating the mains input from the rest of
the pulse oximetry system, therefore preventing any form of electric shock to the patient.
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4.5 Applications of Pulse Oximetry
Pulse oximetry has become one of the most commonly used tools in the clinical environ-
ment for assessing patients blood oxygenation status. The pulse oximeter provides an
indicator of arterial oxygen saturation, a quantity that is extremely simple to interpret,
thus providing a rapidly responding indicator of hypoxaemic events [110]. They are non-
invasive, easy to use, and readily available. Pulse oximeters are now a monitoring standard
equipment in anaesthetic rooms, operating theatres, intensive care units, ambulances, etc.
Pulse oximeters are used to provide useful clinical information in many different settings,
including physiological monitoring, vascular assessment and autonomic function [87].
In physiological monitoring, pulse oximeters are now used to measure parameters beyond
SpO2 and heart rate. Recent advancements include measurement of blood pressure [120],
venous oxygen saturation [121], and respiration [122]. However, these new parameters
are not currently available in clinical monitors and are confined to research systems. In
vascular assessment the technology is used to assess microcirculation [123], arterial com-
pliance and ageing [124], and endothelial function [125]. Pulse oximeters are also used
in the assessment of vasomotor function [126]. Assessment of vasculature and vasomotor
function by pulse oximetry is however, still in an early research stage.
4.6 Summary
Pulse oximetry is an optical technique used in the monitoring of tissue perfusion and is
essentially a combination of oximetry and photoplethysmography. By shining light at two
wavelengths (red and infrared) onto a tissue and receiving either the transmitted light or
reflected light, oxygen saturation levels can be estimated. Pulse oximetry takes Beers law
as its basis, and although this does not effectively account for scattering effects when used
in conjunction with empirical calibration, it provides a reliable estimation of saturation.
The pulse oximeter sensor is the heart of pulse oximeter, as the accurate functioning of
the device depends on the probe. Pulse oximeter sensors are available in reflectance and
transmittance configurations. Most commercial devices use transmittance finger sensors.
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— The reputation of the technique
of pulse oximetry can be main-
tained only if its limitations are al-
ways borne in mind. Currently, this
is not the situation, and the indi-
cated value of SpO2 is relied on to-
tally by most users.
John TB Moyle, Pulse oximetry,
1994
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Limitations and recent advancements in Pulse
Oximetry technology
In recent years, continuous assessment of arterial oxygen saturation during anaesthesia and
surgery has become increasingly dependent on pulse oximetry, as the technique has proved
to be accurate and capable of detecting hypoxic changes in sedated patients. In fact, pulse
oximetry has been made a standard of practice for the administration of general anaesthetic
in the USA [1]. Many publications have reported the durability of the technique for
measuring arterial oxygen saturation. However, the technique has also been reported to
fail in some circumstances [59].
The limitations by which pulse oximeters fail to estimate accurate SpO2 can be classified
into technical and physiological. Some of these limitations are harmless where the device is
unable to measure SpO2 but makes the observer aware that it is not functioning properly,
but others can be dangerous and can cause false sensing of patients wellbeing. One of the
well-known scenarios in which pulse oximeters fail to produce an accurate estimate of SpO2
is under conditions of compromised peripheral perfusion, where the detected peripheral
pulse is very weak. This chapter briefly discusses the technical and physiological limitations
of pulse oximetry before describing the recent advancements made in the technique to avoid
such limitations. The last section of the chapter presents a possible solution for monitoring
arterial oxygen saturation in conditions of poor peripheral perfusion.
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5.1 Technical limitations
Numerous factors have been shown to affect the absorbance characteristics or signal-to-
noise ratio of pulse oximetry negatively. These limitations include motion artefacts, cal-
ibration assumptions, electromagnetic interference, nail polish, time-lag due to over av-
eraging, skin pigmentation, centre wavelength variability of LEDs and probe positioning.
Some of these limitations are more likely to have an effect on the pulse oximeter than
others. Nonetheless all these confinements introduce a certain degree of error in the es-
timated SpO2 value measured by the pulse oximeter. This section describes some of the
main technical limitations.
5.1.1 Motion Artifacts
One of the most commonly occurring and clinically troublesome limitation of pulse oxime-
try is motion artefact. Mechanical disturbances between the probe and the anatomy of the
patient should be avoided as much as possible while using pulse oximeters as it may lead to
inaccurate results. The change in absorption of energy during the cardiac cycle accounts
for only 1-2 % of the total absorption, any motion that alters the remaining fraction of
absorption (especially when due to venous blood) will drive the absorbance ratio (ROS)
near 1 and SpO2 to a value close to 85 % [127, 128]. Most modern pulse oximeters are
equipped with microprocessors which attempt to limit these issues by longer averaging,
holding data, or alarm delays. However, rhythmic motions or vibrations with a frequency
similar to the heart rate (0.5 − 3.5 Hz) can be accounted as the normal signal, and this
would lead to inaccurate SpO2 readings [129, 130].
5.1.2 Calibration assumptions
As mentioned earlier in Section 4.2.6, arterial oxygen saturation derived from the ab-
sorbance ratio was initially based on the Beer-Lambert law, but the results obtained led
to a gross overestimation of oxygen saturation as the light reflecting and scattering prop-
erties are ignored in Beer’s Law [129]. The accuracy of the results was improved using
the empirically derived calibration curves (Section 4.2.6). These calibration curves are
obtained by correlating the measured absorbance ratio (ROS) with arterial SaO2 values
obtained from a large group of healthy volunteers over a range of desaturation values [127].
However, the results produced by CO-Oximeters typically have an inaccuracy of ±0.5 %
[1]. Hence, the value of SpO2 obtained from pulse oximeters can only be as accurate
as their empirical calibration curves. It is also unethical to desaturate volunteers below
SaO2 levels of 80 %, therefore lower SpO2 values are derived by extrapolation and, hence,
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are less accurate. Moreover, because the subjects recruited for calibration purposes are
healthy young adults, the applicability of calibration data to patients at the age extremes
has been questioned [131, 132].
5.1.3 Electromagnetic interference
The likelihood of electromagnetic interference (EMI) corrupting the pulse oximeter’s per-
formance is usually low. However, they can be sensitive to EMI at times due to the
microelectronic circuitry and many microprocessors used. Pulse oximeters are prone to
EMI from both radio and visible regions of the electromagnetic spectrum. One of the
most powerful sources of EMI that is likely to be encountered by a pulse oximeter in a
clinical setting is from the radio-frequency produced by a surgical diathermy unit. These
electrosurgical units used in operating theatres produce radio-frequency energy up to 400
W at mixed frequencies, which can interfere with pulse oximeters to produce erroneous
SpO2 readings [1].
Intense visible or infrared light also might interfere with pulse oximeters [133]. The ex-
cessive increase of light energy reaching the photodiode from ambient light or other light
sources can saturate the photodiode and drive the ROS value towards unity which corre-
sponds to a SpO2 of 85%. This phenomenon, known as the flooding effect is far worse
if the light source is pulsatile. The new-generation sensors avoid this by insulating the
sensors from any ambient light entering the photodiode. Health care professionals, partic-
ularly those who handle neonates exposed to phototherapy, must be aware of this potential
limitation [127].
5.1.4 Time lag in detecting hypoxic events
While most conventional pulse oximeters present fast response times, there may be a
clinically significant delay between a sudden change in alveolar oxygen tension and the
related change in the oxygen saturation readings. It is possible for arterial oxygenation
to reach dangerous levels before the pulse oximeter alarm is activated. This time, lag is
primarily associated with the sensor location [133, 134]. Desaturation could be detected
earlier if the sensor was to be placed on a more central site, other than finger or toes. The
other source of time delay is the complexity of the algorithms used in the modern pulse
oximeters (i.e. the time over which the pulse signals are averaged) and this might exceed
15 to 20 seconds [127]. Verhoeff and Sykes found that a delay of 1 min between a change
in alveolar oxygen tension and an indication on the pulse oximeter could potentially result
in damaging hypoxia [135, 136].
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5.1.5 Other technical limitations
One of the other limitations in the design of pulse oximeters is the type of light source
used. Although LEDs are reliable sources of narrow wavelength light, the peak wavelength
of different emitters of the same type is known to vary [26]. There might be a variation of
up to 15 nm in the centre wavelength between any two LEDs of the same type. From the
absorption spectra of Hb and HbO2 in Figure 4.4, it is evident that any shift in wavelength
of light source leaves the oximeter working with a different set of extinction coefficients,
therefore leading to an error in the estimation of SpO2. This is why it is critical to choose
wavelengths in the flatter region of the absorption spectrum. Modern sensors are equipped
with a coding resistor with a specific value in the probe connector. This resistor helps the
pulse oximeter to choose an appropriate calibration curve to be used for calculating SpO2
[1].
Skin pigmentation has shown variable effects on pulse oximetry. Although according to
the theory, the constant level of absorption presented by skin pigmentation is subtracted
in the calculation of SpO2, dark skin pigmentation has been implicated for erroneous SpO2
readings, especially at SpO2 values of < 80 % [129]. The mechanism of such artefact, if
present, is unclear, and could arise from optical interference, low signal-to-noise effects,
or as a reflection of the relative lack of darkly pigmented subjects in calibration trials
[137, 138].
Probe placement also plays an important role in the estimation of accurate SpO2 by a
pulse oximeter. Inappropriate probe placement leads to errors readings, especially on the
small fingers of neonates and infants [131]. In this case, the emitted light can be projected
tangentially to the detector, sometimes without crossing an arterial bed, leading to optical
shunting. This pitfall can be avoided by positioning the emitter and the detector exactly
opposite to each other and by using probes of appropriate size for neonates and infants
[139].
5.2 Physiological Limitations
Along with the technical limitations, pulse oximeters additionally suffers from few physio-
logical limitations (i.e., errors resulting from physiological conditions). These constraints
include intravenous dyes, anaemia, abnormal haemoglobin molecules, venous pulsations,
morbidity and reduced perfusion.
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5.2.1 Intravenous dyes
Dyes such as methylene blue, indocyanine green, patent blue, nitrobenzene and indigo
carmine are commonly injected intravenously or intra-arterially into the uterine cavity
or lymphatics during surgical procedures. Usage of pulse oximeters during or shortly
after the induction of these dyes has shown to have resulted in falsely low SpO2 values
without actual desaturation [141–144]. These errors occur as the pulse oximeter cannot
distinguish between the absorption of light by intravenous dye and the absorption by
haemoglobin species [140]. For example, methylene blue has its peak spectral absorption
at 668nm, hence it absorbers most of the light emitted by the red emitter (Figure 5.1). This
absorption is interpreted by the pulse oximeter as the presence of reduced haemoglobin,
leading to inaccurate estimation of SpO2. With methylene blue administrations as little





















Figure 5.1: Absorbance spectra of three commonly used intravenous dyes, dashed line at
668 nm corresponds to the peak absorption of methylene blue and one of the wavelengths
emitted and sensed by most pulse oximeters (Redrawn from [140])
5.2.2 Abnormal Haemoglobin molecules
Pulse oximeters provide a measure of arterial oxygen saturation by quantifying the ab-
sorption of light at two wavelengths, using the assumption that the light is only absorbed
by oxyhaemoglobin and deoxyhaemoglobin. However, unfortunately, this is not true; the
transmitted light is also absorbed by other haemoglobin species and would interfere with
pulse oximetry readings. The two most significant false absorbers are Carboxyhaemoglobin
(COHb) and methaemoglobin (MetHb).
Absorption due to COHb causes the pulse oximeter to overestimate arterial oxygenation
[145]. This effect is caused by the specific absorption characteristics of COHb, which
exhibits red light absorption similar to that of oxyhaemoglobin. Therefore increased COHb
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causes the pulse oximeter to overestimate SpO2. Pulse oximeter overestimates SpO2 by
1 % for every 1 % increase of circulating COHb [146, 147]. Methaemoglobin absorbs
approximately equal amounts of energy in the red region as deoxyhaemoglobin, and in the
infrared region, it absorbs more than the other haemoglobin species. Hence, an increase
in MetHb causes the SpO2 reading to be low when SaO2 is above 85 % and high when
SaO2 is below 85 %, thus underestimating high saturation values and overestimating severe
hypoxaemia [146, 148].
5.2.3 Anaemia
Patients suffering from anaemia are known to have a reduced number of red blood cells
or haemoglobin in the body. The condition usually causes tissue hypoxia as the oxygen
binding capacity of blood is reduced [149]. In principle, anaemia should not affect pulse
oximetry at all, as changes in total haemoglobin concentration inside a specimen does
not impact the proportion of relative absorbances [129]. However, severe anaemia has
shown an adverse effect on the accuracy of the pulse oximeter [150, 151]. Though in non-
hypoxic patients with acute anaemia from haemorrhage, pulse oximeters have shown good
accuracy [152]. This suggests that the effect of anaemia on pulse oximetry is profound
only in patients suffering from hypoxia.
5.2.4 Venous pulsations
Pulse oximeters assume that the pulsatile component of the light absorbance is due to
the arterial blood. However, this assumption is not entirely true in all circumstances.
Conditions such as arteriovenous anastomoses, glomuses and tricuspid incompetence with
regurgitation may cause peripheral veins to become sufficiently pulsatile. In these cases,
the pulse oximeter would not be able to distinguish between the absorption due to pulsatile
veins and arteries, leading to inaccurate estimation of SpO2 [153, 154]. A study conducted
by Sami et al. on a patient with ischaemic cardiomyopathy has shown marked central
venous pulsations and a pulse oximeter bias of -18 % [155]. The error may be worst when
the sensors are utilised on the forehead compared to when the sensor is placed on the
finger [156].
5.2.5 Morbidity
Although pulse oximeters are noninvasive and considered very safe, morbidity has been
associated with its use [133]. Skin ischaemia and necrosis have been reported due to
the pressure exerted by the sensor, especially under conditions of low perfusion [157]. In
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the intensive care situation, digital injury from pulse oximetry may have an incidence as
high as 5 %, with the highest incidence being in very sick patients with noradrenaline
(norepinephrine) infusions reducing the peripheral perfusion [158]. There have also been
reports of burns on fingers in children [159]. The Medicines and Healthcare products
Regulatory Agency (MHRA), a UK government-run body, has issued a safety notice to
healthcare facilities warning that the site of application of pulse oximeter probe should be
regularly inspected in accordance with the manufacturer’s instructions [160].
5.2.6 Inadequate peripheral perfusion
Compromised peripheral perfusion is presumably the most common cause of pulse oxime-
try failure after motion artefacts [127]. Pulse oximeters rely on the presence of adequate
arterial pulsations to distinguish between the light absorbed by the arterial blood from
that absorbed by the venous blood and other tissues. With the loss or diminution of the
peripheral arterial pulse, the estimated SpO2 reading quickly becomes very inaccurate or
non-existent. These inaccuracies occur due to the inability of the pulse oximeter to distin-
guish between light absorbed by arterial blood from that of venous blood, in the absence
of arterial pulse [73]. Poor peripheral pulsation can result from hypotension, hypothermia,
low cardiac output, hypovolemia, peripheral vascular disease, infusion of vasoactive drugs,
proximal blood pressure cuff inflation, leaning on an extremity, Raynaud’s phenomenon
(Figure 5.2) and from performing a Valsalva manoeuvre [9, 162]. Under these conditions
most pulse oximeters do not produce a reading, some modern pulse oximeters, however,
display a message such as “Low Quality Signal” or “Poor Perfusion” on the screen to make
the user aware of the situation.
Figure 5.2: Thermograms of a healthy hand (left) and the hand of a person with
Raynauds disease (right) after 2 minutes immersion in cold water. Hotter areas are shown
in yellow and orange, while colder areas are in blue, black and purple. These hands are
from two different people, one male and one female. ([161])
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Other factors reported to contribute to low perfusion and pulse oximeter failure includes
the very young and very elderly patients, ASA III and IV patients, prolonged duration
of the intraoperative procedure and chronic renal failure [16]. The failure rates of pulse
oximeters under conditions of poor peripheral perfusion have been investigated before by
many researchers, some of the results from their studies are listed here.
• A study by Moller and co-workers from their hand-kept anaesthesia records, reported
a total failure rate of 2.5 % in 10,802 patients, but it increased to 7.2 % in patients
who were American Society of Anaesthesiologists (ASA) physical status IV [163, 164].
• Freund and colleagues reviewed 11,046 cases from four University of Washington
Hospitals and reported an overall failure rate of 1.24 %, but it increased to 4.24 % at
the Veterans Hospital, where ASA physical status tended to be greater. They had
also reported that, when the device did fail in a patient, it did not function for 32 %
of the mean anaesthesia time [165, 166].
• Reich and co-workers studied predictors of pulse oximetry data failure by reviewing
9203 electronic medical records and reported a failure rate of 9.18 % [16]. Another
study by Reich suggested that the pulse oximeters are more likely to fail in patients
undergoing cardiopulmonary bypass surgery than in other anaesthetised patients
[167].
• Shafique et al. has investigated the failure rates in transmittance and transreflectance
pulse oximeters in conditions of artificially induced hypothermia, in 20 healthy vol-
unteers. The results show that at low-temperature ranges, from 13 to 210C, the
failure rate of the trans-reflectance pulse oximeter was 2.4 % as compared to the
transmittance commercial pulse oximeter with a failure rate of 70 % [168].
• Hummler et al. has examined the accuracy of pulse oximetry measurements in 37
adult anaesthetized, ventilated rabbits, during sepsis. The results show that modern
pulse oximeters have a bias beyond ± 3 when compared to SaO2 values, in more
than 21 % of the subjects [169].
Other interesting studies evaluating the performance of pulse oximeters in conditions of
compromised peripheral perfusion are described in [3–15]. The failure rates discussed
in these studies are directly associated with the application of pulse oximeter sensors to
extremities such as the finger or toe, where the pulsatile flow is very easily compromised.
Many attempts were made previously to improve the signal detection such as application
of vasodilation creams [11], administration of intra-arterial vasodilators [17], digital nerve
blockers [18–20], and applications of sensors on better perfused areas such as forehead [13]
and the nose [21]. However, it is not always possible to use vasodilators and nerve blockers
in critically ill patients. Moreover, the actual failure rate has increased when pulse oximeter
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sensors were used on nose and forehead [156, 170, 171]. Thus, SpO2 readings are often
unobtainable or inaccurate at just the time when they would be most valuable. To curb
this limitation, many researchers have successfully developed pulse oximeter sensors to
measure SpO2 from more centrally perfused sites such as the oesophagus [22], the pharynx
[172], the anterior fontanel [173], and other splanchnic organs [174]. These technologies
and other advancements in pulse oximetry in the recent past are discussed in the following
sections.
5.3 Recent advancements in pulse oximetry
Since the introduction of pulse oximeters into clinical practice in the 1980’s most amend-
ments to pulse oximeter technology have been largely cosmetic modifications, such as the
size of the device, user interface, and size and colour of the readout. These modifications
have made the device a less expensive and effective means for health monitoring in clinical
setting and in home care. In recent years, however, manufacturers and researchers have
developed oximeters that are better able to distinguish between motion artefact, electronic
noise, and authentic patient events [175].
Advancements in pulse oximeter technology have particularly been in four main streams.
(1) Analysis of the photoplethysmographic waveform (2) Multi-wavelength analysis to
quantify chemical component fractions in blood, (3) Advancements in algorithms to im-
prove signal detection and (4) development of novel reflectance pulse oximeter sensors.
5.3.1 Advancements in analysis of the photoplethysmographic waveform
Despite its simple appearance, the PPG waveform is a highly intricate signal that contains
far more information in its shape, height, and timing than just pulse rate. The raw PPG
waveforms are considered to be a true projection of the haemodynamic output of the
entire cardiovascular system [176]. Various algorithms were developed by researchers in
recent years to analyse the PPG waveform in both the time and frequency domain [177].
Parameters such as respiration rate, sympathetic tone, pulse transit time, perfusion index
and path variability index can be estimated from the developed algorithms. However,
some of the developed algorithms are not yet in clinical use.
5.3.1.1 PPG signal amplitude analysis
The auto-scale function in the pulse oximeter usually conceals the amplitude changes of
the PPG signal. However if this was to be turned off, relative changes in the amplitude
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of the PPG signal could be observed [177]. The changes in the amplitude of PPG signals
can be linked to significant changes in arterial blood pressure (BP) and vascular tone.
For example, during episodes of increased sympathetic tone, the amplitude of the PPG
signal decreases due to the resultant vasoconstriction. Conversely, with vasodilation the
PPG signal amplitude increases. This is particularly true in patients who are critically
ill, or who are anaesthetised, undergoing surgery, or in labour [176]. Currently, none of
the commercially available pulse oximeters display not auto-scaled PPG signals over a
large duration of time. However, a new variable providing similar information known as
Perfusion index (PI) was introduced by Masimo (Masimo Corp., Irvine, CA, USA) in
their pulse oximeters (Rad-8, Rad-5, ISpO2Rx etc.) [178]. PI is defined as the ratio of
pulsatile (AC) and non-pulsatile (DC) components of the infrared photoplethysmographic
waveform as shown in Figure 5.3.
Perfusion Index (PI) =
AC
DC
× 100 % (5.1)
PI is used to assess peripheral perfusion and circulatory strength of the peripheral mea-
surement site. PI values usually range from 0.02 % for a frail pulse (suggesting peripheral
vasoconstriction) to 20 % for an extremely strong pulse (suggesting vasodilation) [179]. PI
has been shown to be useful in assessing the severity of illness in newborns, to determine
the effectiveness of epidural blocks, and to quantify peripheral perfusion for diagnosis of
congenital heart disease in newborns [180–184].
5.3.1.2 Analysis of amplitude variability due to respiration
Both the baseline (DC) and pulsatile (AC) components of the PPG signal are known to
oscillate with spontaneous and positive pressure ventilation [177]. The ability to detect


















Figure 5.3: Computation of Perfusion Index (PI) and Pleth Variability Index PVI
from the pulsatile AC and non-pulsatile DC components of the photoplethysmographic
waveform
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(a) Peak, trough detection (red markers) and mean en-
velope detection (green signal) using cubic spline inter-
polation



















1.9 Hz (Cardiac component)
3.8 Hz (Cardiac component harmonic)
(b) Fast Fourier Transform of the PPG signal showing
the respiration and cardiac components
Figure 5.4: Extraction of respiration component using time domain and frequency
domain methods
these oscillations enables whole new possibilities. At the very least, respiratory rate can be
reliably determined using the PPG signals. Several methods are used to extract respiration
rate from the PPG signals, one of the common methods is to filter the raw PPG signals
using a band pass filter with cut-off frequencies of 0.1 Hz and 0.5 Hz and then calculating
the respiration rate from the resulting signal [122, 185–190]. The accuracy of this method
is low, mainly during shallow breathing. In a more accurate time domain method, the
respiration signal is extracted by detecting the peaks and troughs of the PPG signal and
by constructing the upper and lower envelopes using cubic spline interpolation [191, 192].
The mean envelope of the upper and lower envelopes shows the respiratory modulation as
shown in Figure 5.4(a). Spectral analysis techniques such as Fast Fourier Transformation
(FFT) based on Welchs averaged periodogram can also be used to characterise respiratory
oscillations as shown in Figure 5.4(b) [186, 188, 193].
The variability in PPG signal amplitude due to respiration has recently been used as a
dynamic parameter in functional haemodynamic monitoring. This new parameter called
the Pleth Variability Index (PVI) was first introduced by Masimo (Masimo Corp., Irvine,
CA, USA) in their new pulse oximeters [194]. Masimo defines PVI as a measure of the
dynamic changes in the perfusion index that occur during one or more complete respiratory
cycles (Figure 5.3).
Pleth Variability Index (PVI) =
PImax − PImin
PImax
× 100 % (5.2)
Numerous clinical studies have shown PVI to detect occult haemorrhage and its resulting
hypovolemia and to assess fluid responsiveness in surgical and intensive care patients [195–
198]. The greater the PVI, the more likely the patient will respond to fluid administration.
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5.3.1.3 Time variability analysis of PPG signals
The variations in the time interval between arterial pulsations (heartbeats) can reveal
further information regarding the heart’s function and its association with the autonomic
nervous system. The variability in time duration between consecutive heart beats is known
as Heart rate variability (HRV) [199, 200]. HRV is traditionally measured from the QRS
complex of the electrocardiogram (ECG). Since PPG also reflects the cardiac rhythm,
variability in heart rate can also be estimated from the PPG signal. HRV measured
from PPG is referred to as Pulse Rate Variability (PRV) [201]. PRV is measured as the
time difference between the peaks (PP - peak to peak) of consecutive pulses (as shown in
Figure 5.5). A high PRV usually indicates good health, whereas low PRV is associated
with higher risk of death, mainly in patients with coronary heart disease.
The autonomic nervous systems control over the heart’s function can be determined by
analysing the PRV signal (black trace in Figure 5.5) in the time and frequency domains.
Standard indices such as SDPP (standard deviation of all PP intervals), RMSSD (the
square root of the mean of the sum of the squares of adjacent PP intervals), and nPP50
(percentage of pairs of adjacent PP intervals differing by more than 50 ms) can be estimated
in time domains. Frequency domain parameters such as PLF (power of low frequency
component [Range: 0.003 - 0.04 Hz]), PHF (power of high frequency components [Range:
0.15 - 0.4 Hz]), and the ratio between PLF and PHF can also be estimated [202, 203].
From the measured indices the influence of parasympathetic and sympathetic activity is
determined.
The main difference between HRV and PRV is the time the pulse wave takes to travel from
the heart to the finger [201]. This time called the pulse transit time (PTT) is measured
as the time difference between the R-wave of the ECG and the corresponding foot of
the PPG signal (Figure 5.6) [204]. PTT is an effective parameter for estimating arterial
stiffness and local vascular resistance and hence can be used as a potential diagnostic tool






















Figure 5.5: Computation of PRV from the AC photoplethysmographic waveform. Black
trace shows the changes in times interval between consecutive pulses for 35 seconds.
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Figure 5.6: Computation of PTT from ECG and PPG signals. PTT is the time differ-
ence between points ‘a’ and ‘b’ (illustration inspired from [204])
for cardiovascular diseases [205]. However, PTT measurements require the use of ECG
in conjunction with the PPG signal. Also, large variability in PTT may affect the PRV
measurements. Nonetheless, if the distance from the pulse measurement site to the heart
and PTT are known, then the velocity of the pulse can also be measured
Pulse Wave Velocity (PWV) =
Pulse Propagation Distance (PPD)
Pulse Transit T ime (PTT )
(5.3)
“Just as with SpO2 measurements, PI, PVI, PTT, and respiration measure-
ments are subjected to measurement sites. In conditions of compromised pe-
ripheral perfusion, none of these parameters can be estimated accurately due
to the absence of the peripheral pulse. Hence, the advancements in the analysis
of the PPG signal are truly only possible if the peripheral pulse is detectable”.
5.3.2 Advancements in multi-wavelength analysis
Pulse oximeters estimate arterial oxygen saturation based on the ‘assumption’ that when
light is shone on vascular tissue, it is only absorbed or attenuated by oxygenated and deoxy-
genated haemoglobin. However, this assumption is not true, as dysfunctional haemoglobins
such as carboxyhaemoglobin and methaemoglobin also absorb transmitted light (Sec-
tion 5.2.2). The presence of these dysfunctional haemoglobins can interfere with pulse
oximeters performance. Besides, pulse oximeters have for long been limited to the use of
just two wavelengths in determining SpO2 [146, 206].
The possibility of multi-wavelength pulse oximetry has been a topic of research for many
years. However, a commercial pulse oximeter with such technology was not available till
2006, when Masimo Corp. (Irvine, CA, USA) introduced their new ‘Rainbow Technology’
pulse oximeters [207]. Before this, Aoyagi, who invented the pulse oximeter has developed a
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three wavelength sensor to improve the accuracy of the estimated SpO2 in 2002 [208, 209].
Another noteworthy development is the four wavelength pulse oximeter that estimated
total Haemoglobin (Hbt) by Noiri et al. However, this device never made it into the
commercial market [210]. Masimo’s ‘Rainbow SET’ pulse CO-Oximeter (Models: Rad-57,
Rainbow-7 etc.) uses 8 wavelengths of light to measure SpO2 as well as SpCO (estimate
of COHb %) and SpMet (estimate of MetHb %). This technology has enabled continuous
monitoring of haemoglobin species, which was not possible before, and now stands as an
alternative to the time and labour consuming invasive blood tests, done in hospitals with
laboratory CO-Oximeters [207, 211]. In an attempt to test the reliability of the Pulse CO-
Oximeter in victims of carbon monoxide poisoning, Coulange et al. conducted a study
in 12 patients. The results of the study have shown an overestimation of COHb by 1.5
%, compared to the results obtained using a CO-Oximeter [212]. Layne et al. measured
SpCO and COHb % in 130 patients, they also found a bias of 0.65 % and a precision of
1.8 %, in a COHb range from zero to 31 % [213].
Although the pulse CO-oximeters work reasonably well, they have two main limitations.
• The SpO2 calculation algorithm does not make use of the light absorbances from 8-
wavelengths, instead sticks to the conventional red and infrared wavelengths. Hence,
the estimated SpO2 values are still subjected to inaccuracies under the presence of
significant levels of COHb or MetHb.
• The device has also been reported to have ‘crosstalk’ between the MetHb and COHb
measurement channels. In 2008, the Masimo Radical 7 pulse oximeter were also
equipped with algorithms to measure Hbt as well [214].
5.3.3 Advancements in signal processing algorithms
As mentioned earlier in Section 5.1, motion, low perfusion, and optical shunting can induce
considerable errors into pulse oximeter accuracy, resulting in loss of data, erroneous read-
ings, and false alarms. These technical difficulties were in the past dealt with by longer
averaging, holding data, or by inducing alarm delays. In recent years, however, researchers
have developed many intelligent signal processing algorithms for analysing motion affected
PPG signals in both off-line and on-line modes. There have been numerous publications
describing the developed algorithms and their effectiveness [215–220]. Although at the
present moment, this motion resistant technology is only available in pulse oximeters
manufactured by Masimo Corp., NellcorTM and Phillips Healthcare. The fundamentally
distinct method of acquiring, processing and reporting arterial oxygen saturation and
pulse rate in Masimo pulse oximeters is called the Signal Extraction Technologyr (SET)
[221]. Nellcor and Phillips refer to their motion tolerant technology as OxiMaxTM Tech-
nology [222] and Fourier Artifact Suppression Technology (FAST-SpO2) [223] respectively.
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Masimo SET technology uses a highly sophisticated adaptive filter with Discrete Satura-
tion Transform (DST) and four other parallel engines, to distinguish between venous and
arterial pulsations, and remove noise produced by movements. Thus, enabling the direct
calculation of arterial oxygen saturation and pulse rate [221].
It has been publicised over the years, that the Masimo’s SET is far superior in its perfor-
mance over other motion tolerant technologies. A study comparing six “motion resistant”
pulse oximeters by Baker found that the Masimo SET was the only product with no drop
outs, high sensitivity and specificity under challenging motion and low perfusion condi-
tions [224]. More than 100 such studies describe Masimo SET technology to provide the
most reliable SpO2 and pulse rate measurements [225]. However, an article by Giuliano
et al. explains that none of the new-generation oximeters differ from each other in clinical
performance. In this article, Giuliano et al. reviewed 17 published studies comparing the
performance of different motion resistant pulse oximeters from 1995 to 2003. They found
that there is a lack of consistency among study variables and techniques and discrepancies
between the results of the studies, making it difficult to make any overall recommenda-
tions about which of the new-generation motion-tolerant devices are best suited for use in
critical care [226].
Masimo SET pulse oximeters have also been shown to fail in patients experiencing ‘low
perfusion states’ [227–230]. Frode et al. found the system to be misleading in patients
experiencing profound bradycardia [228], as the pulse oximeter was producing pulse tone
measurements when the patient’s heart stopped. To further investigate this incident,
Frode et al. conducted experiments by occluding the measurement hand of a volunteer
using a non-invasive blood pressure cuff and found the pulse oximeter to produce tone
measurements for 8 seconds after the plethysmograph is flat and there is no palpable
pulse. Hummler et al. conducted a study on anaesthetised and ventilated rabbits, to
evaluate the effect of deteriorating perfusion caused by sepsis on the accuracy of pulse
oximetry measurements [169, 231]. The results showed a bias beyond ±3 % in 22.6 % of
the measurements made with Masimo SET pulse oximeter. Nonetheless, the developments
in this area have resulted in pulse oximeters with better capability to acquire and display
PPGs and calculate SpO2, compared to conventional oximeters.
5.3.4 Advancements in novel reflectance PPG sensors
Pulse oximeters rely on the presence of adequate arterial pulsations to distinguish between
the light absorbed by the arterial blood from that by other absorbers. With the loss or
diminution of the peripheral arterial pulse, as in the case of hypothermia or peripheral
vascular disease, the device ceases to function. The problem arises as the majority if not
all clinically used pulse oximeter sensors operate in transmission mode. Hence limiting
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the sensors applicability or usage to extremities such as the finger, toe, or earlobe, where
perfusion is easily compromised.
In order to overcome this limitation plus enable the investigation of SpO2 in specific
organs and or tissues, researchers have developed novel reflection based sensors utilising
either miniaturised optoelectronic components or optical fibres. These sensors were used
to measure PPGs directly from more central organs such as the oesophagus [22], larynx
[172], liver, Kidney, bowel [174], brain [110], and other vascular areas such as the forehead,
anterior fontanelle [232] and free flaps [233]. These new sensors have been shown to
estimate SpO2 reliably in the presence of compromised peripheral perfusion and have
responded well to changes in blood oxygenation. Some of the recent sensor developments,
their advantages and disadvantages are discussed here.
Forehead reflectance sensor – The only reflectance pulse oximeter sensor which is
currently commercially available from most major pulse oximeter manufacturers is the
forehead pulse oximeter sensor. The hypothesis behind this sensor development is that
the forehead is more central than the finger and hence should register changes in satu-
ration faster than the finger or other peripheral sites. The perfusion at this site is also
preserved at times when the periphery fails, as it is essentially supplied by the internal
carotid artery. Numerous studies have examined the efficacy of this sensor site and found
conflicting results in different clinical settings [234–238]. Sugino et al. conducted a study
to compare the sensitivity of forehead sensors and finger sensors in 18 patients receiving
general anaesthesia [171]. They concluded that forehead SpO2 monitoring (in the range
SpO2 = 90 % - 100 %), has a sensitivity similar to conventional finger monitoring under
normal conditions during general anaesthesia. Barker et al. conducted studies on a mixed
group of surgical and intensive care paediatric patients, to test the accuracy of forehead
pulse oximeter probes. These studies revealed that the arterial saturation estimated by
forehead reflectance pulse oximetry has an error greater than 7 % for 28 % of the monitor-
ing time when compared to earlobe and blood gas analyser [170]. Another study comparing
the finger and forehead sensors by Cheng et at. found the forehead pulse oximeter sensor
works well on healthy, well-oxygenated volunteers, but experienced difficulties when used
in critically ill patients [237].
Although the forehead sensor is non-invasive and offers fast response time, signal strength
is usually low and thus the potential for artefacts is high. Forehead sensors also suffer
from attachment problems, a loose-fitted sensor using medical tape introduces inaccuracies
due to motion and venous pulsations [156, 239]. If the sensor was to be applied using
a headband, then the pressure applied on the sensor will occlude the vascular bed of
the forehead. There have also been reports of patients developing tissue necrosis due to
prolonged application of a forehead pulse oximeter sensor under a headband [240]. A very
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(a) Oesophageal reflectance sensor (b) anterior fontanelle sensor
Figure 5.7: New optoelectronic reflectance sensors for measuring PPG directly from (a)
The oesophagus and (b) The anterior fontanelle
slight pressure of 4 - 5 mmHg on the probe, however, seems to correct the attachment
problem.
Faisst et al. and May et al have explored the possibility of applying the forehead sensor on
other scalp locations where SpO2 monitoring may be unaffected. Faisst et al. explored the
possibility of measuring SpO2s from the forehead, cheek, and back of the head of thirty-
one neonates using a forehead reflectance sensor [241]. May et al. developed a reflectance,
3-wavelength sensor to investigate the possibility of measuring SpO2 from the anterior
fontanelle of 16 neonates (Figure 5.7(b)) [173]. The SpO2s estimated from the fontanelle
sensor have a mean difference of 2.2 % to the SpO2 estimated by commercial finger pulse
oximeter and a 1.7 % difference to the blood gas results.
Oesophageal sensor -One of the well known optoelectronic sensors developed in the
recent past is the oesophageal pulse oximeter sensor by Kyriacou et al. In this work, the
oesophagus was proposed as an alternative site for measuring PPGs and SpO2s, on the
hypothesis that this central site will remain adequately perfused in conditions leading to
peripheral shut down [108]. Kyriacou et al. developed the oesophageal sensor using four
surface mount emitters and a photodetector to detect blood volume changes at red and
infrared wavelengths from the oesophagus (Figure 5.7(a)). The developed sensor was fitted
inside a disposable and sterilised stomach tube (size 20-Fr), prior to its usage. The per-
formance of the oesophageal probe was evaluated in 49 patients undergoing hypothermic
cardiothoracic bypass surgery [242]. The results from the study demonstrated that reliable
acquisition of PPGs and SpO2 values is possible from the oesophagus. Of the 49 partic-
ipants in the study, the finger pulse oximeter has failed to record pulsatile PPG signals
and display SpO2 values in 5 (10.2 %) patients for at least 10 min, where the oesophageal
readings remained reliable [243–246].
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Similar developments and studies were carried by Chen et al. in 45 patients undergoing
controlled hypoxemia, and the results from his study showed accurate and earlier detection
of hypoxemia when compared to conventional pulse oximetry [247]. Kyriacou et al. also
developed a miniaturised oesophageal sensor for use in neonates [248]. Although the
oesophageal sensor has shown promising results, there are a few limitations associated
with the technology. Firstly, the developed technology is semi-invasive, hence is only
suitable for patients who are anaesthetized, as it would cause discomfort if inserted in
conscious patients. The use of the sensor also requires the patient to be administered
with muscle relaxants to suppress the cough reflex, as coughing would inevitably induce
unwanted motion artefact. The sensor requires it to be inserted in the oesophagus initially
at various depths, to find an optimum depth at which the patient has good quality and high
amplitude PPG signals. This insertion can only be carried out by a trained anaesthetist,
as untrained staff can accidentally insert the probe in the trachea or the lungs. The
proximity of the probe to the lungs may induce heavy ventilator artefact into the acquired
PPG signals.
Fibre-optic reflectance sensor -Another exciting advancement in pulse oximeter
sensor technology is the fibre-optic reflectance sensor, used to measure PPGs directly from
the surface of the organs such as the brain, small bowel, large bowel, liver and stomach.
Hickey et al. developed the fibre optic sensor suitable for intra-operative monitoring
of splanchnic perfusion [174, 249]. This sensor has made it possible for early detection
of inadequate tissue oxygenation, reducing the risk of hypoperfusion, severe ischaemia
and multiple organ failure. The performance of the fibre optic sensor was evaluated by
Hickey et al., in 20 patients undergoing laparotomy. The results obtained from their
study demonstrated that good quality PPG signals can be obtained from the surface of
the small bowel, large bowel, liver and stomach. Also, the SpO2values estimated from the
sensor showed good agreement with an optically identical peripheral sensor [250, 251]. The
similar sensor was also developed by Phillips et al., for monitoring the oxygen saturation
of blood within the tissue of the cerebral cortex. The sensor was developed for use in
patients recovering from traumatic head injury or stroke. Phillips et al. has demonstrated
that good quality PPG signals could be obtained from human brain tissue using their fibre
optic sensor by conducting a study on six patients undergoing neurosurgery [110, 252].
Although this sensor works well, it has a few limitations. The use of the sensor requires
it to be held on top of the measurement site, hence making continuous monitoring of
oxygen saturation during surgery very difficult. The sensor can not detect postoperative
complications such as shock and internal haemorrhage as the design of the sensor prevents
it from being used postoperatively. Nonetheless, the results acquired by Hickey et al., show






































Table 5.1: Summary of the recent advancements in pulse oximetry and their limitations
Advancements Description Limitation
PPG waveform analysis With further analysis of the PPG signal in time and
frequency domains, parameters such as PI, PVI, PRV,
PTT and respiration rate can be obtained. These vari-
ables if measured can enhance the clinical outcome of
patients in critical care
Just as with SpO2 measurements, PI, PVI, PRV, PTT,
and respiration measurements are subjected to mea-
surement sites and cannot be estimated in conditions
of compromised peripheral perfusion.
Multiwavelength pulse oxime-
try
Multi-wavelength pulse oximeters were developed to
avoid pulse oximeter failing from the presence of dys-
functional haemoglobins. Masimo introduced Pulse
CO-Oximeter which uses eight wavelengths of light to
measure lethal haemoglobin species such as COHb and
MetHb
The SpO2 measurements made by Pulse CO-
Oximeters do not take advantage of the light ab-
sorbances from 8- wavelengths instead sticks to the
conventional red and infrared wavelengths. Hence, the
estimated SpO2 values are still subjected to inaccura-
cies under the presence of significant levels of COHb
or MetHb
Signal processing algorithms Various Signal processing algorithms such as the
Masimo’s SET were introduced in modern pulse oxime-
ters to detect PPG signals in the presence of motion.
These algorithms have resulted in pulse oximeters with
better capability to estimate SpO2, compared to the
conventional oximeters.
Although these new signal processing algorithms have
reduced false alarms and improved PPG signal detec-
tion, they have failed to estimate SpO2 accurately in
patients experiencing ‘low perfusion states’. Also, the
degree of failure during low perfusion varies across dif-
ferent manufacturers
Novel reflectance sensors tech-
nology
In order to avoid pulse oximeter failure in low perfusion
states, novel reflection based sensors were developed
to measure PPGs and SpO2s from alternative mea-
surement sites such as the oesophagus, larynx, liver,
bowel, brain, forehead, and anterior fontanelle. These
new sensors had shown to estimate SpO2 accurately in
conditions when the finger pulse oximeters failed
These new sensors suffer from few functional difficul-
ties such as attachment problems, venous pulsations,
motion artefacts and require considerable expertise to
use them. Some of these sensors are invasive, hence
limiting their usage to patients undergoing surgery and
under anaesthesia.
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5.4 Summary of the advancements and proposed research
Pulse oximeters, since their invention, have been under constant development in both
hardware and software aspects. These developments have made the device into a clinical
tool with a potential to provide far greater clinical information than just oxygen saturation.
However, there are still unsolved problems that limit their performance. A summary of
these advancements in the technology and their limitations are provided in Table 5.1.
Significant improvements were made in utilising the PPG signal from a pulse oximeter.
The PPG signal is now used to estimate parameters such as perfusion index, pleth vari-
ability index, respiration rate and pulse rate variability. These parameters provide vital
information that can enhance the clinical outcome of the patients in critical care. However,
as with SpO2 measurements, all these parameters are subjected to the ability of the pulse
oximeter to detect an undistorted peripheral signal. Hence in conditions of compromised
peripheral perfusion or heavy motion, none of these parameters can be estimated. To avoid
this limitation, manufacturers have developed many algorithms that can better detect the
PPG signal, in conditions of motion and low perfusion. Pulse oximeters equipped with
these algorithms have proven to perform better than the conventional pulse oximeters.
However, they have failed to estimate SpO2 in patients experiencing ‘low perfusion states’,
although the degree of failure varied across different manufacturers.
Few researchers have taken an alternate route to counter this issue, as opposed to working
on peripheral sites which are usually affected by low perfusion states, they have developed
reflectance sensors to detect PPG signals from more centrally perfused areas of the body.
These new sensors had shown promising results in detecting PPG signals and estimating
SpO2 accurately in conditions when the finger pulse oximeters failed. These novel sensors
have also made it possible to monitor perfusion of vital organs in the body. However,
some of these sensors experience functional difficulties such as attachment problems, ve-
nous pulsations, motion artefacts and require considerable expertise to use them. Other
sensors which are semi-invasive can only be used in patients undergoing surgery and under
anaesthesia.
Hence, there is a clear need for a non-invasive PPG sensor system which can detect PPGs
reliably and estimate SpO2 accurately from an area where perfusion is not easily compro-
mised. To address this issue, we propose the ear canal as an alternative location for oxygen
saturation monitoring on the hypothesis that this central site will have much-reduced in-
fluence from low perfusion states and, as a result, a better quality PPG signal during
critical conditions. The ear canal as a measurement location offers many physiological
and mechanical advantages over other peripheral and central sites. A complete review on
the choice of the ear canal as a measurement site is provided in Chapter 6, some of the
key advantages are highlighted here
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• The ear canal provides stable temperature close to the core temperature of the body
and is less influenced by the sympathetic nervous system during low perfusion states.
• This sensor location is non-invasive and provides factor of comfort and invisibility
of the sensor as it can be concealed by the ear and hair
• As proven by hearing aids and headsets, the ear canal provides a natural anchoring
point for the sensor, thus avoiding the need for adhesives or bands
• Furthermore, ear canal offers fewer motion artefacts, as the head is less affected by
motion than the other extremities
To validate this hypothesis, a micro-optic reflectance ear canal sensor was developed along
with the instrumentation and software required for acquisition of PPG signals and com-
putation of variables from the PPG signals. An optically identical finger sensor was also
developed to allow for comparison between the peripheral and central circulations. De-
tailed description of the developed technology is provided in Chapter 7 and Chapter 8
5.5 Summary
Although pulse oximeters give reliable readings of blood oxygen saturation, there are sig-
nificant limitations on the accuracy and the availability of pulse oximetry data in some
circumstances. These limitations include motion artefact, low perfusion, electromagnetic
interference, venous pulsations, etc. In the past two decades, researchers and manufactur-
ers have constantly improved the pulse oximetry technology to overcome these limitations.
The improvements to the technology were in four main streams, namely the analysis of
the PPG waveform, multi-wavelength PPG signal analysis, signal processing algorithms
and novel reflectance sensors. These developments to the device have made it into a
clinical tool with a potential to provide far greater clinical information than just oxygen
saturation. However, there is still room for further improvement and optimisation of the
technique. Particularly in tackling the problems associated with pulse oximeters in low
perfusion states. Hence, the ear canal is proposed as an alternative measurement site for
measuring PPG signals in conditions of compromised peripheral blood supply. A detailed
description of the choice of the ear canal as a measurement site and previous work carried
out is discussed in the next chapters.
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— I’m not enthusiastic about the
forehead, I don’t have high hopes
for this sensor site. Researchers
and manufacturers need to explore
other probe sites on the head.
Steven J. Barker, during 2004
annual meeting of the Society for
technology in anaesthesia
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The ear canal as a location for oxygen saturation
monitoring
Since their invention in 1974, pulse oximeters have undergone many technological changes.
The device has become a quasi-standard, if not standard, monitoring device in hospital
critical care units and surgical theatres. The oximetry measurements provided by the
instrument are often referred to as the “fifth vital sign”.
However, as with any technology, the device possesses a few limitations. Despite many
efforts over the years to curb these limitations, the device is still reported to fail in a few
conditions. One of the major situations, where pulse oximeters fail to yield an accurate
SpO2 reading, is in conditions of compromised peripheral perfusion. Failure in such cir-
cumstances is related to the utilisation of the sensor in locations where perfusion is easily
compromised (i.e. finger, toe, earlobe). In order to overcome this limitation, the ear canal
has been proposed as an alternative monitoring site on the basis that this central site
would not experience effects of compromised perfusion.
This chapter describes the basic anatomy and blood circulation of the human ear canal.
The hypothesis and the justification of choosing the ear canal as the alternative measure-
ment site are provided in this chapter. Also, previous attempts made to develop an ear
canal PPG/SpO2 sensor are discussed in this chapter.
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6.1 Anatomy of Ear
The human ear is divided into three main regions: (1) the external ear, which funnels the
sound through the external auditory canal, to the tympanic membrane; (2) the middle
ear, which conveys sound vibrations from the eardrum to the oval window and converts
the sound vibrations to liquid form; and (3) the internal ear, which translates the fluid





Figure 6.1: Frontal section through the right side of the skull showing the three principal
regions of the ear, the external, middle and internal ear (illustration inspired from [255]).
6.1.1 The external ear
The external ear consists of the auricle, external auditory canal and tympanic membrane.
The auricle is the cartilaginous part of the external ear on the outside of the head (Fig-
ure 6.2(a)). It is shaped like the flared end of a trumpet and is also referred to as Pinna.
The auricle, which extends from the skull with an approximate angle of 30 degrees, is
attached to the head by way of three extrinsic muscles, the superior, anterior, and poste-
rior auricular muscle. Major cartilages of the auricle are the helix, antihelix, tragus, and
antitragus. The depression in the centre is the concha and the ear lobe is called lobule
[256].
External auditory canal (external auditory meatus, external acoustic meatus) is a curved
tube about 25 mm in length and 8 mm in diameter. The opening of the ear canal is oval,
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(a) Auricle (b) Ear canal frontal view (c) Ear canal transverse view
Figure 6.2: Shows (a) the auricle: cartilaginous part of the external ear, (b) the frontal
view of ear canal showing the osseo-cartilaginous junction and (c) the transverse view of
the ear canal showing the two less pronounced bends
averaging 9 mm in height and 7 mm in width [257, 258]. The outer part of the canal
consists of a soft cartilaginous body and a 0.5 - 1.0 mm thick skin with glands and hair
follicles. The outer part forms one-third to one-half of total canal length. The rest of the
canal is a more sensitive skin lining a bony canal. The skin here is approximately 0.2 mm
thick. When seen from the front, as in Figure 6.2(b), there is a curvy bend in the junction
between the cartilage and bone sections. This junction is termed the osteocartilaginous
junction [259]. When seen from above, as in Figure 6.2(c) there are two less pronounced
bends. The first of which is in the lateral part of the canal near the canal entrance. The
second is near the junction of the cartilage and the bony parts. The ear canal also narrows
down towards the second bend. The tympanic membrane is a thin pearl-gray membrane
with an average thickness of 0.074 mm and separates the external ear from the middle ear
[258]. Sound waves reaching the tympanic membrane cause it to vibrate.
6.1.2 The middle ear
The middle ear is the air-filled cavity of the ear; it extends from the tympanic membrane
to a bony wall containing two small openings called the oval window and the round win-
dow. Three small bones are found between the tympanic membrane and the oval window,
collectively called the ossicles. These bones called the malleus (hammer), incus (anvil)
and stapes (stirrup) are the smallest bones in the human body (Figure 6.3) [260]. The
sound vibrations from the tympanic membrane push the malleus, which then begins to
vibrate in sync with the sound. When the malleus vibrates against the incus, it also begins
to vibrate and transfers the vibration to the last ossicle, the stapes. The plate at the end
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of the stapes lies on top of the oval window of the cochlea and the vibration of the plate
creates pressure waves into the fluid-filled cavity of the cochlea in the inner ear. There is
a tube connecting the tympanic cavity in the middle ear with the nasal cavity called the
eustachian tube. This tube permits equalisation of air pressure. The eustachian tube is

















Figure 6.3: Diagram of the middle and inner ear showing parts for hearing and equilib-
rium.
6.1.3 The inner ear
The inner ear is a fluid-filled chamber with various passages and cavities. The inner
ear can be divided into three regions; the semi-circular canals, the vestibule and cochlea
(Figure 6.3). The semi-circular canals and the vestibule provide information regarding
rotational and gravitational equilibrium. The cochlea is a fluid-filled coiled structure
consisting of three canals called the vestibular canal, the cochlear canal, and the tympanic
canal [254]. The cochlea is lined with about 18,000 microscopic hair cells, on top of
which are hair-like structures called stereocilia, and it transforms fluid motion into electric
energy. These electrical impulses are passed to the auditory cortex of the cerebral cortex,
for interpretation.
6.1.4 Blood supply to ear
To monitor the blood oxygen saturations from the ear, it is important to understand how
oxygenated blood is supplied to the ear and deoxygenated blood is drained from the ear.
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As mentioned in Chapter 2, oxygenated blood from the left ventricle of the heart enters
the aorta during systemic circulation. The aorta branches into many arteries, which carry
blood to various body parts. The arch of aorta gives out two main arteries that supply
blood to the head and the neck; the right and left common carotid arteries. The common
carotid arteries branch in the neck to form the external and internal carotid arteries. The
internal carotid arteries supply blood to the brain. The external carotid arteries supply
blood to face, ears and other external parts of the head. The ear, in particular, gets
a rich blood supply blood supply from two main branches of the external carotid artery,
namely the posterior auricular artery and the superficial temporal artery (Figure 6.4) [261].
Additional supply to the deeper parts of the ear comes from branches of the maxillary and
occipital arteries.
The auricular branches of the superficial temporal artery distribute blood to the lobule,
anterior portion of the auricle, and to the external auditory canal. The posterior auricular
artery supply blood to the posterior portion of the auricle [262]. The ear canal is partially
provided by the same vessels as the auricle, but the deeper portion, including the external
surface of the tympanic membrane, is supplied by the deep auricular artery, a branch of
the internal maxillary artery [256]. Venous drainage is primarily through the posterior
auricular vein. The superficial temporal vein and the maxillary vein also return blood
from the middle and inner parts of the ear. All three veins drain blood into the external
jugular vein, which returns blood to the heart via superior vena cava.
Figure 6.4: Branches of common carotid artery which supply blood to human ear [33].
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6.2 Ear canal as a location for oxygen saturation monitoring
Blood oxygen monitoring using peripheral pulse oximetry is susceptible to inaccuracies
in conditions of compromised peripheral perfusion and motion. Such a situation usually
occurs in patients experiencing hypothermia caused due to decreased heat production (hy-
popituitarism, hypothyroidism), increased heat loss (vasodilation, erythrodermas, burns),
impaired thermoregulation, drug administration (such as anaesthetic agents, clonidine,
neuroleptics), and dehydration. Motion artefact from shivering and the lack of detectable
peripheral pulse due to peripheral vasoconstriction causes the pulse oximeter to fail.
In order to address this issue, the ear canal has been proposed as a new monitoring site
for measuring blood oxygen saturation. The rationale behind the proposal is that the
ear canal being closer to the trunk will have a much-reduced influence from low perfusion
states and, as a result, a better quality signal during critical conditions. For instance, in
conditions of severe hypothermia or multiple organ failures due to cardiogenic shock, the
circulatory system reacts by shutting down blood supply firstly to the periphery followed
by kidneys and mesenteric vascular bed. This is so that blood can be shunted to essential
organs such as the heart and the brain, at the expense of other non-essential organs. Since
blood supply to the ear is by the same arteries which supply blood to the brain (Carotid
arteries), it should be possible for oxygen saturation to be measured from the ear canal in
such cases. Additionally, the ear canal offers many advantages over other peripheral and
central sites, which are listed below.
Figure 6.5: Thermogram of the ear of an adult male showing variations in temperature.
The temperature runs from red (warmest) through yellow, green, cyan and blue to mauve
(coldest) [263].
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Physiological advantages of the ear canal
• The walls of the ear canal and the tympanic region follow the body’s core temper-
ature with high fidelity as they share the blood supply with the “hypothalamus”
- the body’s thermostat, making it a uniquely desirable site for SpO2 monitoring
(Figure 6.5).
• The ear canal is an alternate monitoring site with easy access during surgery, resus-
citation, in patients with finger deformities, or when digit access or other peripheral
sites are not accessible. It also allows for hands-free monitoring.
• The ear canal as a location provides a factor of comfort and invisibility of the sensor,
as it can be concealed by the ear and hair, thus widening the possibility of its use in
day to day activities.
• The changes in beat-to-beat rhythm due to respiration are more pronounced in the
ear canal than other sites such as finger due to the relatively short distance from the
heart. This makes it possible for accurate determination of respiration rate extracted
from the ear canal PPG signals.
• The influence of sympathetic and parasympathetic nerve activity on cerebral blood
flow is reported to be peculiarly little even in conditions of haemorrhagic hypoten-
sion. Although this remains controversial, if true, it would enable uninterrupted
monitoring of SpO2 from the ear canal at all times.
Advantages of ear canal over other sensor locations
• This central site could offer fast desaturation response time and high sensitivity which
is invaluable in patients at risk of hypoventilation and hypoxaemia. The routinely
used finger clip pulse oximeter has the slowest response time of up to two minutes
in healthy subjects.
• Compared to some of the other central sites discussed in Chapter 5, this sensor
location is non-invasive and does not require any training or expertise to place the
sensor.
• As with reflectance forehead sensor, the ear canal does not suffer from attachment
problems, as the shape and structure of the ear canal provide a natural anchoring
point for the sensor, thus avoiding the need for adhesives.
• As shown in Figure 6.5, the ear canal offers better perfusion than the ear lobe. i.e.
improved signal quality in the ear canal than the ear lobe.
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• The ear canal probe would not suffer from the effects of EMI (from the visible
region), as the hollow, tube-shaped cylindrical structure of the ear canal prevents
any excessive ambient light energy from saturating or flooding the photodiode.
• The commercial applications of the device are also numerous and are associated with
patient monitoring during surgical procedures, diagnostic procedures, alternative
care, etc. A unique niche market for the ear canal sensor is in patients suffering from
Chronic Obstructive Pulmonary Disease (COPD) and sleep apnoea. The sensor can
also be used for vital sign monitoring from emergency operators such as fire-fighters,
military combatants, law enforcement officers or paramedics operating in harsh and
hazardous environments.
Based on a similar hypothesis, a team of biomedical engineers from Philips Chair for
Medical Information Technology (MedIT) and the CiS Research Institute for Micro Sensors
and Photovoltaics GmbH (Erfurt, Germany) have previously developed a wearable in-ear
measuring system (IN-MONIT) for 24/7 monitoring of vital parameters in cardiovascular
patients [264]. The IN-MONIT sensor system consisted of a micro-optic reflection sensor
(MORESr technology, CiS Research Institute for Micro Sensors and Photovoltaics GmbH)
and a body box containing the signal processing unit. The MORESr sensor consists of
two LEDs with peak emission wavelengths at 760 nm and 900 nm and a photodiode placed
2 mm away from the LEDs. This in-ear sensor was designed to acquire PPG signals from
the back of the targus (small pointed eminence of the ear canal- Figure 11.11) [265].
Their initial investigation was focused on estimating heart rate from the red and infrared
PPG signals acquired from the targus of the healthy volunteers [266]. The results demon-
strated that accurate determination of heart rate is possible. The developed sensor was
then calibrated using a hypoxic study in 10 healthy volunteers [267]. The accuracy level
of the global calibration curve acquired from this study was, however, reported to be
unacceptable for use in SpO2 measurements. More recently, Venema et al. investigated
the feasibility of measuring heart rate and SpO2 in 29 adult patients undergoing various
surgeries [268]. They compared their in-ear SpO2 measurements with simultaneous SaO2
measurements from a blood gas analyser, and SpO2 measurements from two reflectance
commercial pulse oximeters. The estimated SpO2 values were reported to be inaccurate
with standard deviation (STD) in most cases exceeding -3 ± 7 %, which is well beyond
the requirements for medical pulse oximeters.
The red PPG signals acquired from the IN-MONIT system were also reported to be noisy.
Venema et al. has attributed the low SNR of the red PPG signals to the small separation
distance between the emitter and the photodiode (2 mm). The other possible source of
error in their design could be from the use of red LED with peak emission at 760 nm. As
the selected wavelength is close to the isobestic point, the difference in absorption between
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the Hb and HbO2 at this wavelength will be smaller (Figure 4.4). Hence, the absorption
measured at this wavelength would not be proportional to the concentration of Hb, leading
to inaccurate SpO2 readings. So far, none of the studies by Venema et al. have presented
any investigations into the morphology or the quality of PPG signals that can be acquired
from the targus or from any other site from the ear.
To overcome the drawbacks of Venema’s design, and the difficulties associated with at-
tempts to measure SpO2 in conditions of poor peripheral circulation, the investigation
of PPG signals from the surfaces of the external auditory canal is suggested. This novel
location - the ear canal - could offer better quality PPG signals than the targus, eventually
allowing for reliable monitoring of SpO2.
To validate the hypothesis that perfusion in the ear canal might be preferentially preserved,
an earphone shaped ear canal probe has been developed and is described in detail in the
next chapter. Along with the reflectance ear canal probe, an optically identical finger
probe, instrumentation unit (Chapter 8) and the software required for data acquisition
and storage (Chapter 9) was also implemented. The developed technology was then used
to
• investigate the quality and morphology of PPG signals obtainable from different
surfaces of the ear canal (i.e. top, bottom, left and right sides of the ear canal).
• investigate the suitability of the ear canal for monitoring PPG signals and arterial
oxygen saturation in conditions of induced local hypothermia using a cold pressor
test (healthy volunteer study, n= 15).
• investigate the differences in the quality of PPG signals, pulse amplitude and SpO2
measured from the ear canal, finger, toe, and the earlobe sensors during induced
hypothermia by whole body cold exposure (healthy volunteer study, n= 15).
• study the differences in the degree of sympathetic nerve activity over cerebral and
peripheral blood circulations utilising low-frequency analysis.
6.3 Summary
The external auditory canal has been proposed as a new measurement site for PPG and
SpO2 monitoring in conditions of poor peripheral perfusion. The ear canal is a curved tube
approximately 25 mm in length and 7 mm in diameter. It has a rich blood supply from
the branches of the external carotid artery. The ear canal is a suitable choice for SpO2
monitoring as it offers many physiological and technological advantages over other central
sites. To validate this hypothesis, a miniaturised ear canal probe has been developed and
is described in detail in the next chapter.
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— The robustness of the PPG sig-
nal in this location is no great sur-
prise given that the ear canal has
long been recognised as an environ-
ment maintained at a stable tem-
perature close to the core tempera-
ture of the body.
Steve Perring, IPEM SCOPE,
2014
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Design and development of the reflectance ear
canal PPG probe
To overcome the limitations of commercial pulse oximeters (Chapter 6), in cases of poor
peripheral perfusion, it is proposed that the ear canal could be used as an alternative
measurement site to monitor photoplethysmograph (PPG) signals and measure arterial
oxygen saturation (SpO2). For this purpose, two identical ear canal PPG probes with
different dimensions were initially developed. These sensors were used to investigate the
quality of PPG signals from different surfaces and depths of the ear canal. Based on the
results of the preliminary investigation and feedback from a participant survey, the probe
underwent evolutionary design optimisations. This chapter describes in-detail the various
stages in the design and fabrication of the reflectance ear canal PPG probe.
The chapter also describes the design and development of two conventional PPG probes
which are used to acquire PPGs from the finger or the toe. These sensors were developed
to facilitate comparisons between the ear canal (central site) and the finger (peripheral
site). All sensors were designed to be optically and electrically identical. All sensors
were constructed to be reusable, to eliminate any sensor dependent variables that may
influence the data during clinical investigations. To avoid any infections, all the probes
were manufactured with medical grade materials, which can be sanitised with standard
sanitization fluids/wipes. Finally, the performance evaluation tests carried out in the
laboratory at all stages of the probes’ design are described in this chapter.
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7.1 Reflectance ear canal photoplethysmography (RECAP)
probe I
Two identical ear canal PPG probes with different dimensions were initially developed
for the measurement of photoplethysmograms from various depths and different surfaces
across the circumference of the ear canal. The probes comprised of two surface mounted
LEDs and a surface mounted photodetector. As transmission mode measurements are not
possible from the tissue lining the ear canal, the ear canal probe was designed to operate
in reflection mode. In this configuration, both the LEDs emitted light into the tissue
lining of the ear canal and the photodetector detected the backscattered radiation and
produced an output proportional to the detected radiation level. The detected signals
were preconditioned and preprocessed by a PPG instrumentation unit. The probe was
connected to the instrumentation unit using a multi-core cable, interfaced through a DE9
connector. The preprocessed signals from the instrumentation unit were digitised by a
National Instruments data acquisition card (NI PCIe-6321) and were displayed and stored
on a computer running LabVIEW (National instruments corporation, Texas, USA). These









Figure 7.1: Block diagram of the ear canal PPG probe connected to the PPG processing
system.
7.1.1 Choice of optical components
The red and infrared emitters used in the design of the probes are surface mount ceramic
chip type LEDs, with peak emission wavelength at 658 nm and 870 nm respectively (CR
50-1M and CR 50 IRH, Excelitas technologies, USA). The reason for the choice of these
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wavelengths is that the absorption spectra of oxyhaemoglobin and deoxyhaemoglobin at
these wavelengths is relatively flat and there is a large difference in the absorption char-
acteristics. The physical dimensions of both the LEDs are 3.2 mm× 1.27 mm× 1.2 mm.
The photodetector used is a flattop photodiode with an active area of 0.65 mm2 and
peak sensitivity at 900 nm (SR 10 BP-BH, Excelitas technologies, USA). The physical
dimensions of the photodiode are 3.2 mm × 1.6 mm × 1.2 mm. The optical, electrical
and packaging specifications of the LEDs and the photodiode are shown in Table 7.1 and
Table 7.2 respectively.
Note that the peak emission wavelength of the infrared LED (870 nm) differs from the
wavelength commonly used in pulse oximetry (940 nm). This, however, is not an issue
since the absorption spectra of oxyhaemoglobin and deoxyhaemoglobin in the region of
820 nm to 940 nm are relatively flat (see Figure 4.4).
Table 7.1: Optical, electrical and packaging specifications of the red and infrared emit-
ters
Optical and electrical characteristics CR 50-1M CR 50-IRH
Peak emission wavelength (λ) 658 nm 870 nm
Radiation power or luminous intensity at 20 mA 50 mcd 4.5 mW
Power dissipation (PD) 130 mW 130 mW
Forward voltage (Vr) at 20 mA 1.8 V 1.35 V
Minimum reverse voltage 5 V 8 V
Reverse leakage current 100 µA 100 µA
Peak forward current at 10 µs 600 mA 800 mA
Light emitting angle 180◦ 160◦
Size 1206 (imperial) 1206 (imperial)
Packaging details:
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Table 7.2: Optical, electrical and packaging specifications of the photodiode
Optical and electrical characteristics SR 10 BP-BH
Peak wavelength sensitivity (λmax) 900 nm
Radiation sensitive area 0.65 mm2
Junction capacitance 10 pF
Open circuit voltage 400 mV
Reverse breakdown voltage 170 V
Reverse dark current 10 nA
Size 1206 (imperial)
Packaging details:
7.1.2 Geometry of the probe
The physical dimensions and the shape of the ear canal probes were determined by the
anatomical characteristics of the auditory canal. In adults, the external auditory canal
is approximately 25 mm in length and 8 mm in diameter. The opening of the ear canal
is oval, averaging 9 mm in height and 7 mm in width [259]. The outer auditory canal is
skin lined soft cartilage connected to a hard bony inner auditory canal. There is a slight
angulation between the outer and inner parts (see Figure 6.2(b)). Therefore, the physical
dimensions of the probe should be small enough to fit comfortably inside the external
auditory canal, while being big enough to firmly hold itself against the walls of the ear
canal. The length of the probe should also be slightly smaller than the outer auditory
canal so that the angulation between the cartilaginous outer canal and bony inner canal
can be avoided. Hence, the dimensions of the ear canal probe should ideally be between
10 mm - 15 mm in length and 6 mm - 8 mm in diameter.
7.1.3 Fabrication of RECAP probe I
With the optical components and the dimensions specified, it was decided that two round
nosed cylindrical (bullet shaped) probes will initially be developed. The probes were
intended to assess a suitable length and a surface across the circumference of the ear canal
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at which good quality PPG signals can be acquired. The probes were designed to fit
10 mm and 15 mm inside the ear canal (measured from the targus as the reference point).
These prototype probes were designed to be cylindrical so that they can be rotated in
the ear canal to acquire PPG signals from various surfaces. Hence avoiding the need for
the development of multiple PPG probes. The developed probes consisted of two main
modules; a miniaturised optoelectronic sensor, and a specially designed sensor case. Note
that both the probes are identical in design and only differ from each other in dimensions.
7.1.3.1 Miniaturised optoelectronic sensor
The miniaturised optical sensor is a small Printed Circuit Board (PCB) consisting of a red
and an infrared LED and a photodiode. As with any reflectance probe, the emitters and
the photodiode were placed next to each other and were separated by a center-to-center
distance of 5 mm. The source-detector separation was chosen to be 5 mm, as experimental
studies have shown that a separation of 4 to 5 mm provides the best sensitivity in terms
of detecting adequately large pulsatile PPG signals [117]. The LEDs in both the probes
were connected anti-parallel to each other as shown in Figure 7.1 and were switched on
and off alternatively by a constant current produced from the PPG instrumentation unit.
The dimensions of the optical sensors developed were 15 mm × 5.5 mm × 0.3 mm and
10 mm × 5 mm × 0.3 mm respectively. The 3D models and the mechanical drawings of
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Figure 7.2: The 3D model and mechanical drawing of the optoelectronic reflectance
sensor used in the smaller version (10 mm) of the RECAP probe I.
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Figure 7.3: The mechanical drawings of the both the probe cases.
The sensors were first virtually designed using Altium designer (Altium Limited, Sydney,
Australia), an electronic design automation software package. Once the design was ready,
the PCBs were manufactured by the process of photolithography. In this process, the
completed designs were first printed on a LaserStar PCB printing paper using a laser
printer to produce PCB artwork. The artwork was then aligned on top of a photo-resist
coated copper-clad board and was exposed to UV light. Once sufficiently exposed, the
copper boards were rinsed in photoresist developer and were then dipped in a bubble tank
containing ferric chloride solution maintained at 40◦C to etch the tracks. The sensors were
then cut to the designed length and were tip plated using tin sulphate solution to stop
the tracks from oxidation. The width of the etched copper tracks was 0.4 mm. All optical
components were then soldered to the respective copper pads of the PCBs, using a reflow
soldering oven maintained at low temperatures (180◦C to 220◦C).
7.1.3.2 Sensor case
The sensor case which holds the miniaturised optical sensor was designed to fit comfortably
inside the ear canal. The cases were designed using Solid Works 2012 (Dassault Systemes
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SolidWorks Corp., Velizy, France) and were manufactured using 3D printing technology.
Solid Works is a 3D CAD draughting software which utilises a parametric feature-based
approach to creating models and assemblies. As specified previously, both sensor cases
were designed to be bullet shaped with varying dimensions. The mechanical drawings of
the sensor cases are shown in Figure 7.3. The total length of the probes was 20 mm and
13 mm respectively while the diameter of the probes is 8 mm and 7 mm respectively. The
sensor casing consisted of a small rectangular aperture to accommodate the optical sensor.
The dimensions of the rectangular slots were the same as the optoelectronic sensor (i.e.,
15 mm × 5.5 mm × 0.3 mm and 10 mm × 5 mm × 0.3 mm). The cases were designed to
fit approximately 15 mm and 10 mm inside the ear canal.
Both the sensor cases were designed with a 2 mm hollow bore extending from one side
of the probe to another and two small holes perpendicular to the bore. These apertures
were used to run a four core ultra-flexible cable which provided electrical contact between
the optical components and the PPG processing system. To stop the probe from being
inserted too deep into the ear canal, the diameter of the probes distal end was increased by
a few millimetres. The front end of the probe was designed to be dome-shaped to provide
a smooth and comfortable feeling while placing the probe in the ear canal.
Once the 3D models were ready, the files required for 3D printing the models such as
STereoLithography (STL) files and print path files (G–code) were generated. Using the
generated files, the sensor cases were then 3D printed. The 3D printer used to manu-
facture the designed sensors was the Objet24 Desktop 3D Printer (Stratasys Ltd., Min-
nesota, USA). The material used to 3D print the sensor cases was Polymerized Objet
VeroWhitePlus–RGD835 (Stratasys Ltd., Minnesota, USA). VeroWhitePlus–RGD835 is
a rigid opaque white material used for rapid prototyping of highly accurate and complex
medical device models. The sensor cases were printed with a Z resolution (layer thickness)
of 30 µm.
Once both the optoelectronic sensors and the sensor cases were manufactured, a four core
screened cable (external ⊘: 3.5 mm) was drawn through the mechanical casing of the
ear canal sensor and was soldered onto the PCB using the vertical interconnecting access
(vias) holes. Once the wires were soldered, the PCB was fixed firmly into the specially
designed PCB slot in the sensor casing. The other end of the screened cable was soldered
to a male DE9 connector, which provides communication between the probe and the
PPG processing system. In order to avoid direct contact between the optical components
and the skin lining the ear canal, the whole aperture holding the PCB was sealed using
medical graded clear epoxy resin (DYMAX 141-M, Dymax Corporation, Torrington, CT).
The other end of the multicore cable was soldered to a male DE9 connector. Figure 7.4
displays 3D models and photographs of the RECAP I probe.
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Figure 7.4: 3D models and photographs of one of the first prototype RECAP probes.
7.2 Preliminary evaluation of RECAP probes I
The following evaluation tests were carried out in the laboratory to validate the function-
ality of the prototype ear canal probes. The probes were tested with the help of the PPG
processing system and the software described in Chapter 8 and 9.
7.2.1 Acquisition of PPG signals from different depths of the ear canal
Following Institutional Senate Research Ethics approval, a brief study was carried out in
7 healthy volunteers, with the following objectives
• to investigate the likelihood of measuring good quality PPG signals from the external
auditory canal
• to determine an optimal length within the ear canal at which PPG signals with high
amplitude can be recorded
• to check with the help of a participant survey the compatibility and factor of comfort
the developed prototype probes offer, and to enquire about the possible modifications
in the probe’s shape and structure to make it more comfortable.
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7.2.1.1 Method
During the study, each volunteer was made to sit comfortably in a chair, and the ear
canal probes were placed inside the left and right ear canals of the volunteer. One of
the probes was placed 15 mm into the ear canal (left) and the other probe was inserted
10 mm into the (right) ear canal (measured from the targus as a reference point). Prior
to the study, both the probes were cleaned thoroughly using disinfectant alcohol wipes
to avoid cross-contamination. Once the sensors were in place, the red and infrared PPG
signals were acquired from the volunteer for approximately 3 min. The prototype PPG
processing system comprised of two constant current sources, which drove the red and
infrared LEDs alternatively at 40 mA. The output of the processing system was then
digitised and acquired by the NI USB-6212 and a virtual instrument (VI) designed in
LabVIEW.
As a next step in the study, all volunteers were asked to wear both the probes for an
additional 15 min, at the end of which, they were asked to fill in a participant survey. In
this survey the volunteer was asked to answer a few questions concerning the comfort level
of the probes. They have been invited to rate the comfort level of the probes on a scale of
0 (unbearable) to 10 (very comfortable). Volunteers were also requested to give input on
any aspects of the probe design which would make the probe more appealing for everyday
use.
7.2.1.2 Results
The raw PPG signals recorded from both 10 mm and 15 mm inside the ear canals of the
volunteers were extracted for analysis in MATLAB (The MathWorks Inc., Massachusetts,
USA). The AC components of the PPG signals were derived by filtering the raw PPG
signals using an equiripple band-pass filter with cut-off frequencies at 0.5 Hz and 12 Hz
respectively. The DC component was extracted using a low-pass filter with a cut-off
frequency of 20 Hz.
The red and infrared AC PPG signals detected from the auditory canal of the volunteers
were generally of good quality with large amplitudes and high signal to noise ratio. Fig-
ure 7.5 depicts the typical red and infrared AC PPG traces acquired from variable depths
(10 mm and 15 mm) of the ear canal in a random volunteer. As expected, the variability
in PPG signal amplitude due to respiration was pronounced in both the AC and DC PPG
signals acquired from the ear canal. The DC PPG signals acquired from 10 and 15 mm
inside the ear canal of a volunteer, during normal breathing are shown in Figure 7.6.
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Figure 7.5: Typical red (black trace) and infrared (green trace) AC PPG traces acquired
from variable depths (10 mm and 15 mm) of the ear canals in a random volunteer.
2.44
2.46
















0 0.5 1 1.5
0.85
0.86
Red PPG signal (15 mm)
Time (min)
Figure 7.6: The DC PPG signals acquired from 10 and 15 mm inside the ear canal of
a randomly selected volunteer.
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Although PPG traces were detected at both depths inside the ear canal, there were clear
differences in the amplitude of the PPG signals acquired in both locations. To quantita-
tively assess the differences between the amplitude of PPG signals obtained from the outer
ear canal and the inner ear canal, the mean normalised pulse amplitude (NPA) of the red
and infrared PPG signals was computed and compared. NPA, also known as normalised
pulse volume (NPV), is usually expressed as ∆Ia/I, where ∆Ia is the intensity of pulsatile
component superimposed on the transmitted light I (i.e., AC component of PPG signal
divided by the DC component).
The NPA was measured instead of conventional pulse amplitude (PA) as NPA reflects ∆Va
(the pulsatile component of the arterial blood volume) in a more exact manner than PA.
Also, the magnitude of both the pulsatile (AC) and the non-pulsatile (DC) components
usually differs from one site to another, hence to draw a true comparison, all the signals
were normalised.
Table 7.3 shows the mean NPA and the standard deviation (±SD) of red and infrared
PPG signals acquired from the outer (10 mm) and inner (15 mm) ear canals of 7 healthy
volunteers. The data is graphically displayed with the use of a bar plot in Figure 7.7. The
red and infrared PPG signals acquired from the outer ear canal of the volunteers were
smaller in amplitude when compared to those acquired from the inner ear canal. However,
the red PPG signals recorded deeper inside the auditory canal (15 mm) were slightly noisy
and sensitive to artefacts caused due to heavy breathing and jaw movements. This is
expected as the Eustachian tube conducts respiratory and jaw movements to the middle
ear and deeper regions of the outer ear.
To check for any statistical significance between the mean amplitude of PPG signals mea-
sured from the outer and the inner ear canal, a paired t-test was performed on the data.
Table 7.3: Shows the mean NPA of red and infrared PPG signals acquired from the
outer and inner ear canals of 7 healthy volunteers
Volunteer









1 41.8± 12.7 21.2± 6.3 31± 9.3 15.2± 4.6
2 20.5± 6.5 6.7± 2 40.7± 12.4 10.1± 2.8
3 18.9± 5.8 6.6± 2 15.3± 4.6 7.1± 2
4 11.9± 3.6 5.3± 1.6 21.5± 6.5 6.9± 2
5 18.7± 6 10.5± 3.3 47.2± 15.1 20.9± 6.6
6 18.2± 5.8 10.2± 3.2 45.3± 14.4 18.8± 5.8
7 29.9± 9.4 10.5± 3.3 42.6± 13.6 16± 4.7
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Figure 7.7: Mean of the means (n=7), ±SD of normalised infrared and red PPG signals
acquired from 10 mm and 15 mm deeper inside the ear canal.
The normality was tested using the KolmogorovSmirnov test. All statistical tests were
carried out using SigmaPlot-12.0 (Systat software Inc., Chicago, USA). It was found that
all the data were normally distributed, and there was no statistical significance (infrared:
P= 0.07, red: P= 0.26) between the amplitude of PPG signals acquired from the outer
and the inner ear canals. From these observations, it is safe to say that the outer ear canal
is possibly the best location for PPG signal monitoring, especially since the PPG signals
acquired in this area are not noisy and free from respiratory artefacts. However before
making any decision on the sensor location, the participant survey was also considered.
In this survey the participants were asked to answer seven questions in the survey, which
were designed to aid the further development and optimisation of the technology.
Table 7.4 shows the participants’ responses and comments to the questions asked in the
participation survey. Some of the participants in the study have expressed discomfort
with the larger size of the ear canal sensor (15 mm) placed in the left ear canal. Most
volunteers were comfortable wearing the slightly smaller version of the prototype (10 mm)
even for long periods of time. Some of the volunteers have, however, reported that both
the sensors were slightly tight inside the ear. A couple of the volunteers have also reported
that the probes were slightly warm when worn for more than 15 min. Overall, none of the
volunteers found the probes to be completely uncomfortable. Based on these comments
and responses from the survey, and the results obtained from the preliminary investigation,
it is evident that the outer auditory canal would be the optimal site for monitoring PPG
signals and arterial oxygen saturation.
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Table 7.4: Summarises the responses of the volunteers to the participation survey
Questions
Volunteers
1 2 3 4 5 6 7
On a scale of 1-10, how comfortable is
the probe in your left ear
8 6 7 7.5 7 6 5.5
On a scale of 1-10, how comfortable is
the probe in your right ear
9.5 8 9 10 10 9 9
How does the probe feel when worn in
the ear? Please number all that ap-
ply (1.Tickling, 2. Tight 3. Prickle 4.
Warm)
1 ✗ 4 ✗ ✗ 2, 4 2
Was it uncomfortable to wear the probe
for any of the previously stated rea-
sons? (Yes/No)
No No No No No No No
Would you wear the device on a routine
basis? (Yes/ Maybe/ No/ Dont know)
Yes Maybe Maybe Yes Yes Maybe No
How long would you be willing to wear
the probe over a 12 h interval? (> 1 h,
> 3 h, > 6 h, > 8 h, < 8 h)
> 3 h > 6 h > 3 h > 3 h > 6 h > 3 h > 3 h
Please provide any specific comment
regarding the probe
Comment–1: Can the probe be designed to look
like a discreet hearing aid. That might increase
the sensor’s acceptability
✗ – No answer
7.2.2 PPG signal acquisition from various surfaces of the ear canal
Similar to the earlier experiment, a short study was conducted in 7 healthy volunteers
(following Institutional Senate Research Ethics approval) to determine the surface (ante-
rior, ventral, posterior and dorsal) along the circumference of the ear canal from which
the acquired PPGs will be of the best possible quality (Figure 7.8). It is essential that the
PPG signals acquired from the ear canal are of good quality with large amplitudes, since
the quality of the signals acquired has a direct impact on the SpO2 estimated. Different
surfaces across the circumference of the outer ear canal (10 mm inside the ear canal) were
explored during this experiment. Investigations were focused only on the outer region
since the earlier study has shown the outer ear canal to be the optimal site for monitoring
PPGs.
7.2.2.1 Methods
Four different surfaces across the circumference of the outer ear canal were investigated
during this study. The experiments were carried out in the research laboratory under room
temperatures between 22± 2◦C. During the experiment, each volunteer was first made to
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(a) Anterior (b) Ventral (c) Posterior (d) Dorsal
Figure 7.8: 3D models showing the frontal (a and c) and transverse views (b and d) of
the RECAP probe inside the ear canal. PPG signals were recorded from (a) anterior, (b)
ventral, (c) posterior and (d) dorsal surfaces of the ear canal.
sit comfortably on a chair, after which the ear canal probe was inserted 10 mm inside the
right ear canal. To provide a reference measurement to the PPG signals being acquired
from the ear canal, data was also acquired from a commercial finger pulse oximeter probe
connected to the processing system. The probe used was an LNCS DCI-Masimo reusable
finger probe (Masimo corp., CA, USA). The raw PPG signals from both the ear canal
and the finger were stored on a desktop computer for oﬄine analysis.
Once the setup was ready, PPG signals were recorded from the ear canal for a duration of
2 min with the optical components in the probe facing the top (anterior) surface of the ear
canal. At the end of the 2 min recording, the probe was rotated by 90◦ - clockwise inside
the ear canal, and the recording was continued for another 2 min. The same procedure was
repeated another couple of times. This was to acquire PPG signals from all four surfaces
(anterior, ventral, posterior and dorsal) of the ear canal as shown in Figure 7.8. During
this process, PPG signals were continuously acquired from the finger clip sensor attached
to the right index finger.
7.2.2.2 Results
The raw PPG signals acquired from the ear canal and the finger were analysed in Matlab.
The AC and the DC components of the red and infrared PPG signals were extracted by
filtering the raw PPG signals using band-pass (fc = 0.4 Hz and 12 Hz) and low-pass
filters (fC = 20 Hz). Figure 7.9 shows the AC PPG signals acquired from the posterior
surface of the ear canal and the simultaneously acquired finger PPGs for 10 sec. The first
observation that can be made from Figure 7.9 is the differences in the morphology of PPG
signals acquired from the ear canal and the finger. The dicrotic notch is clearly visible in
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Figure 7.9: The AC red (black trace) and infrared (green trace) PPG signals acquired
from the posterior surface of the ear canal and simultaneously acquired finger PPGs for
a period of 10 sec.
the diastolic phase of the finger PPG signals, whereas in the ear canal PPGs, it seems to
be almost merged with the systolic peak of the PPG signal. Secondly, there is an expected
time delay between the ear canal and the finger PPG signals. These changes in the
morphology of the PPG signals are thought to be due to variations in vascular compliance
and peripheral resistance of various arteries. An in-detailed investigation looking at these
changes is presented in Chapter 10.
The mean NPA (AC/DC) of red and infrared PPG signals (acquired from all four surfaces
of the ear canal) was measured, to quantitatively determine a surface from which PPGs
with high amplitude and quality can be acquired. Figure 7.10 shows the red and infrared
PPG signals acquired from all four surfaces of the ear canal in a randomly selected vol-
unteer. As can be seen from Figure 7.10, the PPG signals acquired from all locations
were of good quality and were more than adequate for SpO2 measurements. However, the
amplitude of the PPG signals acquired across all four locations differed.
Table 7.5 summarises the mean NPA (± SD) of red and infrared PPG signals acquired
from all four surfaces of the ear canal in 7 healthy volunteers. Figure 7.11 presents the
mean PPG amplitudes from all 7 volunteers along with the mean of the mean NPA of the
red and infrared AC PPG signals measured at the index finger. From the graph, it can be
observed that the mean NPA measured from the ear canal varied across all four locations
while the mean NPA of the simultaneously acquired PPG signals from the index finger
stayed relatively constant. This suggests that the changes noticed in the NPA of PPG
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Figure 7.10: The red (black trace) and infrared (green trace) PPG signals acquired
from anterior, ventral, posterior and dorsal surfaces of the ear canal.
Table 7.5: The mean NPA (± SD) of red (R) and infrared (IR) PPG signals acquired
from anterior, ventral, posterior and dorsal surfaces of the ear canal.
Surface PPG signals
Volunteers
1 2 3 4 5 6 7
Anterior
(Top)
IR ± SD (mV) 21 ± 6 39 ± 12 5 ± 2 10 ± 3 10 ± 3 18 ± 6 8 ± 3
R ± SD (mV) 9 ± 3 19 ± 6 2 ± 1 4 ± 1 4 ± 1 9 ± 3 2 ± 1
Ventral
(Right)
IR ± SD (mV) 41 ± 13 29 ± 9 8 ± 2 5 ± 2 12 ± 4 26 ± 8 27 ± 9
R ± SD (mV) 21 ± 7 11 ± 3 3 ± 1 3 ± 1 3 ± 1 13 ± 4 14 ± 5
Posterior
(Bottom)
IR ± SD (mV) 28 ± 9 49 ± 16 19 ± 6 35 ± 11 40 ± 4 30 ± 10 50 ± 16
R ± SD (mV) 9 ± 3 24 ± 8 7 ± 2 16 ± 5 17 ± 1 13 ± 4 12 ± 3
Dorsal
(Left)
IR ± SD (mV) 32 ± 10 49 ± 16 24 ± 8 34 ± 11 12 ± 13 37 ± 12 29 ± 9
R ± SD (mV) 11 ± 3 23 ± 7 10 ± 3 17 ± 5 5 ± 5 15 ± 5 5 ± 2
signals acquired from different surfaces of the ear canal are purely due to the difference in
tissue vasculature of the respective surfaces, rather than from any external changes such
as temperature, etc. From Figure 7.11, the amplitude of PPG signals acquired from the
finger are almost ten times the size of the ear canal PPGs. This was however expected,
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Figure 7.11: Mean of the means (n=7), ±SD of normalised infrared and red PPG signals
acquired from all four surfaces of the ear canal and the index finger.
since there is less tissue lining the ear canal (approx: 1-2 mm) than the finger (approx:
10-15 mm), and, therefore, lower light absorption in the ear canal than the finger.
To check for any statistical significance among the amplitudes of the PPG signals acquired
from anterior, ventral, posterior and dorsal surfaces of the ear canal, a paired t-test was
performed on the data. Before performing a paired t-test, the normality of the data was
tested using the Kolmogorov–Smirnov test. All the data were normally distributed. A
significant difference was found between the amplitude of PPG signals acquired from the
anterior and posterior surfaces of the ear canal (P value: Red – 0.008, Infrared – 0.006).
No significant differences were found when other surfaces were compared. From these
observations, it can be said that the posterior (bottom) surface of the ear canal will be
the best surface for monitoring good quality PPG signals and, therefore, SpO2.
7.2.3 Summary of the preliminary investigations
The prototype probes developed to monitor PPG signals from the ear canal performed very
well during the preliminary investigations. It is evident from the results that the posterior
surface of the outer ear canal is the most optimal site for monitoring good quality PPG
signals. However, the preliminary tests and the participant survey have also highlighted a
few constraints in the probes design, which are discussed as follows:
• As mentioned earlier, most volunteers have reported one of the probes (L:13 mm,
⊘:7 mm) to be more comfortable than the other. However, some of the volunteers
have expressed a tight feeling inside the ear with both the probes. Hence careful
considerations were taken in refining the probes dimensions.
• Although the operating current used to drive the LEDs was relatively low (40 mA),
a couple of the volunteers have reported the sensor to be slightly warm inside the
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ear canal. Hence, there is a need to test the probability of direct thermal damage to
the skin lining the ear canal.
• Although the cylindrical shape of the sensor offers universal fit (i.e., would fit in both
left and right ear canals in most of the population), the probe needs to be redesigned
to make it more appealing for the user, as suggested by one of the volunteers in
Table 7.4 (comment-1).
• The material used to manufacture is very rigid and is non-biocompatible. Hence,
new biocompatible materials need to be explored.
The further development of the probe was therefore focused on eliminating these elements.
7.3 RECAP probe II
Building upon the previously developed prototype, a new ear canal PPG probe was de-
signed and fabricated. The probe underwent evolutionary design modifications to overcome
the above-mentioned limitations. The 2nd prototype probe was designed to look like an
earphone and was made from a more flexible material.
7.3.1 Optical components and their characteristics
The red and infrared emitters and the photodiode used in the 2nd prototype are the
same as the ones used in the 1st prototype. The optical and electrical characteristics and
packaging details of these components are shown in Table 7.1 and 7.2. However, before
using these components in the next prototype, it was important to determine the amount
of thermal radiation emitted by the LEDs, especially since a couple of the volunteers
have reported that the sensor felt slightly warm after long periods of usage. Thermal
safety tests at various drive currents are usually carried out to test the effect of thermal
stress on surrounding tissue. In vitro and in vivo thermal safety tests using these optical
components were previously carried out by Kyriacou et al. in [108]. During the in vitro
and in vivo tests, they found the temperature of their probe to raise by 3◦C and 0.7◦C
respectively. To reiterate these results and to test the thermal emission of the RECAP
probe, an in vitro investigation was carried out.
The investigation was carried out in a room maintained at 25 ± 0.5◦C. Measurements were
made of the changes in temperature at the surface of the RECAP–I PPG probe and of the
changes in room temperature using two type–K (chromel–alumel) thermocouples (Omega
Engineering Limited, Manchester, UK). The first thermocouple was attached to the outer
surface of the RECAP probe directly on top of the LEDs with kepton tape. The second
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Figure 7.12: Measurement of the changes in thermal emission by the LEDs in the
RECAP probe and the simultaneously recorded ambient temperature.
thermocouple was attached to the measurement unit and was exposed to the surrounding
air. Two thermocouple amplifiers (AD595CQ, Analog Devices, MA, USA) were used to
produce linear voltage outputs with sensitivity of 10 mV/◦C. The AD595CQ is a complete
instrumentation amplifier and thermocouple cold junction compensator on a monolithic
chip. The output of the thermocouple amplifiers was recorded into a text file using NI
USB-6212 DAQ card and a virtual instrument (VI) designed in LabVIEW (Chapter 9).
The measurements started with a one minute off-time (LEDs off) recording followed by
a 30 minute on-time recording. Both the LEDs were driven at 20 mA of current during
the on-time recording. Figure 7.12 shows the changes in the temperature of the RECAP–I
probe and the simultaneously acquired measure of room temperature.
As it can be seen from Figure 7.12, the temperature of the probe has raised with time
in the first 5 minutes of the study and has then remained relatively constant. While the
ambient temperature has remained constant throughout the study. This shows that the
rise in temperature of the probe is purely due to the thermal emission of the LEDs. The
maximum rise in temperature of the probe during the study was 3.2◦C. The maximum
temperature of the probe was 28.7◦C. Based on these results, it is safe to assume that
there is a negligible risk of tissue damage from thermal heating, as the temperature of the
skin surrounding the ear canal (34 and 35◦C) is much greater than the maximum probe
temperature. The warm feeling reported by the volunteers could be associated with the
insulation factor provided by the probes. Also, none of the volunteers has reported the
temperature change to be uncomfortable. Therefore, same optical components were used.
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7.3.2 Fabrication of RECAP probe II
A new dual-wavelength reflectance PPG sensor was designed and fabricated to acquire
PPG signals from the bottom surface of the outer ear canal. Similar to the earlier design,
the probe consisted of a miniaturised optoelectronic sensor and a sensor casing.
7.3.2.1 Miniaturised optoelectronic sensor
The optoelectronic sensor itself was a small PCB consisting of a red and an infrared
LED and a photodetector. The emitters and the detector were placed 4 mm apart from
each other. The separation distance between the optical components was reduced by a
millimetre when compared to the previous design. It is hoped that the change in separation
distance will not have an impact on the quality of the PPG signals or the estimated SpO2
since previous studies have shown that a separation between 4 mm and 5 mm results in
PPG signals with similar SNR [117]. The dimensions of the PCB were also reduced to
9 mm × 5 mm × 0.2 mm. The mechanical drawings of the optoelectronic sensor are shown
in Figure 7.13.
Similar to the optoelectronic sensor described in Section 7.1.3.1, the PCB was first vir-
tually designed using Altium designer (Altium Limited, Sydney, Australia), and was then






































Figure 7.13: The mechanical drawings of the optoelectronic sensor and the earphone
shaped sensor casing.
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in this design was 0.4 mm. All optical components were then soldered to the respective
copper pads of the PCBs, using a reflow soldering oven maintained at 200◦C.
7.3.2.2 Sensor case
The sensor case which holds the optoelectronic sensor was designed to look like an ear-
phone. The sensor was designed to fit approximately 9 mm inside the ear canal. The
external diameter of the part of the casing which is inserted into the auditory canal is
7 mm. The mechanical drawings of the sensor casing are shown in Figure 7.13. The sen-
sor case consists of a small rectangular extruded cut in which the micro-optic sensor is
sealed. The dimensions of the rectangular slot are the same as the optoelectronic sensor.
The casing also contains an inverted ‘L’ shaped hollow cavity extending from one side of
the probe to the other and two small holes perpendicular to the cavity with a diameter
of 2 mm. These apertures are used to run a four core cable, which provides electrical
contact between the optical components and the PPG processing system. The cable used
in this design was a four core ultra flexible cable with an external diameter of 2.1 mm.
A lightweight miniaturised cable was used as opposed to the previously used four core
screened wire (⊘ 3.5 mm), this is to avoid the added weight of the wire from dragging the
Figure 7.14: 3D models and photographs of the RECAP probe II.
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sensor out from the ear canal. The diameter of the sensor at the distal end was increased
by 3 mm to prevent the probe from accidently being inserted too deep into the ear canal.
The case was designed using Solid Works 2012 (Dassault Systemes SolidWorks Corp.,
Velizy, France), and was 3D printed using the FORMIGA P-110 SLS 3D printer (EOS -
Electro-Optical Systems, Munich, Germany). The material used to manufacture the case is
different from the one used in the previous design, this is to make the probe biocompatible.
The material used was Feinpolyamid PA-2200 (Nylon) (EOS - Electro-Optical Systems,
Munich, Germany). The PA-2200 is a strong, flexible and biocompatible material (EN ISO
10993-1 & USP/level VI/121◦C). Figure 7.14 shows the 3D models and the photographs
of the RECAP probe prototype 2.
7.3.3 Functionality test of RECAP probe II and further development
The functionality of the 2nd prototype was tested in the laboratory. The RECAP probe
was connected to the PPG processing system, and PPG signals were acquired from 3
healthy volunteers. All three volunteers have reported the probe to be very comfortable
inside the ear canal. The PPG signals acquired from the ear canal of the volunteers were
again of good quality and high amplitude. Figure 7.15 shows the typical red and infrared
PPG traces acquired from one of the volunteers using the 2nd prototype probe. The peak-
to-peak amplitude of a typical IR AC PPG signal was approximately between 200 mV -
400 mV.
















Red and Infrared PPG signals from the ear canal
Figure 7.15: The AC red (black trace) and infrared (green trace) PPG signals acquired
from the ear canal using the RECAP probe II.
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Although the sensor performed very well at rest, during motion the probe was susceptible
to motion artefacts. The smaller dimensions of the 2nd prototype also meant that the
probe was loosely fitted in the ear canal for someone with large ears. This caused the
probe to fall out of the ear, whenever there was heavy motion.
To avoid this limitation, the probe needs to be fixed to the ear in a more effective and
comfortable manner. Hence, it was first decided that an earhook (that can anchor on top
of the helix) will be incorporated into prototype probe as shown in Figure 7.16. However,
this will restrict the probes’ usage to either left or the right ear, and might not fit all
ear sizes. Hence, it was decided that replaceable ear hooks (commonly used in blue-tooth
headsets) will be used to anchor the probe to the ear. This will enable the probe to be
used either in the left or the right ear. The hook can also be interchanged to fit all ear
sizes. Hence, ear hooks of three different sizes were used. For added support and comfort
it was decided that replaceable silicon ear fins will also be used. The silicone ear fins fit
inside the concha of the ear and hold the probe in place during motion. The ear fins used
were the DelTex StayHear ear buds (DelTex®, UK), which are available in three different
sizes. To accommodate both the earhook and the silicon ear fin, the earphone shaped
probe was further modified as shown in Figure 7.16.
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RECAP 1 
The posterior surface of 
the outer ear canal was 
found to be the best site 
for PPG signal monitoring
RECAP 2.0 
An ear bud shaped probe 
was developed to acquire 
PPGs from the posterior 
surface of the outer ear 
canal. However, this 
design resulted in motion 
artefacts during heavy 
motion. 
RECAP 2.1
Hence, a new probe with 
incroporated ear hook 
was developed. However 
this restricted the probes' 
usage to right ear  
RECAP 2.2
The probe was hence 
redesigned so that a 
replaceable ear hook
can be used to anchor 
the probe to the ear.
RECAP 2.3
For added support and 
comfort replaceable 
silicon ear fins were used.
Figure 7.16: A flowchart of 3D models and photographs illustrating the incremental
design and development of the RECAP PPG probe.
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7.4 Reflectance finger PPG probes
Two reflectance finger PPG probes, optically and electrically identical to the RECAP
probe, were also designed and manufactured. The probes were designed to acquire PPG
signals from the finger or the toe. The probes were intended to facilitate comparison be-
tween the PPG signals acquired from the ear canal with that acquired from the periphery.
By comparing the PPG signals acquired from both sites, especially in conditions of poor
peripheral perfusion, it will help in supporting the hypothesis.
7.4.1 Optical components and their characteristics
The finger PPG probes consisted of red and infrared surface mount LEDs and a surface-
mount photodiode. The emitters and the detector are the same as the ones used in the
fabrication of the RECAP probe. The optical, electrical and packaging details of the
optical components are provided in Table 7.1 and 7.2.
7.4.2 Fabrication of the reflectance finger PPG probes
The mechanical design of the finger PPG probes is similar to the most commercial pulse
oximetry probes. The probes consist of a small PCB with all the optical components
arranged next to each other. The dimensions of the PCB are 13 mm × 20 mm × 0.6 mm.
On the PCB, the emitters are arranged perpendicularly 4 mm away from the detector.
The 3D models of the components and the PCB itself were first designed virtually in
Altium Designer. Based on the artwork generated from Altium, the tracks were etched
onto a copper clad board through the process of photolithography. Once the PCB was
manufactured, the optical components were soldered to the respective pads using reflow
Figure 7.17: Close up photographs of the reflectance finger PPG probes.
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soldering oven maintained at 200◦C. A four-core screened cable was used to provide elec-
trical contact between the optical components and the PPG processing unit. A DE9 male
connector provided the interface between the probe and processing system.
Two damaged commercial finger clip type pulse oximeter probes were used to accommodate
the PCBs containing the optical components. The optical components and cable of the
commercial finger probe were removed and only the finger clip was used. To avoid direct
contact with the optical components and the skin the PCBs have been entirely sealed using
clear epoxy resin (DYMAX 141-M, Dymax Corporation, Torrington, CT). Figure 7.17
shows the close-up photographs of the reflectance finger PPG probes.
7.4.3 Performance evaluation of the reflectance finger PPG probes
The performance of the finger probes was tested in the laboratory using the prototype
PPG processing system. The developed probes were tested in two healthy volunteers.
During the test, the finger clips were attached to the right and left index finger of the
volunteer. The probes were then connected to the PPG processing system to acquire raw
PPG signals. The PPG processing system consisted of the circuitry required to drive the
LEDs, acquired the PPG signals and preconditioned the signals. The drive current used
to power the LEDs was 40 mA. The raw PPG signals acquired from the PPG processing
system were then digitised using an NI DAQ card (NI USB-6212, National instruments



























Figure 7.18: The AC red (black trace) and infrared (green trace) PPG signals acquired
from the ear canal using the 2nd probe.
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corporation, Austin, Texas). The digitised PPG signals were displayed and stored on the
computer with the help of a LabVIEW VI.
The PPG signals acquired during the preliminary testing were of good quality with large
amplitude and high signal-to-noise ratio. Figure 7.18 shows the typical red and infrared
AC PPG traces acquired from the left and right index fingers of a volunteer using the
reflectance finger PPG probes.
7.5 Summary
To investigate the hypothesis that the ear canal is better perfused than extremities such
as the finger in cases of compromised peripheral perfusion, an ear canal PPG probe based
on reflection photoplethysmography was developed. Two cylindrical bullet shaped PPG
sensors with different dimensions were first developed to investigate the quality of PPG
signals acquirable from different depths and surfaces of the ear canal. The developed
sensors were optically and electrically identical and consisted of a micro-optic sensor and
sensor casing. The micro-optic sensor is a small PCB consisting of two emitters and a
photo-detector. The sensor’s case was manufactured using a 3D printer.
Preliminary investigations were carried out in 7 healthy volunteers to determine (1) an
optimal probe length at which PPG signals of good quality and high amplitude can be
acquired, (2) and a surface along the circumference of the ear canal from which the acquired
PPGs will be of the best possible quality. A participant survey was also conducted to
enquire if the probes required any further modifications in its shape and structure to
make it more comfortable. The results of the investigations showed that PPGs with high
amplitude and quality can be acquired from the posterior surface of the outer auditory
canal. The results and the participant survey also suggest that the ear canal sensor with
smaller dimensions (length: 13 mm, diameter: 7 mm) to be optimal in monitoring PPG
signals from the ear canal.
Building upon the first prototype, a new earphone shaped ear canal PPG probe was
designed and fabricated. This probe underwent further modifications to make it more
comfortable to use and to reduce motion artefact. Two identical finger PPG probes were
also developed to facilitate comparison between the PPG signals obtained from the central
and peripheral locations. Both the finger probes are optically identical to the ear canal
probe. The signals obtained from the finger PPG probes during preliminary evaluation
were of good quality. The following chapter describes the PPG instrumentation system,
developed to drive the optical components, detect both the ear canal and the finger PPG
probes, as well as enabling measurements of PPG signals from both sites.
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— Complexity that works is built
up out of modules that work per-
fectly, layered one over the other
Kevin Kelly, The Healthcare
Forum Journal, vol. 38, no. 1, Feb
1995
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Design and development of ZenPPG – A modular
PPG processing system
Together with the ear canal PPG probes and the finger PPG probes described in Chapter 7,
a PPG processing system was designed and developed. The system consists of three main
channels – two dual wavelength PPG channels and an ECG channel. The system was
designed to drive the optical components, detect and sample the red and infrared PPG
signals from both locations, and precondition the acquired PPG signals.
The electronic circuitry required to perform these tasks was split into individual mod-
ules which are connected together by a double sided system bus. Through this modular
approach, various functions in the system were kept independent of each other, allowing
for incremental improvements during subsequent development. The main modules in the
system are: the system bus, PPG modules (current supplies, probe connector board and
transimpedance amplifiers) and the power supply conditioning module. The system was
named ‘ZenPPG’. This chapter describes the theory of operation, high-level and low-level
design architecture and the implementation of the system. A complete review of the
systems circuit optimisation and measured performance is also provided in this chapter.
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8.1 Design brief and specifications
The successful validation of the developed sensors requires the use of multiple PPG sys-
tems which work in sync with one another, so that a true comparison can be made between
the ear canal and the periphery. Most commercially available systems only produce ampli-
tude modulated, phase modulated and post processed signals. This post processing often
results in suppression of PPG signal features, and loss of valuable clinical information.
It is also meticulous to simultaneously acquire data from two or more pulse oximeters
along with data from other physiological systems such as electrocardiogram (ECG) ampli-
fier, temperature sensor, respiration monitor etc. The phase differences between multiple
measurement systems can also be a major concern while analysing the acquired data, as
the acquired signals will be out of phase with one another. Hence, it was decided that a
portable, multi-channel, multi wavelength, multi parametric PPG system with the added
capability to record other physiological signals such as ECG signals or respiration signals
will be designed and developed.
The design of the system was based on previous instrumentation developed by the Research
Centre for Biomedical Engineering (RCBE), at City University London. The system was
designed to satisfy the following requirements:
• The design of the system should be modular and allow for incremental improvements,
so that further improvement of any single module should ‘not’ affect the performance
or the architecture of other modules
• The system should be portable in size, and contain a minimum of two PPG channels,
with each channel capable of generating PPG signals with at least two wavelengths
• The system should accommodate an ECG amplifier with standard 3-lead or 5-lead
connector, so that the ECG signal can be used as a timing reference for the PPG
signals
• The system should operate with both custom built PPG probes and standard com-
mercial pulse oximeter probes
• The system should output ‘raw’ PPG (AC and DC) and ECG signals with no am-
plitude or phase modulations
• The system should be easy to use and run on both batteries and power supplies
• To keep the system cost effective, all the mechanical and electrical components used
in the system should be standard components.
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Taking these requirements into consideration, the ‘ZenPPG’ was constructed. The current
version of the system accommodates two dual-wavelength PPG channels along with an
ECG amplifier, and an airflow pressure sensor to measure respiration. The name ’ZenPPG’
introduced in this project, will be used further in this work to refer to the developed PPG
signal monitoring system prototype.
8.2 Top-level design architecture
The block diagram shown in Figure 8.1 gives the top level architecture of the ‘ZenPPG’.
The electrical and design characteristics of both the PPG channels in the system are
identical. This is to ensure that the ear canal PPG signals and peripheral PPG signals
can be qualitatively and quantitatively compared. As both PPG channels are identical,
their design here is described collectively. Before describing the circuit level design and
implementation of the system, a generic overview of the systems operation is provided
here.
The red and infrared emitters in each channel are driven by a constant emitter driver
which consists of three parts: a reference control voltage circuit, a multiplexer and a
modified Howland current source. The reference voltage circuit generates the constant
PPG
signal 








































































Figure 8.1: Top-level architecture of ZenPPG.
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voltage required to drive the LEDs. This voltage can be altered by the user on-demand
using the controls on the back panel of the system, and digitally using the computer user
interface. Hence, providing independent control over LED currents on both channels.
The multiplexer is to generate a timed switching signal used to turn on the red and
infrared LEDs alternatively. The LEDs are switched on alternatively in order to allow
for independent sampling of red and infrared light by the photodetector. A modified
Howland’s current source is then used to convert the switching voltage signal into the
current that is used to turn the LEDs in the probe ‘on’ and ‘off’.
The reflected or transmitted light photons from the vascular tissue are then detected by the
photodetector, which generates a current proportional to the incident light power. This
current is then converted into a mixed voltage signal consisting of both red and infrared
components by the TransImpedance Amplifier (TIA). A Sample-and-Hold Amplifier (SHA)
separates the TIA output into red and infrared PPG signals. A programmable micro-
controller is used to control the LED switching and demultiplexing of the signals. The red
and infrared PPG signals are then lowpass filtered to remove the high frequency switching
noise. The AC component of the PPG signals was extracted by highpass filtering the raw
PPG signals. The system also hosts an ECG amplifier to detect the QRS complex of the
ECG signal and an airflow pressure sensor that can be used to measure respiration rate.
The raw AC and DC PPG signals, the ECG signal and the respiration signal are digitised
by a National Instruments data acquisition (DAQ) card (National Instrument Corporation,
Austin, Texas) and are displayed and stored on the laptop computer. Software to handle































































































































































CORE MODULE - FRONT END
CORE MODULE - BACK END
CURRENT SOURCE MODULETRANSIMPEDANCE MODULE
POWER MODULE
ECG MODULEPOWER RAILS : PR
Figure 8.2: Detailed block diagram showing the architecture of ZenPPG
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8.3 Circuit-level design architecture
The circuitry of the entire system was split into five individual modules which were inter-
connected by a double sided system bus. Each individual module has a specific function
in acquiring and processing various signals. The PPG modules are the TransImpedance
Amplifier (TIA) module, the Current Source (CS) module, and the Core module. The
other two modules are the power supply conditioning module and the vital sign monitor-
ing module. The core module is the ”heart” of the PPG processing system. The circuitry
within the core board can be divided into two parts, the front-end and the back-end. The
front-end consists of the circuitry required for emitter driver control, and the back-end
consists of demultiplexers and filters, as shown in Figure 8.2. For ease of understanding,
both parts are detailed separately. The vital sign monitoring module consists of an ECG
amplifier and a pressure sensor. A detailed block diagram showing the architecture of the
ZenPPG is shown in Figure 8.2. The theoretical description of the circuits in each module
are described below. The schematic diagrams of all the modules are given in Appendix A.
8.3.1 System bus
To make the system modular and re-usable, a system bus was designed, which interconnects
all other modules together. The system bus consists of six (three on each side) receptacle
50 way surface mount connectors (SAMTEC, Indiana, USA). It is designed in such a way
that every single pin in any connector corresponds to the same pin in all the connectors.
Since all the 50 pins on every connector are the same, it provides a medium of interaction
between various modules. All the PPG modules, ECG modules and the power supply
conditioning board are furnished with gold plated, through-hole, right angle 50 way headers
that connect to the bus. Each pin in the system bus is assigned to a particular net, hence
making it the only module in the system that is inflexible or unalterable. Table 8.1 shows
the pin-out of the system bus in ZenPPG.
8.3.2 Power supply conditioning module
The ZenPPG system runs on two standard 9 V PP3 batteries encased within the portable
system case or on the 5 V supply from a mini USB. The batteries used were rechargeable
NiMH batteries with a capacity of 280 mAh (Extreme power, UK). These have been
set in a parallel configuration to give a total of 580 mAh charge capacity. The power
supply conditioning module consists of the circuitry required to regulate the main battery
power supply into multiple DC power rails. This is to reduce power consumption, provide
operational stability and improve system efficiency.
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Table 8.1: Pin-out of the system bus in ZenPPG
Description Net Pin Pin Net Description
Not Connected NC 1 26 MAN0 Monitoring Photodiode Anode 0
Not Connected NC 2 27 MKA0 Monitoring Photodiode Cathode 0
Not Connected NC 3 28 PSENSE0 LED Optical Power Sense 0
Not Connected NC 4 29 ICTRL0 LED Current Source Control Voltage 0
Not Connected NC 5 30 ISRC0 LED Current Source (Drains to IGND) 0
Not Connected NC 6 31 ISENSE0 LED Current Sense 0
SPI / Micro-wire Serial Interface MOSI0 / TWD0 7 32 ICTRL1 LED Current Source Control Voltage 1
SPI Serial Interface MISO0 8 33 ISRC1 LED Current Source (Drains to IGND) 1
SPI / Micro-wire Serial Interface SCK0 / TWCK0 9 34 ISENSE1 LED Current Sense 1
Gain Control 0 GC0 10 35 SEL0 LED selection 0
Gain Control 1 GC1 11 36 SEL1 LED selection 1
Not Connected NC 12 37 NC Not Connected
Not Connected NC 13 38 NC Not Connected
Not Connected NC 14 39 NC Not Connected
Not Connected NC 15 40 NC Not Connected
Not Connected NC 16 41 NC Not Connected
Not Connected NC 17 42 MIX0 Transimpedance Output 0
Temperature TEMP 18 43 IPOS Current Source Power Positive = +5 V
Respiration RESP 19 44 IGND Current Source Ground
ECG Lead 1 ECG 20 45 INEG Current Source Power Negative = -5 V
Transimpedance Output 1 MIX1 21 46 APOS Analogue Power Positive = +3.3 V
Not Connected NC 22 47 AGND Analogue Power Ground
Power Cable (USB connector) CBLV 23 48 ANEG Analogue Power Supply Negative = -1.4 V
Power Supply (from power switch) PSV 24 49 DPOS Digital Power Supply Positive = +3.3 V
Power Supply Ground PSGND 25 50 DGND Digital Power Supply Ground
The 9 V battery power supply (BATV) from the batteries is first regulated down to 5 V
using a positive voltage regulator (MC78M05CDTG, ON Semiconductor, Arizona, USA).
This is to keep both the battery and USB power supply at the same voltage. Also, since
all the microchips used in the system are based on CMOS technology, the system does not
require high power. When powered with USB, this microchip is switched off. Switching
between USB and battery supply is through a two pin mini jumper. Figure 8.3(a) shows
the configuration of the circuit.
The 5 V supply from the regulator (RBATV) or the USB (CBLV) is passed through an
isolated point-of-load DC-DC converter (IA0505D, XP power, singapore) that regulates
the 5 V input to +5 (IPOS) and -5 (INEG) volts, and a common ground (IGND). These
±5 V supplies are used to power the current source module, the multiplexers in the Core
module and the ECG module. INEG, IPOS, and IGND are also further regulated to
power the rest of the system. The isolation barrier in the DC-DC converter separates
the input (CBLV or RBATV) and the output power supplies (INEG, IPOS and IGND).
Hence protecting the system, sensors and the user (patient) from any malfunction. The
high frequency transformer in IA0505D withstands up to 10,000 V. Figure 8.3(b) shows
the configuration of the circuit.
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All other analogue microchips in the system run on +3.3 V (APOS) and -1.4 V (ANEG)
supplies. These power rails are generated using IPOS and INEG. The +3.3 V supply is
generated using a linear low drop-out voltage regulator (MCP1703T, Microchip Technol-
ogy, Arizona, USA), while the -1.4 V supply is generated using a low drop-out negative
micro-power regulator (LT1964ES5, Linear Technology, California, USA). The circuit




































































































































Figure 8.3: The circuits used to generate various supply rails in power board: (a) the
5 V regulator to regulate the 9 V battery supply to 5 V, (B) The DC-DC converter to
convert the 5V supply to ± 5 V (IPOS, INEG) (c) The 3.3 V regulator generate APOS–
positive supply to analogue microchips, (d) the -1.4 V regulator to generate ANEG–
negative supply to analogue microchips and (e) a 3.3 V regulator to generate DPOS–
supply to digital microchips.
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A separate +3.3 V supply is generated using a linear low drop-out voltage regulator
(MCP1703T, Microchip Technology, Arizona, USA), and is used to power digital mi-
crochips such as the micro-controller. Digital circuitry usually draws large currents from
its supply during switching and are very noisy. On the other hand analogue circuitry is
quite vulnerable to noise on both supply rails and grounds. Thus, to prevent digital noise
from corrupting analogue performance, separate power rails and ground returns were im-
plemented in the system. The circuit configuration of DPOS and DGND are shown in
Figure 8.3 (e).
8.3.3 Core module - Front end
As mentioned earlier, the red and infrared emitters on each channel are driven by an
emitter driver circuit consisting of three main parts: a reference control voltage circuit, a
current multiplexing circuit and a modified Howland current source. The front end of the
core board hosts both the reference control voltage circuit and the multiplexing circuit.
These circuits were designed by keeping two main specifications in mind:
• Each LED has to be able to switch on and off at a frequency of at least 100 Hz, as
it is sufficient to sample the PPG signal
• Each LED ‘on time’ should be sufficient to obtain an undistorted light intensity
sample.
8.3.3.1 Reference control voltage circuit
The purpose of the reference control voltage (RCV) circuit is to provide independent con-



































(b) Voltage regulator output configuration
Figure 8.4: Circuit configuration used to generate reference voltage source in Channel-1
and Channel-2.
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by an individual RCV circuit. The design of all four RCV circuits is similar, and con-
sists of two parts – a reference voltage source and a voltage attenuator. The reference
voltage (VRef) on channel-1 is generated by a 16-bit NI DAQ card (National Instrument
Corporation, Austin, Texas). VRef on channel-2 is by a constant on-board 1 V regulator.
This configuration allows for digital control of LEDs on channel-1 and analogue control
of LEDs using trimmers on the other. Digital control of LEDs on both channels is not
possible in this design, as the number of analog output channels on the DAQ card are
limited. Figure 8.4 shows the configuration of the reference voltage source circuit used in
Channel-1 and Channel-2.
On channel-1, the DAQ card’s analogue output ports AO0 and AO1 were used to generate
VRef. The DAQ card has an analogue output voltage range of ± 10 V, with a 16-bit
resolution. Hence each port can drive the LED current source with voltages between -10
to 10 V and a resolution of 20 V/216 = 305 µV . In the current setup, AO0 was configured
to generate voltage between -5 and 0 V. Port AO1 was configured to generate voltage
between 0 and 5 V. On channel-2, VRef was generated using a low noise drop-out 1 V
regulator (LM4140ACM, Texas Instruments, Texas, USA).
The output ranges of AO0 and AO1 were then attenuated down to -1 – 0 V (ICNEG0) and
0 – 1 V (ICPOS0) using the voltage attenuator circuit. The attenuator circuit is a simple
voltage divider with an op-amp buffer, which divides the input voltage by 5, as shown
in Figure 8.5(a). Similarly, the 1 V output from the voltage regulator in channel-2 was
attenuated to ± 1 V using the attenuator circuits shown in Figure 8.5(b). The variable



































































(b) Voltage attenuators for channel-2
Figure 8.5: The four voltage attenuator circuits used to control LED currents in both
channels of the system
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voltage between -1 to 0 V and 0V to 1 V. The positive and negative voltage generated
by RCV circuits in channel-1 are referred to as ICPOS0 and ICNEG0, while in channel-2
they are referred to as ICPOS0 and ICNEG1. The op-amp used in the attenuator design
is the OP484FSZ quad op-amp (Analog Instruments, Massachusetts, USA).
8.3.3.2 Voltage multiplexing circuit
The positive and the negative voltages from the RCV circuits of each channel are time
multiplexed using the multiplexing circuit. This is to switch the red and infrared LEDs
alternatively. The positive voltage switched the infrared LED ‘on’, while the negative
voltage switched the red LED ‘on’. Hence, this allowed independent sampling of red and
infrared light by the photodetector.
The voltage multiplexer circuit consists of a double pole 4–throw (DP4T) analogue multi-
plexer (MC14052BD, ON Semiconductor, Arizona, USA) that connects to a timing gen-
erator as shown in Figure 8.6(a). The multiplexer produces a continuous switching signal
by selecting one of its four inputs (X0 to X3 and Y0 to Y3) on each channel, and making
the selected inputs appear on the respective output (X and Y). The data select lines (A,B
and INHIBIT) determine which input is passed on to the output. The truth table in
Figure 8.6(b), shows how the inputs of the multiplexer relate to its outputs. For instance,
if A, B and INHIBIT are at a logic level low (i.e, 0), then the outputs X and Y receive X0
and Y0. Similarly, if A was at logical high, B and INHIBIT were at logical low, then X
and Y would receive X1 and Y1.
In the current design, this multiplexer was configured as shown in Figure 8.7(a). The RCV
circuit outputs ICPOS0 and ICNEG0 were connected to the multiplexer inputs X0 and























    INHIBIT
0 0 0 X0 Y0
0 1 0 X1 Y1
0 0 1 X2 Y2




Figure 8.6: The (a) functional diagram of the multiplexer and the (b) truth table of the
multiplexer.
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Figure 8.7: (a) The configuration of the multiplexer circuit used in the ZenPPG and
(b) the clocks used to control the multiplexer.
each channel of the multiplexer (X2, X3 and Y2, Y3) were connected to AGND. The data
select lines A and B of the multiplexer were connected to the timing generator, which is
an 8–bit Atmel ATtiny 2313–20SU micro-controller unit (MCU) (Atmel corp, CA, USA).
Two timed clocks (CMUX0 and CMUX1) at a frequency of 800 Hz were generated from
the port-D of the MCU. Figure 8.7(b) shows the timing clocks CMUX0 and CMUX1 used
to control the multiplexer. The INHIBIT of the multiplexer was always set to logical low
by connecting it to DGND.
This configuration has yielded two outputs (ICTRL0, ICTRL1) which fluctuated between
positive and negative voltage. When timing clocks CMUX0 and CMUX1 were at logical
low, then the outputs were positive (ICPOS0 and ICPOS1), which switched the infrared
LEDs ‘on’. When CMUX0 was at logical high and CMUX1 was at logical low, then the
outputs were negative (ICNEG0 and ICNEG1), which switched the red LEDs ‘on’. Finally,
when CMUX0 was at logical low and CMUX1 was at logical high, the output was AGND,










Figure 8.8: One of the outputs (ICTRL0) of the dual- 4 channel multiplexer. The
infrared LED is first switched on for 416 µs, followed by the red LED, and then an off
period, where both LEDs are off.
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× d; where d =
Time the signal is active
Total period of the signal
× 100 % = 416 µs (8.1)
Each emitter was hence switched ‘on’ every 125 ms for a duration of 416 µs. The multi-
plexer outputs – ICTRL0 and ICTRL1 are passed through the system bus into the current
source module, where the voltage is converted into current required to power the LEDs.
8.3.4 Current source module
The current source module consists of two identical current driver circuits that are used to
drive the LEDs on both the channels. The module also consists of two current monitoring
circuits, which are used to continuously monitor the red and infrared LED currents. As
both current driver circuits are identical, their design is described collectively.
8.3.4.1 Current driver circuit
The current driver circuit used in this system is a modified Howland current source. The
basic configuration of this classic circuit is shown in Figure 8.9. A detailed explanation
of the circuit and its variants is given in [269]. The primary advantages of the Howland
current source over other current sources are its simplicity and the ability to produce high
output impedance. This ground referenced current source is controlled by the positive



















Figure 8.9: Circuit diagram showing a linear modified Howland current source with a
tranconductance gain of 1.
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by other current sources such as the H-bridge or transistor based switching current sources.
However, when using the Howland current source, the resistors R1, R3 and R2, R4 must be
precisely matched for good linearity. Also the ratio R1/R2 must be stable, to keep good
current accuracy. Under ideal op-amp characteristics (V− = V+), the current across the








Hence, by precisely selecting resistors R1, R2, R3, and R4 to the same value, and choosing
the load resistor (R5) to be 1 Ω, as shown in Figure 8.9, a linear current source with a
transconductance gain of 1 can be achieved. With this current source, a linear current
proportional to the input voltage – e1 can be supplied to the load. However, if the load
(IL) has large impedance, then the circuit can sometimes present significant current error.
Since the current load in this application is an LED, which has a fairly small impedance in
active stage, particularly in comparison with R4, LED current accuracy is not a concern.
Therefore, by replacing the load with the red and infrared LEDs as shown in Figure 8.9,
and making e1 a bidirectional switching voltage, LEDs can be turned on intermittently.
However, in the current setup, if e1 was replaced by the bidirectional voltage from the
multiplexer (ICTRL0 or ICTRL1), then the maximum current produced by the current
source will be 1 A, at a maximum reference voltage of 1 V. Such large current can burn
the LEDs in the probe. Therefore, the output of the multiplexer needs to be brought down
by at least 10 fold, so that the maximum reference voltage of the multiplexed signal will
be 100 mV and the maximum current through the LEDs will be 100 mA. This can either
be achieved by adjusting the resistors R1 and R5 on the current source, or by passing the
outputs of the multiplexer (ICTRL0, ICTRL1) through a voltage divider circuit which
















Figure 8.10: The voltage attenuator circuit which divides the input voltage by 10.
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currents, voltage dividers with op-amp buffers were used. The circuit diagram of the
voltage divider with an op-amp buffer used to divide ICTRL0 is shown in Figure 8.10.
This modified Howland current source with the voltage divider input worked very well
during laboratory testing, however possessed two key limitations:
• As there are no current limiters in the circuit, in the event of a malfunction, large
currents can pass through the LEDs, causing damage to the developed sensors.
• An ordinary fast op-amp cannot deliver sufficient current to drive power LEDs and
available power op-amps do not have good static and dynamic characteristics.
To overcome these limitations, a fast power push–pull (NPN–PNP) transistor switch
(PMD3001D, NXP Semiconductors, Eindhoven, Netherlands) was added between the op-
amp output and the LEDs, as shown in Figure 8.11. In this circuit, when the current
source driving voltage is positive, the NPN transistor is active and switches one emitter
on and, when the driving voltage is negative, the PNP transistor is active, switching the
other emitter on. The maximum current supplied to the LEDs is limited to 100 mA by
resistors R6 and R7. When the input reference voltage is between ± 100 mV, the transistor
is in open state, and the current across the LED will be proportional to the set reference
voltage. In the event of a malfunction, if the driving reference voltage was fortuitously











































Figure 8.11: Ground referenced Howland current source with fast power NPN-PNP
transistor switch used to protect the LEDs.
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allowing for current to flow from the collector to the emitter, which is limited to 100 mV.
The value of the current limiting resistor can be calculated using:
R =
VCC − VCEsat − Vf
Imax
(8.3)
where VCC is the supply voltage (IPOS or INEG), VCEsat is the collector–emitter satu-
ration voltage, Vf is the voltage drop across the LED (forward voltage), and Imax is the
maximum limiting current. The VCEsat of the NPN–PNP transistor used is 30 mV and
-40 mV respectively. The forward voltage of infrared and red LEDs used in the PPG
probes are 1.35 and 1.8 V respectively (see Table 7.1). The positive and negative power
supplies are +5 and -5 V. Hence, the value of the limiting resistors will be 36.2 Ω and
31.6 Ω. As resistors with these values are not commercially available, standard resistors
(36 Ω and 33 Ω) close to these values were used.
Before using these components (transistor, resistor and Op-amp), the static and dynamic
performance of the circuit shown in Figure 8.11 was tested through Simulation Program

















































Figure 8.12: SPICE simulation results showing the performance of the modified How-
land current source. Black trace shows the input reference voltage, green traces shows the
output of the transistor, red and blue traces show the current across the red and infrared
emitters.
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Current to the red LED
Current to the infrared LED
Figure 8.13: Simulation results showing the performance of the optimised current lim-
iting circuit. The current limiting resistors in the ciruit were changed to 43 Ω and 36 Ω.
with Integrated Circuit Emphasis (SPICE) modelling. SPICE simulations were carried out
using Altium designer (Altium Limited, Sydney, Australia). During SPICE simulations,
the input reference voltage was set to ±2 V, which is well beyond the systems designed
input range (± 100 mV). This is to check the performance of the current limiting circuit in
the event of a malfunction. The results of the SPICE simulations are shown in Figure 8.12.
Although the designed circuits performed well, the maximum current supplied to the
infrared LEDs was slightly higher than the set value (100 mA). Hence, to further optimise
the circuit’s performance, the current limiting resistors were changed to 43 Ω (R6) and
36 Ω (R7). Figure 8.13 shows the current across the red and infrared LEDs, when the
current limiting resistors were changed to 43 Ω and 36 Ω.























































Figure 8.14: Circuit diagram of the current source used in the ZenPPG system.
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Figure 8.14. In summary, the alternating input voltage from the multiplexer (ICTRL0 or
ICTRL1) is passed through the voltage divider, which divides the input voltage by 10,
and then the current source converts this voltage into current used to power the LEDs.
The current outputs of both the CS circuits – ISRC0 and ISCR1 are passed through the
system bus and the TIA module into the PPG probe, where the LEDs are switched on
alternatively.
8.3.4.2 Current monitoring circuit
LED current monitoring is one of the distinctive features of the ZEN PPG system. The
current across the LEDs in each probe is continuously monitored by an instrumentation
amplifier. This is attained by inputting voltage across the load resistor (VSRC0) and
the current after the load resistor (ISRC0) as differential inputs to the instrumentation
amplifier. The voltage sensed by the instrumentation amplifier (ISENSE0 or ISENSE1)
gives the indication of the amount of current across the LEDs. The sensed voltage signal
is however amplified linearly by the instrumentation amplifier to get a measurable output
that can be sampled by the DAQ card. The signal amplification depends on the gain
resistor, which was set to 5.6 kΩ (gain =10). The circuit configuration of the current
sensing circuit is shown in Figure 8.15. The output of both the current monitoring circuits
(ISENSE0 and ISENSE1) is passed through the system bus into the core module, where




























Figure 8.15: Configuration of the current monitoring circuit. The differential inputs of
the instrumentation amplifier are used to monitor the current across the load resistor.
8.3.5 TransImpedance Amplifier (TIA) module
The TIA module consists of two identical transimpedance amplifiers, that convert the
light photons detected by the photodetector into a mixed voltage signal. This voltage
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Figure 8.16: Pin-out diagram of the DB9 connector.
signal contains photometric information from both red and infrared wavelengths. The
strength of the signal from the amplifier depends on the intensity of light detected by the
photodiode and the TIA gain resistor. The module also hosts two female DB9 connectors
for interfacing with the PPG probes. The connectors and the pin-out of the connector
(Shown in Figure 8.16) used is similar to commercial pulse oximeter probes. Hence, giving
the flexibility to use most commercial PPG probes without any additional requirements.
The TIA is a simple op-amp circuit with a gain resistor in the negative feedback configu-
ration connected to a photodiode as shown in 8.17(a). In applications such as PPG, where
the required gain is in the order of few hundred kΩ to a few MΩ, this simple circuit can dis-
play surprisingly complex AC behaviour. This behaviour complicates the determination of
circuit bandwidth, requires additional phase compensation and makes the noise response
frequency dependent. If attention is not paid during circuit design and layout, the digi-
tizing at the end of the signal path would be unable to discern signal from noise. Hence,
characteristics such as the TIA topology, stability, bandwidth and phase compensation
were studied while designing the TIA, and are described below.
8.3.5.1 Choice of TIA circuit configuration
In optical applications such as PPG, the TIA can particularly be affected by circuit design
topology, as often the detected signals are complex and small. The two most commonly
used TIA design topologies in optical monitoring are zero biased (Figure 8.17(a)) and
reverse biased (Figure 8.17(b)) configurations. In reverse bias configuration, a positive
voltage is applied at the cathode of the photodiode. This causes an increase in the width
of the depletion region of the photodiode and lowers the junction capacitance, hence im-
proving the high frequency performance. However, the design trade-off for this increase in
speed is an increase in dark current (DC error) and nonlinearities. In zero biased configu-
ration, the cathode of the photodiode is grounded (at 0V). The zero bias produces a very
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Figure 8.17: Transimpedance amplifier as a photodiode front-end (a) without reverse
bias voltage, (b) with a reverse bias voltage.
little DC error and very little noise. In addition, the photodiode response is more linear
than can be achieved with reverse biasing. Its parasitic capacitance, however, is higher.
In the current system, a zero biased TIA was used, with the expense of high parasitic
capacitance. The reasons for this are as follows:
• The multiplexing frequency of the ZenPPG system is not high enough (only 800 Hz)
to use the reverse bias circuits
• Linearity to light intensity in the current application is of paramount importance,
as the estimation of SpO2 relies on the detected PPGs.
• Also, since zero biased circuit produces low noise, the detection of small amplitude
PPGs becomes easily possible.
The circuit diagram of the TIA used in the ZenPPG is shown in Figure 8.18. In this
circuit, the operational amplifier maintains zero voltage across the photodiode due to the
virtual ground. Current flows through the feedback resistor (R2) and creates a voltage at
the output that is proportional to the light intensity. The output is given by:
MIXS0 (Output) = R2 × Ip (8.4)
The outputs of both the TIA amplifiers MIXS0 and MIXS1 are passed through the system
bus to the core board back end, where they are demultiplexed and preconditioned. The
TIAs were built into metal screening cans to reduce their susceptibility to stray light.
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Figure 8.18: Circuit diagram of the TIA used in ZenPPG system
8.3.5.2 Bandwidth limiting
In TIA circuits, three separate response limits can potentially set the bandwidth of the
TIA. These are the parasitic capacitance of the photodiode, the bandwidth of the op-
amp, and the phase compensation capacitor [270]. In very high gain cases, the parasitic
capacitance bypasses the feedback resistor; this effect generally sets the bandwidth. Lower-
gain applications reduce the significance of the parasitic bypass, in which case the op-
amp bandwidth and phase compensation set the TIA bandwidth [271]. In intermediate
gain applications, such as in the current PPG system, the op-amp bandwidth, the phase
compensation and the large parasitic capacitance of the photodiode sets the bandwidth.
Hence while designing TIA for ZenPPG:
• Op-amps (OPA380, Texas Instruments, Texas, USA) with large bandwidth (90 MHz)
and open loop gain (130 dB) were used
• Photodiodes with small surface area (0.65 mm2) were used in the desin of ear canal
and the finger probes, to reduce the parasitic capacitance
• A phase compensation capacitor in the order of few picofarads (pF ) was used in the
TIA circuit, to provide stability to the circuit.
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where Ci is the total input capacitance (photodiode junction capacitance : 10 pF + op-
amp input capacitance : 4.1 pF), Rf is feedback resistor value and fc is a unity-gain
crossover frequency of the op-amp (90 MHz). The 0.3pF capacitor (Cf ) is not a standard
capacitor, and since the bandwidth of the op-amp is fairly large, a larger capacitor can be
used without causing a reduction in usable TIA bandwidth and without overcompensating
the TIA response. Hence a 10 pF (Cf ) capacitor was used. The -3 dB frequency and the








2 = 142 kHz (8.7)
Experiments showing the effects of Cf on the TIA’s performance is detailed in Section 8.5.2.
8.3.6 Core module – Back end
The back end of the core module consists of three main circuits
• a micro-controller to generate timing signals that control the multiplexer and the
SHA
• a SHA circuit to separate the mixed signals from the TIAs into red and infrared
PPG signals
• Low pass and high pass filters to precondition the acquired signals.
8.3.6.1 Micro–Controller unit (MCU)
An Atmel ATtiny 2313A-20SU (Atmel corp, CA, USA) micro-controller was used as a
master clock and timing generator. The ATtiny 2313A-20SU is an 8-bit MCU with 18-
programmable I/O lines and a maximum operating frequency of 20 MHz. As mentioned
earlier in Section 8.3.3.2, the port-D of the MCU was used to generate two clocks: CMUX0
and CMUX1, for multiplexing the LEDs. Port B of the MCU was programmed to output
another three clocks: MUX0, MUX1, and SMP INH0. These clocks were used for syn-
chronizing the SHA that separated the mixed PPG signals into red and infrared PPGs.
The clocks from port-B were in synch with the clocks from port-D, as mistiming would
lead to inappropriate sampling of red and infrared signals. Figure 8.7(b) and 8.19(b) show
the clocks generated by port-D and port-B of the MCU. The MCU was programmed using
the Atmel STK500 MCU programmer. A ‘C’ program (Appendix A) written in Win-AVR
studio (Atmel Corp, CA, USA) was flash-programmed onto the MCU through the Serial
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Figure 8.19: (a) The pin-out of the ATtiny 2313A-20SU and (b) the clocks generated
form Port–B of the micro-controller.
In-System Programming (ISP) header on the core module. The pin-out diagram of the
ATtiny 2313A-20SU MCU is shown in Figure 8.19(a).
8.3.6.2 Time multiplexing for PPG signal sampling
As mentioned earlier, the photons detected by the photodetector in a PPG probe are
continuously recorded as a voltage signal using the TIA. Direct sampling and digitisation
of this signal is possible when the photodiode sees just one light source. In which case the








Figure 8.20: PPG signal sampling at two different wavelengths using time windowing
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However, when there are two or more light sources, the photodetector cannot distinguish
between parts of the light power received from different light sources. To overcome this
limitation time windowing is used. An example of a two channel time windowing sequence
usually used in pulse oximeters is shown in Figure 8.20. Although the time diagram might
seem very straight forward, in practice the signal is not as clean as it is in Figure 8.20.
Numerous high frequency distortions are mixed together with the useful PPG signal. When
a light source such as an LED is switched from an ‘off’ to ‘on’ state and vice versa, there
is a slight delay between the transitions, usually referred to as the transient response
of a diode. During these transition states, the intensity of the light detected does not
represent the true light level. Therefore, by sampling the PPG signals during the entire
LED activation period as in Figure 8.20, the switching noise is also sampled.
To overcome this problem, a new schema was implemented in the ‘ZenPPG’. In this new
approach, a slight time delay was introduced between the switching of the emitters and
the triggering of the demultiplexer sampling circuit. In this way, the photodetector output
is sampled from the middle of the ‘plateau’ region of the signal as shown in Figure 8.21.
This ensures that the detection circuit has enough time to settle before sampling. Thus
producing an output signal that is more representative of the true light level. However,
this schema requires the light source activation time window to be sufficiently long so
that a proper sample can be acquired. Long light source activation windows mean low








Figure 8.21: Time windowing solution for avoiding switching noise, by sampling at the
plateau of the LED on time.
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sampled in the middle of the plateau region, there is no need to sample dark light after
activation of each LED. Instead, dark light can be sampled once both the LEDs are
activated. Thereby improving the sampling time and multiplexing rate. In the current
system the LEDs were multiplexed at 800 Hz.
8.3.6.3 Sample-and-Hold Amplifier (SHA)
The mixed voltage signal from the TIA was split into red and infrared PPG signals, using
a sample and hold amplifier (SHA) circuit, which adopted the time windowing schema
shown in Figure 8.21. The SHA circuit consisted of a switch (demultiplexer), an energy
storage device (capacitor), and an output buffer, as shown in Figure 8.22.
The demultiplexer is a switch which connects its input to one of its many outputs lines
depending on the commands from data select lines. The demultiplexer used is a double
pole 4–throw (DP4T) analogue demultiplexer (MC14052BD, ON Semiconductor, Arizona,
USA). The clocks used to control the demultiplexer and its truth table are shown in
Figure 8.6(b) and 8.19(b). The TIA outputs MIXS0 and MIXS1 were connected to the
demultiplexer inputs X and Y as shown in Figure 8.22. In this circuit, when the control
clocks MUX0, MUX1 and SAM INH0 are at logical low, the output is on X0 and Y0.
Similarly, when the MUX0 is at logical high, and MUX1 and SAM INH0 are at logical
low, the output is on X1 and Y1. Hence splitting the mixed voltage signal into infrared
(X0 and Y0) and red (X1 and Y1) components.
However, when the PPG signal is split into red and infrared components, it is necessary to
‘hold’ the sampled voltage until the next clock pulse triggers a new acquisition. Hence a
storage device i.e. the capacitor, is used to hold the sampled voltage. In the sample mode,
the voltage on the hold capacitor follows the specific input voltage (i.e. red or infrared).
In the hold mode, the demultiplexer switch is open, and the capacitor retains the voltage





























































Figure 8.22: The circuit diagram of the SHA consisting of a switch (demultiplexer), an
energy storage device (the capacitor), and the op-amp buffer.
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impedance to the hold capacitor to keep the held voltage from discharging prematurely
[272].
The performance of this circuit is mostly dependent on the switching frequency and the
chosen capacitor value. If the value of the capacitor is too large then there is a corre-
sponding increase in acquisition time and a reduction in bandwidth and slew rate. On
the other hand, if the capacitor value is too small then the capacitor discharges quickly
resulting in chopping effects and ‘saw’ shaped modulations. The frequency of switching
also needs to be sufficiently large as low switching speeds result in the circuit being open
for extended times, during which the capacitor can retain some of its charge. A 220 nF
capacitor was used in the current system to provide optimal performance. Experiments
showing the effect of hold capacitor on the acquired PPG signals is shown in Section 8.5.3.
The other parameters on which the SHA performance is based on are the passive output
of the demultiplexer and the input impedance of the op-amp. Hence, careful consideration
was taken when choosing the op-amp and the demultiplexer. Four SHA circuits were built
to acquire red and infrared PPGs from both channels. In the current version, the dark
light was not sampled.
8.3.6.4 Analogue filters
The outputs of the sample-and-hold amplifiers were fed through individual anti-aliasing
filters with a cut-off frequency of 80 Hz. This is to stop the high-frequency switching noise
or any pickup from the stray signals such as power lines from corrupting the PPG signals.
The filter was designed with the help of specialised filter design software known as Filter
Wiz PRO v3.0. This software automatically computes filter parameters and resistor-
capacitor values, using predefined filter frequency response as its input. The designed
circuit is a fairly simple passive RC filter stage providing a low-frequency path to the

















Figure 8.23: Anti-aliasing filter with a cut-off frequency of 80 Hz to reduce the band-
width of the PPG signals.
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Figure 8.24: Highpass filter with a cut-off frequency of 0.4 Hz used to remove the DC
component from raw PPG signals.
onto the NI DAQ card for digitisation and further analysis from the onboard 68-pin NI
connector.
The lowpass filtered signals contain both AC and DC components, which can be separated
digitally using digital filters. However, to increase the AC resolution, the lowpass filtered
PPG signals were also passed through a high pass filter with a gain of 180. This ensured
that the DC components were removed from the PPG signal and the AC signal was
amplified nearly to the full range of the DAQ card. The filter designed is a passive RC
high pass stage connected to a non-inverting gain amplifier as shown in Figure 8.24.
The back-end of the core module also consists of a battery monitoring circuit, which is
a simple voltage divider that divides the 5 V main supply to 1 V. This 1 V signal is
continuously sampled by the DAQ card, and displayed on the PC, hence giving the user
an indication of the battery’s state of charge.
8.3.7 Vital sign monitoring module
The vital sign monitoring module consists of an ECG channel and a respiratory channel.
The module is designed such that it can easily be modified to accommodate other vital
sign sensors such as temperature sensors, etc. Although the system consists of a pressure
transducer (40PC001B, Honeywell, New Jersey, USA) to measure respiration rate, the
sensor was not used in any of the experiments described in this thesis. Hence, it is not in
the scope of the thesis to explain its design and performance.
A Lead I ECG amplifier was developed for monitoring the R waves of the QRS complex
of the ECG signal, which were used as a timing reference for the PPG signals. The ECG
signals were acquired by placing one electrode on the right arm or right side of the chest
(red lead), and another placed on the left arm or the left side of the chest. A third elec-
trode placed on the left leg or left hip was used as a reference. The differences between
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Figure 8.25: Circuit diagram of the instrumentation amplifier used in ZenPPG system.
these biopotentials were amplified using an instrumentation amplifier. The ECG signal
acquired from the amplifier was band-pass filtered before being digitised and displayed
on the PC. The electrodes were connected to the instrumentation in the system through
a standard 6-pin AAMI connector. The instrumentation amplifier circuit in Figure 8.25
was constructed using INA128 (Texas Instruments, Texas, USA), a general purpose in-
strumentation amplifier providing high common-mode rejection ratio (120 dB) and a very
high input impedance (1010Ω). The gain of the instrumentation amplifier can be set with
an external resistor, RG, to up to 10,000, and is given by:




The value of RG used in the circuit was 4 KΩ, providing a gain of 14 from the instrumen-
tation amplifier.
Measurement of the ECG signal is, however, challenging due to the presence of the large
DC offset and various interference signals. These interference signals include the 50 Hz
interference from the power supplies, motion artifacts due to patient movement, and radio
frequency interferences. Therefore, the signal from the instrumentation amplifier was







































Figure 8.26: The second order Sallen-Key bandpass filter for limiting the bandwidth of
the acquired ECG signal.
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The band-pass filter used consists of a second-order Sallen-Key high-pass filter, to remove
the DC component in the ECG signal, and a second-order Sallen-Key low pass filter which
attenuated high frequencies. The lower and upper cut-off frequencies of the band-pass
filter are 0.37 Hz and 36 Hz respectively. The band-pass filter is of unity gain with both
resistors and capacitors of the same value, giving it a quality factor (Q) of 0.51. Figure 8.26
shows the band-pass filters used in the circuit.
8.4 Mechanical design and implementation
As mentioned earlier, a modular design approach was implemented in the mechanical
design of the ZenPPG system, whereby the entire system was split into sub-systems which
acted independently and were connected together through a bus interface. In addition to
re-usability, this approach provides efficient troubleshooting, since bugs can be traced to
specific system modules.
The ZenPPG system was designed with the aid of 3D CAD modelling software solutions.
The inclusion of 3D modelling and electronic design automation in the design process
has made it easier to recognise potential design flaws, better visualise how the modules
interface with each other in the system and in reducing the number of revisions during
manufacturing.
8.4.1 Enclosure
All six modules in the system along with a dual 9 V PP3 battery case were designed to
fit inside a portable unit measuring 160 × 103 × 56.13 mm. The portable enclosure was
made from clear anodized aluminium (1455N1602, Hammond Manufacturing, Ontario,
Canada). The rugged aluminium body consists of a slide removable belly plate and ex-
truded internal slots that are used to mount the PCBs horizontally. The enclosure consists
of two replaceable metal endplates which were milled in the laboratory to accommodate
the connectors. An anodized aluminium body was used so that it can be connected to
the ground plane, providing better shielding, reducing EMI and minimize electrical shock
hazard.
The front panel of the system incorporated two standard DE9 connectors, an AAMI ECG
connector, and a panel mounted female lure. These connectors are used to connect the
PPG probes, the ECG cable and the breathing mask. The rear panel consists of an on/off
switch to control the system, an LED indicator, a 68-pin serial bus connector for interfacing
with National Instruments data acquisition card, and inlets to access the trimmers which
128
Chapter 8 -Design and development of ZenPPG – A modular PPG processing system
can be used to control the LED currents. The rear panel also hosts the mini USB connector























































1. Core module 
5. CS module 
3. System Bus
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Figure 8.27: 3D mechanical diagrams showing the front panel, back panels, and the exploded isometric view of the system’s assembly.
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The 3D mechanical diagrams of the front and back panels, and the exploded isometric
views of the system’s assembly are shown in Figure 8.27. The CAD software used in
the systems’ design was Solid Works 2012 (Dassault Systemes SolidWorks Corp., Velizy,
France). The front and back panels were manufactured by using the Bungard Computer
Controlled Drilling machine - CCD2 (Bungard Elektronik, Windeck, Germany).
8.4.2 PCBs
All the modules used in the processing system were designed using an electronic design au-
tomation software package known as Altium Designer (Altium Limited, Sydney, Australia)
and were manufactured using a Computer Numeric Control machine (CNC). The dimen-
sions of all the modules were 100×78.95×1.6 mm, except for the current source module and
the system bus. The dimensions of the CS module and system bus are 100× 50× 1.6 mm
and 95 × 47.6 × 1.6 mm respectively. Each and every module in the system is equipped
with gold plated through-hole right angle 50-way header with connects to the system bus.
Schematic symbols and 3D footprints for all the components used in the system were
first designed in Altium. Using these schematic symbols, the schematic circuit diagrams
were implemented for each module. The completed schematics were then transferred
onto double sided virtual PCBs for component placement and routing. The shape and
dimensions of the PC boards were defined using the STEP files (3D models) imported
from Solid Works. Design rules and constraints such as routing width, routing topology,
(a) (b)
Figure 8.28: The 3D model and the assembly drawing of TIA module.
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component clearance, via to via difference, and the clearance between the pads were set for
the virtual PCBs before routing. The maximum and minimum track width used in routing
all the modules were 4 mm and 2 mm respectively. The 3D model and assembly diagram
of one of the finalised virtual PCBs (TIA module) of the system is shown in Figure 8.28.
Once the design of all the PCBs were ready, Computer Aided Manufacturing (CAM) files
such as Numerical Control (NC) drill files and Gerber files were generated for all the PCBs
in the system. These files were then exported into a software package known as LPKF
CircuitCAM (Tracks Laser & Electronics Ltd, Berkshire, UK) to create milling/routing
and drilling data in the file format appropriate for the CNC machine (G-code). The Bun-
gard CCD2 CNC was then used to manufacture PCBs. Double sided copper clad boards
of 1.6 mm thickness were used to manufacture the PCBs. Along with the PCBs, soldering
paste stencils used to transfer solder paste onto bare circuit boards were manufactured.
Figure 8.29: Photographs showing the front and back panel of the ZenPPG system
along with the PCB assembly.
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The PCBs were then tin plated using a tin sulphate solution to protect copper tracks from
oxidising, hence preserving its solderability. The tin plated PCBs were then through hole
plated to connect the top and bottom layers.
Using the soldering paste stencils and the assembly drawings, the surface mount com-
ponents were placed on the respective pads and were soldered using a reflow soldering
oven (CIF-FT02, C.I.F, France), maintained at 200◦C. Through hole components were
hand soldered using a soldering iron. The photographs of the prototype ZenPPG system
showing the front panel and the mechanical assembly of the PCBs is given in Figure 8.29.
8.5 Verification and measured performance
Following the design and fabrication of the ZenPPG system, the individual circuits within
the system were tested thoroughly to verify the system’s performance. The details of the
testing conditions and the results obtained are described in this section.
8.5.1 Emitter driver circuit
The components within the emitter driver circuit, namely the RCV circuit, the multiplexer,
the voltage attenuator, the modified Howland current source and the current monitoring
circuit were tested together. Since the design of both the PPG channels is identical,
they are described together. A 4-channel mixed signal oscilloscope and function generator
(Agilent MSO-X 4024A, Agilent Technologies, CA, USA) was used to test the circuit’s
performance.
8.5.1.1 Test conditions
Two constant DC signals of amplitudes +1 V and -1 V were fed through the RCV circuits
on channel 1 using the dual channel function generator. The output of the emitter driver
circuit was then measured at points P1 (RCV circuit output), P2 (multiplexer output), P3
(attenuator output) and P4 (Current monitor output), as shown in Figure 8.30 using the
oscilloscope. A two wavelength finger PPG probe (described in Chapter 7) was connected




















Figure 8.30: Functional diagram of the emitter driver circuit showing various measure-
ment points– P1, P2, P3, P4.
133
Chapter 8 -Design and development of ZenPPG – A modular PPG processing system
USB stick in a comma-separated values (.CSV) file format. These text files were later
plotted in MATLAB (The MathWorks Inc., Massachusetts, USA).
8.5.1.2 Results
The output of the emitter driver circuit measured at points P1 P2 P3 and P4 are displayed
in Figure 8.31. The output measured at each point is accurate and is representative of
the calculated voltage. At point P1, the output of the circuit is 1/5
th of the input signal
(±1 V), as the RCV circuit divides the input by 5. At P2, the ±0.2 V are multiplexed
to generate a switched signal fluctuating from 0.2 to -0.2 V by the multiplexer. The duty
































Input to the  RCV circuit
P1 : Output of the RCV circuit
P2 : Output of the multiplexer
P3 : Output of the voltage attenuator 
P4 : Output of the current monitor
Figure 8.31: Output of the emitter driver circuit measured at various points in the
circuit: P1–RCV ciruit, P2–multiplexer, P3–voltage attenuator, P4–current monitor.
134
Chapter 8 -Design and development of ZenPPG – A modular PPG processing system
cycle of the signal generated is 33%. The output of the voltage attenuator at P3 is 1/10
th
of the multiplexed signal. These ±20 mV are converted by the Howland current source
into proportional current, i.e. ±20 mA. The current across the load resistor (20 mA) is
sensed by the instrumentation amplifier and is amplified 10 times (0.2 V) to generate a
signal that can be sampled by the DAQ card at P4.
8.5.2 Trans-impedance amplifier (TIA)
As mentioned earlier in Section 8.3.5 the zero biased TIA circuit shown in Figure 8.18
can sometimes display complex AC behaviour, hence careful consideration is required in
stabilising the amplifier. Three important parameters that determine the TIA’s perfor-
mance are the op-amp bandwidth (should be very high), the phase compensation capacitor
(should be very small) and the photodiode junction capacitance (should be fairly small).
However, the choice of the op-amp bandwidth and photodiode junction capacitance are
sometimes limited either by the application or availability. Hence, Cf plays a key role in
providing stability to the amplifier.
The calculated value of Cf for the circuit shown in Figure 8.18 is 0.3 pF, which is very small
and is not available as a standard capacitor. The op-amp and the photodiode used in the
design have high bandwidth (90 MHz) and small parasitic capacitance (10 pF), hence, in
theory, a slightly larger capacitor can be used to stabilise the circuit without reducing the
circuit’s useful bandwidth. Moreover, due to non-linearities in the components, choosing
compensation capacitance is most often by trial and error method. Another more rigorous
method, which is considerably faster than the trial and error approach, is to use simulations
to gain more insight about the loop behaviour over frequency. Hence, both the methods
were employed while configuring Cf for TIA circuit.
8.5.2.1 Test conditions
Simulations– SPICE simulations were carried out to assess the loop stability of the TIA in
NI Multisim 2013 (National Instruments, Texas, USA). The closed loop I-to-V gain trans-
fer function, open loop gain, Phase Margin (PM), and noise gain analysis were performed
on the circuit by varying the feedback capacitor (Cf ). The closed-loop AC transfer func-
tion was measured without the capacitor first and then with the capacitor at 0.3 pF, 5 pF,
10 pF, 47 pF and 100 pF, to determine the change in -3dB bandwidth. Similarly, the PM
and the noise gain of the circuit was quantitatively determined at each capacitor value.
The results were then compared to choose the optimal phase compensation capacitor.
Trial and error method– Transient analysis was carried out to measure the step response of
the TIA with different phase compensation capacitors. In this method, the change in the
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TIA output, to a change in the Cf value was recorded and compared using an oscilloscope.
The output was first recorded with no Cf , and then with Cf at 5 pF, 10 pF, 47 pF and
100 pF. The gain resistor Rf was kept constant at 270 kΩ, throughout the experiment.
The test was carried out with the finger PPG probe connected to the ZenPPG system. The
output recorded by the oscilloscope was then plotted in MATLAB and compared. Based
on the quantitative results from simulations and eye-balling the output of TIA during the
trial and error method, Cf was chosen.
8.5.2.2 Results
Simulations – The simulated closed-loop I-to-V gain response of the TIA without the
capacitor, and with the capacitor at 0.3 pF, 5 pF, 10 pF, 47 pF and 100 pF is shown in
Figure 8.32. With no capacitor in the feedback loop of the TIA, the gain curve shows noise
gain peaking of 8.5 dB just before the -3 dB frequency (2.8 MHz). This indicates that
the circuit is unstable. With a 0.3 pF capacitor in the feedback loop, the gain peaking is
mostly reduced, and the -3 dB frequency is shifted to 2 MHz. Similarly, with an increase
in capacitance to 5 pF, 10 pF, 47 pF and 100 pF the bandwidth (-3 dB) is further reduced
to 117 kHz, 59 kHz, 12.5 kHz and 5.9 kHz. Since the -3dB point at 47pF and 100pF is
close to the sampling clock (SAM INH0: 2.8 kHz) frequency, a capacitor ≥47 pF cannot
be used. From these results, it is safe to assume that the optimal capacitance required for
























Figure 8.32: Closed-loop I-to-V gain response of the TIA without the capacitor, and
with capacitor at 0.3 pF, 5 pF, 10 pF, 47 pF and 100 pF.
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stabilizing the TIA is 5 pF or 10 pF, as they offer no gain peaking and reasonably large
bandwidth.
However, before settling on a choice, the stability of the TIA was tested by finding the
open-loop phase margin (PM) and the noise gain of the TIA circuit. PM is the phase
angle of the open-loop gain transfer function when it crosses 0 dB. The value of PM
should always be greater than 45◦ for good TIA stability. The PM of the circuit was first
measured without Cf in the feedback loop and then with Cf at 0.3 pF, 5 pF, 10 pF, 47 pF
and 100 pF. The simulated open-loop gain and phase response of the TIA without Cf ,
and with Cf (at 0.3 pF, 5 pF, 10 pF, 47 pF and 100 pF) is shown in Figure 8.33.
The low phase margin of 18.9◦ (Figure 8.33) with no capacitor in the feedback loop confirms
the closed loop frequency response peaking which is evident in Figure 8.32. With the
introduction of a 0.3 pF capacitor in the feedback loop, the PM of the circuit has increased
to 62.5◦, hence stabilising the circuit. Similarly, when the Cf was increased to 5 pF and
10 pF, the PM has increased to 86◦ and 84◦. The PM is fairly flat in the capacitance range
between 1 pF - 10 pF. With a further increase in capacitance to 47 pF or 100 pF, the
phase angle has started to decrease, indicating overcompensation. The measured phase
angle in these cases was 78◦ and 73◦. In these situations the TIA will become unstable,
again leading to ringing and noise in the acquired signal.
To further help find the optimal compensation capacitor value, and support the phase
margin analysis, noise gain analysis was performed for various values of Cf . The noise
gain of the TIA at various values of Cf was plotted along with the open-loop gain of the
op-amp, and is shown in Figure 8.34. The optimal Cf value is the one which places a
pole on the noise gain function at the frequency (fi = 1.48 MHz) where it intercepts the
op-amps (OPA380) open-loop gain. Here, fi =
√
fzf .fc, fzf = 1/2pi.Rf .(Ci+Cf ) and fc
= op-amp gain bandwidth of 90MHz. From Figure 8.34, it is apparent that Cf= 0.3 pF
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Figure 8.33: The simulated open-loop gain and phase response of the TIA without Cf , and with Cf at 0.3 pF, 5 pF, 10 pF, 47 pF and 100 pF. The
phase margin should be > 45◦ for good TIA stability.
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Figure 8.34: Noise gain of the TIA at different values of Cf plotted along with the
open-loop gain of the op-amp. The optimal Cf is the one which places a pole on the noise
gain function at the frequency where it intercepts the op-amps open-loop gain.
With an increase in Cf (5pF or 10 pF), the noise gain is further reduced and the open
loop gain curve intersects the noise gain plot in the flat (stable) region. This leads to
overcompensation, and a reduction in bandwidth but provides stability. With Cf = 47 pF
or 100 pF the noise gain is close to 0 dB, which is below the stable gain of the OPA380
op-amp. Hence, these capacitors should not be used. The transimpedance circuit’s output
noise voltage was calculated for various capacitors using a Total Noise Calculator tool
[273]. The total noise (VT ) and the signal-to-noise ratio (SNR) of the TIA circuit with
a 0.3 pF capacitor were 669.66 µV and 61.65 dB. With a 5 pF capacitor in the loop, the
VT was 178.6 µV and S/N was 73.13 dB. Finally with a 10 pF capacitor, the VT and S/N
were 135.4 µV and 75.53 dB.
From the closed loop transient response, phase margin analysis and noise gain analysis, it
is fair to say that a feedback capacitor of 10 pF provides good phase compensation and
stability with large enough bandwidth (59 kHz). This can be verified by obtaining the
closed-loop step response of the TIA with different values of Cf , as shown in Figure 8.35.
The plot confirms that smaller Cf (0 pF or 0.3 pF) values could make the amplifier unstable
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Figure 8.35: The closed-loop step response of the TIA with Cf = 0 pF, 0.3 pF, 5 pF,
10 pF, 47 pF, 100 pF
and produce long ringing noise, and larger Cf (47 pF, 100 pF) could have long settling
times while optimum Cf (5 pF or 10 pF) results in a refined step response with no ringing.
Trial and error method – Having found the optimal capacitor value through simula-
tions, experiments were carried out to check if the TIA performance matches the simulated
results. The step response of the TIA was measured for various capacitor values, simi-
lar to the simulation in Figure 8.35. The changes in the output of the transimpedance
amplifier due to variations in feedback capacitance are shown in Figure 8.36. Without
a feedback capacitor in the TIA, large ringing and noise were observed. This reflects on
the large gain peaking observed in AC transfer function (Figure 8.32). With a capacitor
in the feedback loop of the TIA, the ringing noise and the overshoot started to decrease.
Optimal performance with no overshoot, ringing or overcompensation was observed when
the capacitor value was 10 pF. As the value of the capacitor was further increased to 47 pF
and 100 pF, the leading and trailing edges of the signal became smoother (overcompen-
sation). Since the signal is only sampled in the middle of the plateau region (as shown
in the last sub-plot of Figure 8.36), this overcompensation at 47 pF or 100 pF might not
be a major problem. However, as mentioned earlier, the bandwidth of the TIA decreases
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Cf = 5 pF
Cf = 10 pF Cf = 47 pF
Cf = 100 pF Cf = 100 pF with  sampling clock
Figure 8.36: The changes in the output of the transimpedance amplifier due to variations
in feedback capacitance
linearly with an increase in the feedback capacitance. Hence to have a reasonably large
bandwidth and a stable TIA with no noise, a 10 pF capacitor was chosen.
8.5.3 Sample-and-hold amplifier
As mentioned in Section 8.3.6.3, the size of the hold capacitor in the SHA is critical for
optimal performance of the amplifier. A low-value capacitor provides fast acquisition, but
will increase errors due to hold step and droop (voltage difference in hold mode) caused by
amplifier bias current. A very large hold capacitor, on the other hand, results in increased
hold time and decreased bandwidth. Hence for good SHA performance, a large enough
capacitor that is consistent with acquisition time and dynamic sampling error requirements
is needed. To find the optimal hold capacitor for the SHA, experiments measuring the
static and dynamic performance of the SHA were carried out with various values of hold
capacitors.
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8.5.3.1 Test conditions
Simulations– SPICE simulations were carried out in NI Multisim 2013 to find an optimal
capacitor for the SHA shown in Figure 8.22. The performance characteristics such as
hold mode droop, pedestal error, voltage offset, gain error and aperture delay time were
measured for various hold capacitor values. The capacitor values used in the testing were
22 nF, 47 nF, 68 nF, 100 nF, 150 nF, 220 nF, 330 nF and 470 nF. The optimal capacitor
was determined by comparing the errors and finding the best compromise between errors.
Experimental testing– following the simulations, the transient response and the signal-
to-noise ratio of the SHA were measured to verify circuits performance. Similar to the
simulations, the capacitor values used in the testing were 22 nF, 47 nF, 68 nF, 100 nF,
150 nF, 220 nF, 330 nF and 470 nF. A 1 Hz sine wave with an amplitude of 0.2 V and DC
offset of 1 V was used as the input signal for testing the transient response of the SHA
amplifier. The output was recorded using an oscilloscope.
The SNR of the SHA’s output was also determined at each capacitor value. For this
test, a pre-recorded PPG signal with a frequency of 0.84 Hz was used as the input to
the SHA. The output of the SHA at each capacitor value was recorded with NI DAQ
card. The off-line spectral analysis was performed in MATLAB on the acquired data, to
extract the frequency content of the output signal in the 0-20 Hz range. The frequency
spectrum acquired at each capacitor value was normalised to the component with the
maximum power (i.e. cardiac component) to highlight the changes in the power of the
noise component. Then by comparing the frequency spectrum of the input signal to the
output signal, the noise component was located. The power of the noise component was
then used to calculate the SNR.
8.5.3.2 Results
Simulations – Table 8.2 shows the dynamic and static characteristics of the SHA mea-
sured with different hold capacitors. The offset voltage is the voltage difference between
the input and output when the input voltage is zero and the SHA is in sample mode. For
good accuracy, the offset voltage must be lower than half of the least significant bit (LSB).
LSB is given by
LSB =





= 76.29 µV ; n is the no. of bits (8.9)
The simulations reveal that the offset voltage in the sample mode is much smaller than
1/2 LSB (38.14 µV ) in all cases.
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22 nF 6.863 µV 2.591 µV −38.6 µV 6.06 µs −353.7 µV /ms 1.72 µs
47 nF 6.859 µV 0.406 µV −16.5 µV 5.82 µs −165.8 µV /ms 2.91 µs
68 nF 6.861 µV −1.44 µV −11.1 µV 5.64 µs −114.6 µV /ms 4.27 µs
100 nF 6.861 µV −3.758 µV −7.5 µV 5.08 µs −77.8 µV /ms 6.34 µs
150 nF 6.861 µV −8.387 µV −4.88 µV 3.36 µs −51.8 µV /ms 8.81 µs
220 nF 6.861 µV −1.066 µV −3.23 µV 1.99 µs −31.1 µV /ms 13.2 µs
330 nF 6.861 µV −2.106 µV −2.02 µV 1.37 µs −20.7 µV /ms 18.8 µs
470 nF 6.861 µV −4.052 µV −1.52 µV 1.18 µs −16.5 µV /ms 27.6 µs
The gain error is the deviation of the output voltage from the input voltage (excluding








= 7.629 µV (8.10)
The results from simulations show the gain error of the SHA to increase with an increase
in the hold capacitor value. The minimum (0.00001% of the FSR) and maximum (0.0004%
of the FSR) gain error was seen with 47 nF and 470 nF capacitors.
The pedestal error, as shown in Figure 8.37, is the offset voltage that appears at the SHA
output due to the sample-to-hold transition. Pedestal error must be less than 1/2 LSB
for good accuracy. The pedestal error measured with the 22 nF hold capacitor was 38.6
µV, which is marginally higher than 1/2 LSB. Hence, a 22 nF capacitor is not suitable for
good accuracy. In all other cases, the pedestal error was much smaller than 1/2 LSB and
has decreased with an increase in hold capacitance.
The effective aperture time (Figure 8.37) is the time delay between the generation of the
hold command and the appearance of final held voltage that exists on the hold capacitor.
For an ideal SHA, this delay should be as small as possible. The simulations show the
effective aperture time to decrease with an increase in hold capacitance, suggesting a large
capacitor to be ideal for good accuracy.
Hold mode droop is the rate at which the SHA output voltage changes in hold mode due to
leakage from the hold capacitor. In applications such as PPG, where the sampled voltage
must be held for long periods of time, the voltage drop should not be more than 1/2 LSB
during the hold time. The 22 nF, 47 nF, 68 nF, 100 nF and 150 nF capacitors produce
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Figure 8.37: The sample-to-hold transition of the SHA with various hold capacitors.
The offset voltage that appears in the SHA output during this transition is known as
pedestal error.
a droop rate that is higher than 1/2 LSB. Hence for optimal performance a capacitor
≥ 220 nF should be used.
The acquisition time is the maximum time required to acquire a new full-scale input
signal to 1/2 LSB accuracy, once a sample command has been given. The acquisition time
should be significantly smaller than the sampling period for high accuracy. Simulations
show the acquisition time to increase with an increase in hold capacitance. With a 470 nF
capacitor, the acquisition time is approximately 10% of the sampling period, which is very
large, hence smaller capacitors should be used.
In summary, hold capacitors ≤ 100 nF produced high pedestal error, large effective aper-
ture delay and large hold mode droop. Hence, are not ideal for the current design. Sim-
ilarly, a large capacitor such as 470 nF produced a high gain error, and large acquisition
time, and thus, are also not ideal for the current design. The best compromise between
all errors was found with hold-capacitor between 150 nF and 220 nF.
Experimental testing – Having found the optimal values through simulations, ex-
periments were carried out to verify the simulated results. The transient response of the
SHA was measured with various hold capacitors and is shown in Figure 8.38. The green
trace in the graphs indicates the input signal while the blue trace shows the SHA output.
Looking at the sub-plots, two observations can be made immediately. (1) In the sample
mode, the gain error between the input and the output signals increases with an increase
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C H = 470 nF
Time (s)
0.15 0.15
Figure 8.38: The output of the SHA with various feedback capacitors. The green trace
in the graphs indicates the input signal, while the blue trace shows the SHA output.
in hold capacitor value. The gain error is visibly large at 330 nF and 470 nF. (2) The
voltage droop in the hold mode decreases with an increase in the hold capacitor value.
The hold mode voltage increased with time at 22 nF, 47 nF, 68 nF, and 100 nF, and is
relatively flat with a capacitors ≥ 150 nF.
Similar to the simulations, the acquisition time in sample mode increased with an increase
in the capacitor value. However, the response seems much worse in real time than the
simulations. With a large capacitor such as 330 nF or 470 nF, the acquisition time appears
to be maximum, i.e. equivalent to the sampling time. This usually occurs when the hold
capacitor must charge to a full-scale voltage change. Therefore, capacitors ≥ 330 nF are
not ideal for the current design.
Signal-to-Noise Ratio– A pre-recorded PPG signal shown in Figure 8.39 was used as the
input signal for testing the SNR. The major component in the input signal is the cardiac
component at 0.84 Hz. The output of the SHA was recorded with 22 nF, 47 nF, 68 nF,
100 nF, 150 nF, 220 nF, 330 nF and 470 nF capacitors using a data acquisition card.
Figure 8.40 shows the output of the SHA measured with different hold capacitors.
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Figure 8.39: The pre-recorded input signal (in blue) and the frequency response (in
green) of the input signal used to test the SHA.
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Figure 8.40: Depicts the output of the SHA measured with different hold capacitors.
The noise in the signals reduces with an increase in hold capacitor value.
From the sub-plots, it is clear that the output signal gets smoother with an increase in the
hold capacitor. Visibly large noise can be seen clearly in the output signals acquired with
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Figure 8.41: The frequency spectrum of the input signal and the SHA output when CH
is 22 nF, 47 nF, 68 nF, 100 nF, 150 nF, 150 nF, 220 nF, 330 nF and 470 nF.
22 nF and 47 nF capacitors. To find the frequency and the power of this noise component
in the output signal, frequency domain analysis was performed.
The normalised frequency spectrum of the SHA output together with the normalised
spectrum of the input signal is shown in Figure 8.41. Clear noise peaks were visible in the
frequency spectrum of all the output signals acquired from the SHA between 10 Hz-18 Hz,
as shown in Figure 8.42(a). However, apart from 22 nF and 47 nF capacitors, all other
capacitors produce relatively similar noise level beyond 10 Hz. The signals from 22 nF
and 47 nF capacitors produce large noise between 13 and 15 Hz. This verifies the noisy
transient response is shown in Figure 8.40. Hence, these two capacitors are discarded from
further analysis.
To further discriminate the noise components in the signals acquired from other capacitors,
the 10 Hz noise component was closely examined. Figure 8.42(b) shows the relative changes
in the power of the signals acquired at different capacitors (10 Hz). From this figure, it is
evident that each hold capacitor produces a different level of noise. To compare them, the
SNR was calculated by taking the ratio of the power of the noise component and the cardiac
component. Table 8.3 shows the SNR (dB) of the SHA with various hold capacitors. The
SNR of SHA is close to the original signal with 470 nF capacitor. However, there are no
significant differences between the SNR produced by other capacitors.
From the simulations and the experimental observations, the best compromise between all
errors was found with 150 nF and 220 nF capacitor. Hence, it was decided that a 220 nF
capacitor will be used as the hold capacitor for the SHA.
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C H = 330 nF
C H = 470 nF
(a) The normalised frequency spectrum of the SHA output showing the noise components between 9
and 18 Hz















C H = 68 nF
C H = 100 nF
C H = 150 nF
C H = 220 nF
C H = 330 nF
C H = 470 nF
(b) The normalised frequency of SHA output showing the 10 Hz noise component.
Figure 8.42: The noise components in the SHA output acquired using different values
of hold capacitors.
Table 8.3: Depicts the SNR of the Sample-and-hold amplifier with CH at 68 nF, 100 nF,
150 nF, 220 nF, 330 nF and 470 nF.
Capacitors 68 nF 100 nF 150 nF 220 nF 330 nF 470 nF
Input signal 108 dB
Output signal 100.4 dB 99.07 dB 100.21 dB 99.55 dB 100.12 dB 101.31 dB
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8.5.4 Filters
The frequency response of the lowpass and highpass filters used in ZenPPG system, for
filtering the PPG signals were tested through simulations. The simulated magnitude and
phase response of the lowpass and the highpass filter is shown in Figure 8.43. The blue
trace shows the magnitude of the filters in dB, and the green trace shows the phase response
of the filters.





















































Figure 8.43: The magnitude and phase response of (a) the anti-aliasing filter and (b)
the high pass filter
8.5.5 Signal-to-noise ratio of the ZenPPG system
The SNR of the PPG signals acquirable from the ZenPPG system was measured experi-
mentally. A dual channel function generator was used as a PPG signal simulator (similar to
a commercial SpO2 simulator) and was connected to the ZenPPG system. The reflectance
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finger PPG probe described in Chapter 7 was connected to the ZenPPG system during
testing. The raw PPG signals from the ZenPPG system were digitised by the NI DAQ
card and were stored on the laptop PC using LABVIEW. A simulator was used for SNR
testing so that the output signal acquired can be compared to the reference input signal,
and so that any external interferences can be avoided. Off-line analysis was performed on
the acquired data to extract the frequency contents in 0 to 12Hz range.
The measured frequency spectrum of the input and output signals were normalised to
the cardiac component to highlight the noise component. By comparing the input and
the output frequency spectrum, the noise components were located. A noise peak with
a power higher than the power of the input signal was found at 10 Hz (same noise peak
seen during SHA testing). Figure 8.44 shows the frequency spectrum of the input and the
output signals in 0-10 Hz range and a focused view of the noise components at 10 Hz. Since




































10 Hz peak 
(b)
Figure 8.44: Frequency spectrum of the input and the output PPG signals showing (a)
the cardiac and (b) the noise components. The 10 Hz noise peak is used to calculate SNR.
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the frequency spectrum is normalised, the power of the noise peak at 10 Hz determines the
SNR. Hence, the SNR of the raw PPG signals acquired from the PPG system is 101.31 dB.
8.5.6 ECG Amplifier
The performance of the ECG amplifier in the vital sign monitoring module was tested
using an ECG simulator. During the experiment, the ECG simulator was connected to
the respective leads of the ECG cable (RA, LA and LL), and then an ECG signal with
a frequency of 1 Hz (60 BPM) and an amplitude of 0.1 mV was simulated. The output
of the ECG amplifier from the ZenPPG system was then recorded using a DAQ card and
was stored on laptop PC. Before testing the instrumentation amplifier in the ECG circuit,
the frequency response of the bandpass filter used was tested. Figure 8.45 shows the ECG
signal acquired from the ECG amplifier. The amplitude of the ECG signal is 14 times
the amplitude of the input signal, which corresponds with the gain of the instrumentation
amplifier.
















Figure 8.45: The ECG signal acquired form the ECG amplifier. The ECG leads were
attached to a simulator configured to provide a simulated sinus rhythm of 60 beats per
minute
8.5.7 Power consumption and Battery life
As mentioned earlier, the ZenPPG system works both on batteries and USB power supply.
The power consumption of the system, when powered by either power supply, will be the
same, and was measured using an ammeter. The current consumed by the ZenPPG system
– IZen, was measured by connecting the ammeter in between (in series) the batteries and
the ZenPPG system. During the measurement, both the ear canal and the finger PPG
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Figure 8.46: The changes in battery voltage with time. A steep drop in voltage is
observed at 125th min.
probes, and the ECG cable were connected to the system. The LEDs in each probe were
driven by 40 mA of current.
The load current measured by the ammeter was 214 mA. Hence, the power consumption
of the system PZen = IZen× VZen = 214 mA × 5V (Battery supply) = 1.07 W. From the







× 0.7 = 109.8min . (8.11)
To verify the calculated result (battery time) experimentally, the changes in the battery
voltage were recorded for two and half hours with the system being switched on and con-
nected to all the sensors. The measurements were recorded using LABVIEW. Figure 8.46
shows the results obtained from the battery test. The battery voltage stayed relatively
constant for the first 125 mins, after which there was a fast decline in the voltage. The
system can, therefore, be used continuously for 2 hours when powered by batteries.
8.6 Summary
To drive the optical components of the reflectance ear canal and finger PPG probes and to
pre-process the acquired PPG signals, a PPG instrumentation unit called ‘ZenPPG’ was
developed and tested successfully.
A modular design approach was implemented in the system’s design, whereby the electronic
circuitry in the system was divided into multiple modules, which were connected together
by a system bus. The developed system also hosted an ECG amplifier for detecting the
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QRS wave of the ECG signal. The PPG modules of the system are the TransImpedance
Amplifier (TIA) module, the Current Source (CS) module, and the Core module. The
other two modules in the system are the power supply module and the vital sign monitoring
module. The power module consists of the circuitry required to split the battery or USB
supply into multiple power rails that supply the digital and analogue microchips. The CS
module converts a constant voltage into current required to turn on the LEDs in the PPG
probes. The TIA board converts the photocurrents detected by the photodiode in the
PPG sensors into a voltage signal. The core module hosts the multiplexer, SHA, filters,
and the microcontroller which controls the multiplexer and the SHA. The current of each
LED is controlled digitally on channel-1, and on channel-2 using trimmers. The PPG
signals from the ZenPPG system are digitised by an NI DAQ card, which connects to the
system through a 68-pin connector.
Independent circuits within each module were tested and configured for optimal perfor-
mance. The SNR of the PPG signals acquired from the system was 101.31 dB. Along
with the AC and DC PPG signals, and the ECG signal the ZenPPG system measures the
current on each LED and the battery level. However, the use of the software controlled
emitter driver and absence of onboard DAC means that the PPG instrumentation system
must be used in conjunction with the appropriate LabVIEW software and NI DAQ card.
The following chapter details the implementation of the data acquisition system. This in-
cludes the analogue to digital conversion, VI for emitter driver control, Virtual Instrument
(VI) for data acquisition and other algorithms for data logging and data analysis.
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Data acquisition and hardware control
A data acquisition system was developed which incorporated all the elements required
for hardware control and acquisition of various signals from the PPG processing system
(described in Chapter 8). The data acquisition system comprises a software program,
or virtual instrument (VI), implemented in LabVIEW and a data acquisition card from
National Instruments (National Instrument Corporation, Austin, Texas).
The two main functions of the developed VI are (1) digitization of signals from the PPG
processing system (ZenPPG), and (2) controlling the emitter driver circuit. Other func-
tions of the VI include recording and saving data, digital signal processing and estimation
of SpO2 and heart rate (HR). The data acquisition card used to acquire data was a NI
USB-6212. The details of the digitisation stages together with the development of the
VI for acquisition, processing, and analysis, as well as the performance evaluation tests,
will be the subject of this chapter. Prior to this, a brief introduction to LabVIEW is also
provided in this chapter.
9.1 Data Acquisition system
The data acquisition system was developed to sample, display, store and analyse photo-
plethysmograms from the ear canal and the finger. A generic block diagram illustrating
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the main functions of the system is shown in Figure 9.1. Along with the PPG and ECG
signals, the system was later modified to include the acquisition of signals from tempera-
ture sensors, Laser Doppler Flowmetry monitor and NIRS monitor (discussed further in
Chapters 10 and 11).









































Figure 9.1: Block diagram of the data acquisition system illustrating the key features
9.1.1 Analogue-to-digital conversion
All 12 analogue signals from the PPG processing system (8 raw PPG signals, ECG signal,
LED current sensing and battery monitor signals), were digitised by an analogue-to-digital
converter (ADC) that was embedded in a data acquisition (DAQ) card. The card used
was the National Instrument data acquisition card (NI USB-6212 National Instrument
Corporation, Austin, Texas).
The NI USB-6212 is a multifunction data acquisition (DAQ) device that provides plug-
and-play connectivity via USB for acquiring, generating, and logging data in a variety of
portable and desktop applications. The NI USB-6212 mass termination device features
16 analogue input channels and two output channels. The technical specifications of the
DAQ card are provided in Table 9.1. The device supports differential and Non-Referenced
Single-Ended (NRSE)/Referenced Single-Ended (RSE) signal input configurations. The
USB-6212 mass termination device is connected to the PPG processing system via a 64-pin
NI connector.
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Table 9.1: Technical specifications of the USB-6212 DAQ card from National Instru-
ments.
Specifications USB-6212 Mass termination DAQ card
Number of input channels 16 single ended, 8 differential
Number of output channels 2
Number of Digital input and output chan-
nels
24
Maximum Input Sampling rate 400 kS/s single channel, 400 kS/s multichannel (aggregate)
Maximum Output Sampling rate 250 kS/s per channel
Analogue Input range ±10 V, ±5 V, ±1 V,±0.2 V
Analogue Output range ±10 V
Analogue input signal bandwidth (-3 dB) 1.5 MHz
ADC resolution 16 bits
CMRR (DC to 60Hz) 100 dB
Physical dimensions 19.3 × 9.4 × 3.1 cm
I/O connectors one 68-pin SCSI
Bus interface USB 2.0 Hi-speed
9.1.2 Introduction to LabVIEW
LabVIEW (Laboratory Virtual Instrument Engineering Workbench) is a system design
platform and development environment from National Instruments (National Instrument
Corporation, Austin, Texas). Instead of using traditional text-based programming, as
with C, C++, or Java, LabVIEW uses graphics to create programs in a pictorial form
called a block diagram, eliminating a lot of the syntactical details [274]. This graphical
programming in LabVIEW is called ‘G’.
The functions in LabVIEW are connected in a hierarchical manner by wires which repre-
sent the flow of the data. Each function executes only after receiving the necessary data
from the previous function. LabVIEW programs are called Virtual Instruments (VIs) as
their appearance and operation imitate actual instruments. Any VI developed in Lab-
VIEW consists of two main parts. (1) Front panel: the interactive user interface of a VI,
so named because it simulates the front panel of a physical instrument. The front panel
can contain knobs, push buttons, graphs, and many other controls and indicators. (2)
Block diagram: the VI’s executable source code, constructed in ’G’. The components of
a block diagram are lower-level VIs, built-in functions, constants, and program execution
control structures.
LabVIEW comes with another layer of software for easily communicating with the hard-
ware (i.e. DAQ card), called the NI–DAQmx Driver software. It forms the middle layer
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between the application software and the hardware. The driver software also prevents
register-level programming hence providing easy access to the hardware functions.
9.1.3 Development of Virtual Instrument for emitter control
To digitally control the light intensity of the red and infrared emitters in the PPG probe,
both analogue output ports available on the USB-6212 DAQ card were utilised. Digital
control of LEDs on both channels of the PPG processing system was not possible, as the
number of analogue output channels on the DAQ card were limited. Hence, channel 2 was
driven by on-board circuitry. The two reference voltages (VRef) generated from the DAQ
card were between -5 to 0 V and 0 to 5 V. The positive voltage powered one of the LEDs
while the negative powered the other. As mentioned in the Chapter 8, the reference voltage
generated by the DAQ card was then attenuated such that each volt supplied from the
analogue output port produced 20 mA of current to drive the emitters. Figure 9.2 shows
the source code of VI used to create the signal to control the intensity of the emitters.
The polymorphic function “DAQmx Analogue Output (AO) Voltage” was used to create
virtual channels that will produce VRef on the analogue output terminals of the DAQ card.
The channel on which the voltage is generated was specified using the physical channel
(I/O) selection property, in this case, it was Dev1/ai0 and Dev1/ai1. The maximum and
minimum voltage levels that can be generated were also specified on both the channels
(ai0: 0 to -5V, ai1: 5 to 0V). Once the virtual channel was created, a while loop was used
in conjunction with DAQmx Write, to continuously generate an output voltage on that
channel. The DAQmx Write function writes samples to the task or virtual channel you
specify. The value of the samples that DAQmx Write writes to the channel depends upon
Figure 9.2: Section of the virtual instrument for emitter control, illustrating the gen-
eration of two analogue outputs, used to the control the LED currents on one of the
channels
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the desired VRef selected by the user on the front panel of the VI. Once the user hits the
stop button, the task is cleared using the function DAQmx Clear Task. Before clearing,
this VI aborts the task, if necessary, and releases any resources the task reserved.
9.1.4 Development of Virtual Instrument for data acquisition
The data acquisition part of the VI was designed to acquire 12 signals from the PPG
processing system. They are as follows:
• the red and infrared AC PPG signals from both the channels (4 signals)
• the red and infrared DC PPG signals from both the channels (4 signals)
• the ECG signal
• the LED current sensing signals (ISENSE0 and ISENSE1)
• the power supply monitoring signal (PSVMON).
The DAQ Assistant Express VI was used to acquire all the signals from the PPG processing
system. The DAQ Assistant is a graphical, interactive guide that lets the user configure
the DAQ card, the analogue inputs which needs to be sampled, the sampling frequency
at which the signals needs to be sampled, and the mode of acquisition (i.e. differential,
NRSE and RSE). DAQ Assistant also offers the capability to test the data being acquired.
In the current setup, 12 analogue input channels from port ai0-ai8 and port ai10-ai12 were
selected for sampling. All the input channels were configured in referenced single-ended
mode. The sampling frequency was set to 1 kHz and the samples to read (buffer size) was
set to 100. The maximum and minimum voltage range of the signals being acquired was
set to 5V and -5 V respectively.
The Express VI was then placed inside a for loop, which was nested inside a while loop,
for continuous data acquisition. The inclusion of the for loop is for the calculation of
ratio of ratios (ROS) and SpO2 values, detailed in Section 9.1.6. The for loop executes its
subdiagram n times, where n is the value wired to the count (N) terminal. In this case, it
is set to twenty times. Therefore, for each iteration of the while loop, the for loop iterates
twenty times. Hence, 2000 samples are acquired from each analogue input channel on
each iteration of the while loop. The while loop continues to execute its subdiagram until
execution is stopped by the user by pressing the stop button on the front panel.
The dynamic data output from the DAQ assistant was split into 12 separate signals using
a split signals function. Each unit of the original signal contains the timing information
(t0 and dt) of the waveform.
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9.1.5 Algorithms for digital filters and display
Digital filters were implemented in the VI, to reduce the bandwidth of the acquired signals.
This is so that any noise added to the signals during digitisation, such as quantisation noise
can be removed from the signals. Also, the bandwidth of the analogue filters used in the
PPG processing system was larger (80 Hz) than required (typical bandwidth of a PPG
signal is 0.5 – 10 Hz), hence the acquired PPG signals needs to be filtered.
Three digital filters in varying configuration were hence used to filter the PPG and ECG
signals from the PPG processing system. The Filter Express VI from the Signal Analysis
Express palette was used to configure all three filters. The red and infrared raw AC PPG
signals from the processing system were filtered using a bandpass filter with lower and
upper cut-off frequencies at 0.5 Hz and 18 Hz. The DC red and infrared PPG signals
were filtered using a lowpass filter with the cut-off frequency of 20 Hz. The ECG signal
was filtered using a bandpass filter with lower and upper cut-off frequencies at 0.5 Hz
and 40 Hz. All three filters were Finite Impulse Response (FIR) filters, with the filter
coefficient set to 511 taps. FIR filters were used as FIR return a linear phase response.
All three filters were designed with stop-band attenuation higher than 30 dB. Figure 9.3
shows the magnitude and phase response of all three filters. The filtered AC PPG signals
from both the PPG channels and the ECG signal were displayed on the front panel of the
VI during runtime using a single chart. This enabled the user to monitor the morphology
and the amplitude of the acquired signals. The Waveform chart function in LabVIEW
was used to display these signals. The DC value of the PPG signals was displayed on the
front panel using the Numerical Indicators.
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Figure 9.3: The magnitude and phase response of (a) the bandpass filter used to filter
the AC PPG signals, (b) the lowpass filter used to filter the DC PPG signals, and (c) the
bandpass filter used to filter the raw ECG signal.
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9.1.6 Algorithms for calculating Ratio of ratios (ROS), SpO2 and heart
rate
To provide an indication of the systems performance, blood oxygen saturation levels and
heart rate were estimated. SpO2 was estimated using the following linear equation.





As mentioned earlier, the for loop in this VI executes its subdiagram or functions within
the loop 20 times. After every twenty iterations, arrays of data corresponding to each
signal are collected by a collector and passed out of the loop. This process keeps repeating
unless the user pushes the stop button.
Each iteration of the for loop acquires 100 samples at a sampling rate of 1 kHz. Therefore,
after 20 iterations of the loop, 2000 samples are acquired, or, in other words, every 2
seconds 2000 samples are acquired. The collector Express VI then collects these input
samples and returns the most recent data. Every 2 seconds the collector discards the
oldest data and adds the newest data to the collected samples.
The PPG signals continuously collected every 2 sec are then used to estimate SpO2. A
sub–VI was implemented in LabVIEW for calculation of SpO2, as shown in Figure 9.4. The
sub–VI consisted of Amplitude and level measurement Express VI’s which measured the
mean peak-to-peak amplitude of AC PPGs and the mean value of the DC PPG signals. The
AC and DC amplitudes of both the red and infrared signals were then divided to provide
Figure 9.4: Section of the virtual instrument for ratio (ROS) calculation and SpO2
estimation.
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ROS using Equation 9.2. A Formula express VI was then used to invoke Equation 9.1. The
input variable (x1) to the Formula Express VI is the R value, and the output of the VI
is the estimated SpO2 value. An identical method was applied for both the ear canal and
the finger PPG signals to estimate SpO2 from both the locations. The estimated SpO2
and ROS were displayed on the front panel using Numerical indicators.
The ECG signal acquired every 2 seconds was used to estimate HR. The acquired ECG
signal was processed through the Tone Measurement Express VI, which finds the dominant
frequency within the sampled data. The measured frequency is then used to measure HR
instantaneously using
HR = 60× fd; where fd is the dominant frequency (9.3)
The estimated heart rate was then averaged over every 20 samples to improve accuracy.
Along with the physiological data, other electrical parameters acquired from the PPG
processing system such as the power supply status and the LED current levels were also
displayed on the front panel.
9.1.7 Algorithm for data storage
All the analogue data acquired from the PPG processing system using the DAQ Assistant
VI was saved to a text file for oﬄine analysis. Only raw data were saved to preserve as
much information as possible.
Data was recorded using theWrite to Measurement File Express VI. This DAQmx function
lets the user configure how the data is saved. The VI was designed to save data to a file
(‘.LVM’ file) continuously in an ASCII formatted spreadsheet. Each column in the text
file corresponds to one of the digitised signals. Data is written in the tab delimited method
with an accuracy of 5 decimal places. Figure 9.5 shows the block diagram of the algorithm
for data storage.
The Express VI was configured in such a way that, when the VI was run, the user was
prompted with a system dialogue to input the name and the location of the file. If a file
with the same name already exists in that location, then the user was prompted to change
the name. Although the user was encouraged to choose the file name when the VI was run,
the data recording was not enabled until the user clicked the Record button on the front
panel. The Record button also enabled elapsed time measurement, which is the amount
of time that has elapsed since the recording was started. Since the Express VI was also
placed inside the for loop which is embedded within the while loop, data acquisition and
file writing occurred simultaneously. Writing to the file is continuous until the stop button
is pressed by the user.
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Figure 9.5: Section of the virtual instrument for saving all PPG and ECG data to a
text file.
9.2 Evaluation of the data acquisition system
All the algorithms discussed so far in this chapter were incorporated into one single VI
that could acquire, process, display and save various signals, as well as control the emitter
drive currents (as shown in Figure 9.9). Functionality tests were carried out to check the
performance of different elements in the VI.
Firstly, the reference drive voltage function in the VI was tested using an oscilloscope.




















Figure 9.6: The accuracy and the sensitivity of the measured VRef to a value set on the
front panel.
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Figure 9.7: The accuracy and the sensitivity of measured ISENSE0 to the values set on
the front panel.
Figure 9.6 shows the accuracy and the sensitivity of the measured VRef to the values set
on the front panel. The VRef was changed from 0 V to 4 V, with 1 V increment every 2
seconds. Similarly, the accuracy of the current generated to a VRef set on the front panel
was tested. Figure 9.7 shows the accuracy and the sensitivity of measured ISENSE0 to the
values set on the front panel. Again, the VRef was varied from 0 V to 4 V, with 1 V
increment every 2 seconds. From these results, it is evident that the VRef generated from
the DAQ card is highly accurate and sensitive to the input value.
The functionality of the data acquisition part of the VI was tested by connecting the
probes (Chapter 7) and the ECG leads to the PPG processing system (Chapter 8), and by
acquiring raw signals from it using the DAQ card and the VI. The probes and the ECG
cable were connected to a healthy volunteer during acquisition.
Figure 9.8 and shows the front panel of the virtual instrument during the acquisition of
signals from a healthy volunteer. The front panel consists of two tabs namely the physi-
ological parameters tab and the electrical parameters tab. The physiological parameters
tab hosts the numerical indicators for displaying SpO2, heart rate and mean DC values.
It also hosts graphical indicators for displaying PPG signals, controls for setting the VRef
and a control for choosing the file path. The signals, shown in Figure 9.8 are the red and
infrared AC PPG signals acquired from the ear canal and the index finger of the volun-
teer. The graphical indicator also displays the ECG signal (green trace) acquired from
the volunteer. The electrical parameters tab consists of indicators to display the ratio of
ratios (ROS), the battery level and the LED currents. The block diagram of the entire VI





























Figure 9.8: Front panel of the virtual instrument showing the continuous display of red (red) and infrared (blue) AC ear canal PPG signals, AC red






























Figure 9.9: Block diagram of the virtual instrument showing the blocks used to generate analogue output voltages, acquire signals, store acquired
data, and calculate SpO2.
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9.3 Summary
A data acquisition system with the capability to acquire, display and store various signals
from the PPG processing system was successfully developed. The system incorporated a
VI and a data acquisition card from National Instruments. The developed VI was designed
to acquire 12 raw signals (8 – PPG signals, 1 – ECG signal, 2 – LED current sensing signals
and 1 – battery level sensing signal) at a sampling frequency of 1 kHz. The VRef function
in the VI was used to power the LEDs in one of the probes. This has reduced the power
consumption and the circuitry in the PPG processing system. Algorithms required for the
estimation of heart rate and SpO2 were also implemented in the VI.
The developed VI was tested in the laboratory, and the results show fast and accurate
acquisition of the data, clear display of the waveforms and optimal measurement of the
required parameters. The system was planned to be used in conjunction with the developed
hardware (PPG probes and the processing system) to investigate the hypothesis of this
work.
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Investigation of photoplethysmograms and arterial
oxygen saturation values in healthy volunteers
during a cold pressor test
Over the last three decades, pulse oximeters have been used as a standard device for
monitoring arterial oxygen saturation (SpO2). However, SpO2 measurements made from
extremities such as the finger, earlobe and toes become susceptible to inaccuracies espe-
cially in conditions such as hypovolemia, hypothermia, and vasoconstriction. The failure
of pulse oximeters in these circumstances is triggered by inadequate perfusion at the mea-
surement site. To overcome this limitation, the external auditory canal is proposed as a
potential measurement site for monitoring SpO2. Being supplied by the core circulation,
the auditory canal is expected to have a much-reduced influence from low perfusion states
and, as a result, a better quality PPG signal during critical conditions which might compro-
mise peripheral perfusion. Hence in an attempt to prove this hypothesis, a new reflectance
ear canal PPG/pulse oximetry probe along with a PPG processing system was developed.
Following the successful laboratory evaluation of the developed hardware, firmware and
software, it was decided that the evaluation of the sensor should be conducted through
measurements in healthy volunteers.
Subsequently, a study was carried out in 15 healthy volunteers undergoing artificially in-
duced local hypothermia using a cold pressor test. The cold pressor test is a cardiovascular
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test performed by immersing one of the hands into an ice water container, and changes in
heart’s response are measured. A cold pressor test (CPT) is used as it simulates the pe-
ripheral vasoconstrictive challenges commonly encountered in the clinical setting. During
this study, the volunteers were asked to immerse their right hands into the ice-cold water,
while PPG signals were monitored from the ear canal (EC) (central site), the left index fin-
ger (LIF) and the right index finger (RIF) (peripheral sites). Various methods of analysis
such as the amplitude analysis of AC and DC PPG signals, estimation of SpO2 and other
methods to determine changes in cardiac function were performed on the acquired data.
This chapter gives a brief outline of the main aims of the study, volunteer recruitment
process and the measurement setup through which the PPG signals were acquired in vivo.
The methodology of data analysis and the results obtained are then presented. Finally,
the statistical analysis methods and the consequent results are presented.
10.1 Aims and objectives
• The primary aim of the study was to determine if good quality PPG signals could
be obtained from the surface of the ear canal and to determine if there were any
differences between PPG signals obtained from this central site with those obtained
at the periphery.
• The study aimed to demonstrate the reliability of the PPG signals and SpO2 es-
timated from the ear canal as opposed to the finger under conditions of local hy-
pothermia or profound vasoconstriction.
• The study also aimed to examine the differences in cardiovascular reactivity to the
induced stress stimuli and the neutralising autoregulatory response between the mea-
surement sites by measuring changes in the beat-to-beat interval and Pulse Transit
Time (PTT).
10.2 Methods and Materials
10.2.1 Measurement setup
The measurement setup was designed to simultaneously detect, sample, record and display
PPG, ECG and temperature signals. The block diagram of the entire measurement system
is shown in Figure 10.1. The technical details of every block in Figure 10.1 were described
in the previous chapters. The PPG signals were recorded from the RECAP probe placed
in the right ear canal and from the finger probes connected to the right and left index
fingers of the volunteer. Two identical ZenPPG systems (PPG processing unit) were used
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Figure 10.1: Block diagram showing the measurement setup of the experiment.
to acquire and pre-process the PPG signal from the probes, as each system only allowed
for acquisition of signals from two probes.
The ECG signal was acquired through the Ag/AgCl electrode connected to the volunteer
in Lead I configuration (chest lead). Skin temperature measurements were acquired from
two thermistors attached to the left and the right hand of the volunteer. The PPG, ECG
and temperature signals were acquired simultaneously using three different DAQ cards.
The PPG and ECG signals were acquired using two USB-6212 mass termination DAQ
cards while the temperature data was acquired using a USB 6009 DAQ card. The virtual
instrument controlled acquisition of data from all three DAQ cards. The VI described in
Chapter 9 was modified to include the acquisition and control of all three DAQ cards.
The design, fabrication and evaluation of the PPG sensors and the ZenPPG processing
system was presented in Chapter 7 and 8. Hence, only the development of the temperature
sensing system is described here.
10.2.1.1 Temperature sensing system
Two thermistor based fast response temperature transducers were constructed to assess
the temperature difference between left and right hands, during the experiment. The
thermistor used was TP-TSD202A – a fast response thermistor from BIOPAC Systems,
Inc (CA, USA). The response time and accuracy of the thermistors are 0.6 sec and 0.2◦C
respectively. The physical dimensions of the sensor are L – 5 mm and ⊘ – 1.7 mm.
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Figure 10.2: Circuit diagram of the thermistor linearization amplifier
Since the output of the thermistors was not linear, two identical thermistor linearisation
amplifiers were built to produce a linear voltage output with a sensitivity of 20 mV/◦C.
The thermistor linearization circuit used is shown in Figure 10.2. The circuit consists
of a Wheatstone bridge and a non-inverting amplifier. The thermistor was incorporated
into the Wheatstone bridge which allowed the change in resistance of the thermistor to be
converted into a voltage signal. To eliminate any loading effects, the Wheatstone bridge










Where Rx is the resistance of the thermistor, and Vs is the supply voltage. To obtain a
measurable output that could be sampled by the DAQ card, the measured output of the
linearization circuit was amplified by 11 times using the non-inverting amplifier.
As no calibration data was provided by the thermistor manufacturer, both the thermistors
were calibrated in a controlled environmental chamber (BINDER KMF 115, BINDER
GmnH, Germany). During the calibration process, the temperature of the chamber was
increased from 5 to 40◦C, with 1◦C increment every 10 minutes. A virtual instrument was
used to record the change in voltage as a waveform into a text file in LABVIEW. Once
the calibration procedure was complete, a linear fit polynomial equation was derived for
both the thermistors. These equations (Equation 10.2) were later used to calculate skin
temperature.
T1 = −52.23(x) + 50.01 (10.2)
T2 = −49.06(x) + 47.36
‘x’ refers to the output voltage of the temperature circuit. The thermistor linearization
circuits were assembled and hand soldered on a Veroboard and were powered by two 12 V
batteries. The output of the temperature sensors was acquired and recorded by a USB
6009 DAQ card (National Instruments Corporation, Texas, USA). The circuitry along
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with the batteries and the DAQ card were housed inside an aluminium case (dimensions:
250 mm × 202.8 mm × 64 mm).
10.2.2 Subjects
With the approval of City University London Senate Research Ethics Committee, a cold
pressor study was carried out on 15 healthy volunteers, seven male, eight female, aged
between 18 – 36 (mean age ± SD: 26.2 ± 4.8 years), and with no history of cardiovascular
disease. The experimental protocol was clearly explained to all the participants and written
consent was obtained prior to the experiment. In the informed consent, all the volunteers
were warned that they might experience a mild tingly feeling while the right hand is
immersed in an ice bath and were to give a sign if they prefer to withdraw from the study
at any point of time. The subjects were asked not to smoke or exercise for at least two
hours before the experiment. All volunteers were rested for approximately 10 – 15 min
before the start of the study. The volunteers were asked to keep their movement to a
minimum during the study to avoid motion artefacts.
Figure 10.3: In vivo measurement of red and infrared ear canal and finger PPG signals
from one of a volunteer during the cold pressor test.
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10.2.3 Experimental protocol
The experiments were carried out at the Research Centre for Biomedical Engineering
(RCBE) laboratory, City University London, under room temperatures between 22 ±
2◦C. During the experiments, the subjects were made to sit on a comfortable chair, with
both hands resting on soft cushions, arranged to a height equivalent to their heart position.
Once the volunteer was comfortable in the position;
• The RECAP probe was placed 9 mm deep into the right ear canal
• Two in-house designed finger PPG probes were connected to the index fingers of the
right and left hands
• The skin temperature sensors were attached to the dorsal surface of the right and
left hand of the volunteer
• The red and yellow lead of the ECG cable were connected to the Ag-AgCl easitab
ECG electrodes (SKINTACT, F-WA00) placed directly on the right and the left side
of the chest, and the green (reference) lead connected to the electrode placed on left
side of the hip.
Once all the sensors were in place, baseline readings were obtained from all the volunteer’s
for 2 minutes, before they were notified with a countdown (3 – 1) to start slowly immersing
their right hand into the ice bath maintained at approximately 1◦C. Thirty seconds into
the ice bath, they were notified again to start slowly removing their right hand from the ice
bath and place it back on the surface. The monitoring was continued until the volunteers
hand rewarmed to a minimum temperature above 24◦C.
10.2.4 Data analysis
The raw PPG, ECG and temperature data recorded during the study was extracted sepa-
rately for oﬄine analysis. Prior to any signal processing routines, all the acquired signals
were resampled from the acquired sampling rate (1000 Hz) to 100 Hz. This was to elim-
inate the unwanted noise and to condition the acquired signals. This was implemented
using the resample function in MATLAB (The MathWorks, USA). Figure 10.4 shows the
raw infrared PPG signal acquired at 1000 Hz and the same signal re-sampled at 100 Hz.
The resampled signals were then filtered, and processed to calculate various parameters,
described as follows:
PPG signal Amplitude analysis– The AC and DC components of the PPG signals acquired
from all three sensors were first extracted using a band-pass ( fc = 0.5 Hz and 15 Hz) and
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Figure 10.4: The raw ppg signal acquired at 1000 Hz and the resampled 100 Hz PPG
signal.
a lowpass filter ( fc = 15 Hz) in LabChart–8.0 (ADInstruments, Sydney, Australia). The
filters used were linear-phase Finite Impulse Response (FIR) filters with a transition width
of 20% and pass band ripple < 0.5% (the input amplitude). The effective length of the
lowpass and bandpass FIR filters was 139 and 3980 respectively.
A peak detection algorithm was then used to detect the peaks and valleys of all the AC
PPG signals. The peak-to-peak (pk-pk) amplitude was then calculated for the detected
peaks. Figure 10.5 shows the infrared PPG signal acquired from the LIF and the calculated





































Figure 10.5: Infrared PPG signal acquired from the LIF and the estimated pk-pk
amplitude of the signal as computed by the peak detection algorithm.
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pk-pk amplitude of the signal by the algorithm used. The mean pk-pk amplitude of red
and infrared AC PPG signals, acquired from all three locations was computed for all three
stages of the experiment (before ice water immersion, during ice water immersion and after
ice water immersion). The mean of the mean peak-to-peak amplitude across the entire
study group for all three stages of the experiment was then calculated and compared. To
check for any statistical significance between the amplitude of AC PPG signals between
the ear canal and the periphery during all three stages of the experiment, non-parametric
statistical tests were performed on the data. A P-value < 0.05 was considered to be
statistically significant. Similarly, the mean DC amplitude of the red and infrared PPG
signals was calculated and compared across all three probes and at three phases of the
experiment.
SpO2 analysis– In order to demonstrate the effect of compromised peripheral perfusion on
the estimation of arterial oxygen saturation, SpO2 values were calculated from the PPG
signals acquired from all three probes, during all three phases of the experiment. SpO2
was calculated in a three-seconds rolling window using equation Equation 10.3.









Where ROS is the Ratio of Ratios, ACIR and ACR are the peak-to-peak amplitudes of
the infrared and red AC PPGs, and DCIR and DCR are the DC PPG components at
respective wavelengths. The % drop in SpO2 during ice water immersion (when compared
to the baseline) was then calculated for each volunteer. The mean of the SpO2 estimated
from all three sensors was calculated for baseline, ice immersion period and the recovery
period and was then compared.
Variations in cardiac function (HRV)– The ECG signals acquired from the volunteers
were filtered using a linear phase bandpass FIR filter with cut-off frequencies at 0.5 Hz
and 20 Hz. The R-wave peak of the ECG signal was detected using ECG peak-detection
algorithm in LabChart-8.0. The detected R-wave peaks of the filtered ECG signal were
then used to calculate the beat-to-beat interval (Figure 10.6), the beat-to-beat heart rate
and the R-wave amplitude. The changes in the heart rate, R-to-R interval and r-wave
amplitude were then plotted with the changes in skin temperature measurements. The
mean changes in R–R interval, R-wave amplitude and heart rate during the CPT were
calculated for each volunteer and compared.
Pulse Transit Time (PTT)– PTT measurements were made by calculating the time differ-
ence between the foot of the PPG signal and the R-wave peak of the ECG signal. The foot
of the PPG signal was detected using the second derivative maximum method. This was
to increase the accuracy and detection rate of the inflection points. The second derivative
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Figure 10.6: The ECG signal, the PPG signal and the second derivative photoplethys-
mogram (SDPPG). PTT is the time difference between points ‘a’ and ‘b’.
of the infrared PPG signals was acquired using the SavitzkyGolay method with a win-
dow width of 31 points. The maximum of the second derivative PPG signal (SDPPG)
represented the maximal acceleration point at the foot of PPG signal.
The time difference between the R-wave peak of the ECG signal and the maximum peak
of the SDPPG was then used to calculate PTT as shown in Figure 10.6. Using the SDPPG
signals from the EC, the LIF, and the RIF, mean PTT was calculated for all three stages
of the experiment (before, during and after the ice immersion) for each volunteer. The
mean PTT calculated from the EC, the LIF and the RIF were then compared during the
CPT.
10.3 Results
Baseline raw PPGs– Good quality photoplethysmographic signals with high signal-to-noise
ratio and large amplitude were obtained from the prototype ear canal and finger PPG
probes. Figure 10.7 shows the baseline raw (AC + DC) infrared PPG traces obtained
from the ear canal, the right index finger and the left index finger of a volunteer. Two
key observations that can be made from Figure 10.7 are (1) the pronounced respiratory
modulation in the ear canal PPG signals when compared to the left and right index finger
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Figure 10.7: The raw baseline infrared PPG traces obtained from the ear canal, the
right index finger and the left index finger of a volunteer
PPGs, and (2) the large DC amplitude and small AC amplitude of the ear canal PPG
signals when compared to the PPG signals acquired from the periphery. The disparity in
the amplitude of the PPG signals is expected as the tissue lining the ear canal (2-3 mm)
is much smaller than the finger (10-15 mm). Hence, the light absorption by tissue and
other non-pulsatile absorbers is much higher in the finger than that of the ear canal.
The respiratory modulation in the ear canal PPG signals was further investigated through
spectral analysis. The power spectrum of the baseline raw infrared PPGs acquired from
all three locations was derived. The power spectrum of the EC, RIF and LIF PPG signals
were normalised with the power of the cardiac component to highlight the changes in the
respiration related component. The power of the respiratory component (0.1 Hz to 0.5 Hz)
between all three locations was then compared.
Figure 10.8 shows the frequency spectrum of the EC, the RIF, and the LIF PPG signals in
4 healthy volunteers. From the figure, it is evident that the power of the respiration related
frequency component is much higher in the EC PPG signals than that of the periphery.
Two factors are likely to contribute to these findings. First, the shorter distance of the
EC from the heart compared to the finger, which meant less attenuation of the respiratory
modulation. Second, the blood vessels in the head region are relatively less sensitive to
sympathetically mediated vasoconstriction that may mask respiratory oscillations.
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Figure 10.8: The power spectrum of the infrared DC PPG signals acquired from the
EC, the RIF and the LIF in 4 healthy volunteers highlighting the respiratory and car-
diac components. The power of the respiratory component in the EC PPG signals is
significantly higher.
Baseline AC PPGs– A 8-second sample of the baseline red and infrared AC PPG signals
acquired from the EC, the RIF and the LIF are shown in Figure 10.9. The morphology of
the PPG signals obtained from the ear canal was somewhat different to the PPG signals
acquired from the finger sensors in almost all the volunteers. However, all the signals
correspond accurately with the cardiac cycle. In some volunteers, the morphology of the
PPG signals resembled the aortic pressure waveform. The dicrotic notch is clearly visible
in the diastolic phase of the finger PPG signals when compared to the ear canal PPG
signals. These changes in the morphology of the PPG signals are thought to be due to the
vascular resistance of large arteries that supply blood to the head and the brain (common
carotid arteries). The higher vascular resistance of these arteries causes the dicrotic notch
(reflected wave) to occur in the systolic phase instead of the diastolic phase of the PPG
signal. A slight shift in phase between the finger and ear canal PPG signals is also apparent
in Figure 10.9. This is expected, as the ear being closer to the heart than the finger, the
time taken for arterial pulsations to travel from the heart to the ear canal is less than the
time is taken for the pulsations to reach the finger.
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(a) Infrared AC PPG signals













(b) Red AC PPG signals
Figure 10.9: The (a) infrared and (b) red AC PPG signals acquired from the EC (blue
trace), the RIF (green trace) and the LIF (red trace) of a volunteer.
10.3.1 Variation in amplitude of the AC PPG signals
The infrared AC PPG signals acquired from the ear canal, the right index finger and the
left index finger, and the simultaneously acquired temperature signals from both right and
left index fingers of a randomly selected volunteer are shown in Figure 10.10. The y-axis
on Figure 10.10(A) represents the amplitude of the AC PPG signals, whereas the y-axis on
Figure 10.10(B) represents the temperature in degrees centigrade (◦C) for 10 min. Three
preliminary observations can be made from Figure 10.10 during the ice water immersion.
• the amplitude of the AC PPG signals acquired from the right index finger has de-
creased as soon as the right hand was immersed in the ice water. This is, however,
expected since the ice water immersion causes a significant drop in skin temperature
(from 33.5◦C to 13.5◦C), which leads to profound vasoconstriction in the right hand
• the amplitude of AC PPG signals acquired from the LIF has also reduced signifi-
cantly, although the temperature of the left hand has remained relatively constant.
In addition, the skin temperature of left hand has dropped by approximately one
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Figure 10.10: A. Infrared AC PPG signals recorded from (a) the ear canal, (b) the
right index finger and (c) the left index finger of a volunteer. B. Simultaneously obtained
temperature reading from (d) the left index finger and (e) the right index finger of the
same volunteer for a period of 10 min.
degree at the end of the ice water immersion period (Figure 10.14(e)), which sug-
gests that the significant reduction in blood supply in the left hand (reduction in
amplitude of PPG) caused a drop in the left-hand skin temperature
• in contrast to the peripheral sites, the amplitude of the AC PPG signals from the ear
canal have remained relatively constant. Although a small change in AC amplitude
is noticeable.
Although there has been a significant drop in the amplitude of the AC PPG signals in both
the left and the right index fingers, the cardiac component was still clearly visible in the
PPG signals acquired from most of the volunteers. Hence, accurate estimation of SpO2 is
probable. However, few volunteers had a drop in the pulse amplitude sufficient to diminish
the signal quality, whereby the PPG signals could not be distinguished from noise. Some
volunteers have also reported discomfort and shivering towards the end of the ice water
immersion, which resulted in some movement artefacts. One such case, where the quality
of red PPG signals from RIF and LIF has deteriorated is shown in Figure 10.11. It is in
these circumstances where the estimated SpO2 is more likely to be inaccurate. However,
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Figure 10.11: The quality of the red PPG signals from the right index finger and the left
index finger have deteriorated towards the end of the cold pressor test in few volunteers.
in most volunteers the quality of the LIF PPG signals has remained consistent during the
ice water immersion when compared to RIF.
After the ice water immersion, the amplitude of the RIF AC PPG signals has slowly started
to increase with an increase in the temperature of the right hand. While, the amplitude of
the LIF PPG signals has recovered back to the baseline value within the first few minutes
of the recovery period. On the contrary, the amplitude of the ear canal PPG signals has
stayed relatively constant throughout the experiment. These observations demonstrate
the ability of the body to maintain relatively constant blood flow to the vicinity of the
ear canal and more generally to the head despite changes in peripheral perfusion. Similar
effects were seen in all the volunteers.
The mean of the mean amplitude and the standard error of the mean (±SEM) (across 15
volunteers) of AC red and infrared PPG signals acquired from the EC, the RIF and the LIF
during baseline, ice water immersion and rewarming periods are shown in Table 10.1. The
data is graphically displayed with the use of Box and Whiskers Plot in Figure 10.12. From
the figure, the median value and interquartile range (amplitude of the red and infrared
PPG signals) of the EC PPG signals have remained relatively constant throughout the
experiment, while the LIF and the RIF median value has varied significantly.
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Table 10.1: Mean (±SEM) of the mean AC red and infrared PPG signals acquired from
the ear canal (EC), right index finger (RIF) and left index finger (LIF), during all three
stages of the experiments.
Before immersion During immersion After immersion
EC RIF LIF EC RIF LIF EC RIF LIF
Red
Mean (mV) 109 321 424 121 151 222 104 159 521
SEM (±) 17 51 50 16 20 22 16 35 54
Infrared
Mean (mV) 800 776 1715 790 324 912 797 391 1960
































































The LIF PPG signal 
Figure 10.12: Box and whiskers plot demonstrating the change in mean amplitude of
red and infrared PPG signals obtained from all three sensors during the cold pressor test.
During the ice water immersion, the mean amplitude of the red and infrared RIF PPG
signals has dropped by 52.96% and 58.25%. While the LIF PPG signals have dropped
by 47.64% (red) and 46.82% (infrared). In contrast, with the finger sensors, the mean
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Table 10.2: The percentage change in amplitude of red and infrared PPG signals during
ice water immersion in all the volunteers
% Drop
No. of volunteers
Red EC Infrared EC Red RIF Infrared RIF Red LIF Infrared LIF
< 5% 10 9 1 1 1 0
5 % - 25 % 4 5 3 2 2 3
25 % - 45 % 1 1 2 2 2 5
45 % - 65 % 0 0 5 6 9 6
65 % - 85 % 0 0 4 4 1 1
amplitude of the red EC PPG signals have increased by 11.01% and the infrared EC PPG
signals has decreased by 1.25%. To quantify this further, the % drop in the amplitude
of red and infrared PPG signals during the ice water immersion in all the volunteers was
calculated and is shown in Table 10.2. A substantial drop in amplitude <65% was seen
in four healthy volunteers in the RIF, while, in the LIF the similar drop was seen in one
volunteer.
Once the right hand was out of the ice water, the amplitude of the PPG signals has
started to increase with temperature. However, the amplitude of RIF has never returned
to the initial baseline value within the 10 min recovery period. The amplitude of the red
and infrared PPG signals from RIF has only increased by 5.29% and 20.67% respectively
during the recovery period, although the temperature of the right hand has increased to
a minimum of 24◦C. Compared to the RIF, the EC PPG signals have recovered back to
the baseline value by the end of the measurement period. This is expected as the drop
in the ear canal PPG signals was significantly low compared to the finger. The LIF PPG
signals, on the other hand, have exceeded the baseline value by 22% (red) and 14.21%
(infrared). When compared to the ice immersion period, the amplitude of RIF PPG
signals has increased by 134.68% (red) and 114.91% (infrared) in the recovery period.
10.3.1.1 Temperature vs Amplitude
The mean temperature of the right and the left hand during baseline, ice water immersion
and the recovery period are shown in Table 10.3. From the table, it is clear that the skin
temperature measured from the right hand has dropped significantly in all the volunteers
while the left-hand temperature stayed constant during ice water immersion. The effect
of the significant drop in the temperature of the right hand on the amplitude of the
PPG signals acquired from the bilateral index fingers was studied by comparing the mean
temperature measurements with the mean amplitude of PPG signals.
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Table 10.3: The mean of the mean temperature measured across 15 healthy volunteers
in the right and left hand during all three phases of the experiment. The standard error
of the mean (±SEM) is also depicted here.
Location Baseline Ice water immersion Recovery
RIF 29.3 ± 0.907 8.1 ± 0.936 24.4 ± 1.420
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Figure 10.13: Effect of the right-hand immersion on the amplitude of the infrared PPG
signals from right and left index fingers. The x-error bars represent the standard error of
the mean amplitude (±SEM). The y-error bars represent the standard error fo the mean
temperature.
The mean amplitude of the infrared PPG signals measured from the RIF and LIF during
all three stages of the experiment are plotted against the skin temperature measurements
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from the respective sites in Figure 10.13. In the RIF, the amplitude of the infrared PPG
signal has decreased significantly with temperature during the ice water immersion. The
average rate of change in amplitude of PPG signals from baseline to the end of the ice
water immersion in the RIF was 21.52 mV/◦C. The average rate of change in amplitude of
PPG signals from the cold stimuli to the recovery period was 4.18 mV/◦C. These results
show that the PPG signal amplitude has not recovered with a rise in temperature at the
same rate as they have declined during the ice water immersion. In contrast, with the
RIF, the amplitude of infrared PPG signal from LIF has decreased significantly, although
no detectable change in temperature was observed.
10.3.1.2 Statistical analysis
To check if there were any statistically significant differences between the amplitude of
AC PPG signals measured during baseline, ice water immersion and the recovery period
of the experiment, statistical analysis was performed on the measured data. All statistical
analysis was performed using SigmaPlot 12.0 (Systat Software Inc., Chicago, USA). Prior
to the statistical tests, the normality of the data was tested using the Kolmogorov-Smirnov
test. It is important to determine if the measured data were normally distributed or not
as the appropriate choice of statistical tests depends on it. Table 10.4 shows the results
of the Kolmogorov-Smirnov normality test performed on the red and infrared AC PPG
signals acquired from EC, RIF and LIF during baseline, ice water immersion and recovery
periods of the experiment. The Kolmogorov-Smirnov distance (K-S Dist.) is the maximum
cumulative distance between the histogram of the data and the Gaussian distribution curve
of the data. The P-values represent the observations for normality using the Kolmogorov-
Smirnov test. The data was considered normally distributed only if the computed P-value
was greater than the set P-value (P=0.05). Not all the data were found to be normally
distributed.
Hence, a non-parametric test was used to check if means of the measured AC PPG signals
were significantly different from one another during different stages of the experiment. The
test used was Kruskal-Wallis One Way Analysis of Variance on Ranks. The parametric
equivalent of the Kruskal-Wallis test is the one-way analysis of variance (ANOVA). The
Kruskal-Wallis test is a rank-based test that is commonly used to determine statistical
significance between two or more groups. The test first ranks all the values from low to
high, paying no attention to the group it belongs. The smallest number gets a rank of
1. The largest number gets a rank equal to the sample size. The discrepancies among
the rank sums are combined to create a single value called the Kruskal-Wallis statistic
(H-value). The test also produces a P-value, which is indicative of the difference between
groups. A comparison between two groups of data was recognised as significantly different
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Table 10.4: Results of the Kolmogorov-Smirnov normality test performed on the red
and infrared AC PPG signals acquired from EC, RIF and LIF during baseline, ice water
immersion and recovery periods of the experiment.
Location Wavelength K-S Dist. P-value Result
Baseline
EC
Red 0.132 > 0.2 Passed
Infrared 0.138 > 0.2 Passed
RIF
Red 0.161 > 0.2 Passed
Infrared 0.124 > 0.2 Passed
LIF
Red 0.108 > 0.2 Passed
Infrared 0.144 > 0.2 Passed
Ice water immersion
EC
Red 0.182 > 0.2 Passed
Infrared 0.177 > 0.2 Passed
RIF
Red 0.313 <0.001 Failed
Infrared 0.247 =0.020 Failed
LIF
Red 0.204 =0.116 Passed
Infrared 0.141 >0.2 Passed
Recovery
EC
Red 0.251 =0.017 Failed
Infrared 0.159 >0.2 Passed
RIF
Red 0.257 =0.013 Failed
Infrared 0.319 <0.001 Failed
LIF
Red 0.152 >0.2 Passed
Infrared 0.213 =0.083 Passed
if the computed P-value by Kruskal-Wallis test was < 0.05. A significant difference was
found between the groups. To isolate the group or groups that differ from the others,
all pairwise multiple comparison procedure (Student-Newman-Keuls Method) was used.
The results of the statistical tests together with the corresponding P value are shown in
Table 10.5.
From Table 10.5, it is easily observed that the effect of peripheral vasoconstriction on the
amplitude of ear canal PPG signals is almost negligible. However, significant differences
in the RIF PPG signals were found when the mean amplitude was compared from the
baseline vs. ice water immersion period and recovery vs. baseline. While in the LIF,
a significant difference was found when the mean amplitude was compared between the
baseline and the ice water immersion period. This is expected as the amplitude of the
PPG signals from the LIF has increased to a value equivalent to the baseline after the ice
water immersion, while the amplitude of the PPGs in the RIF have not. These results
demonstrate the robustness of the ear canal as the site for monitoring PPG signals.
186
Chapter 10 - Investigation of photoplethysmograms and arterial oxygen saturation values
in healthy volunteers during a cold pressor test
Table 10.5: Results of One-Way Analysis of Variance Test between the mean amplitudes
of each sensor during all three stages of the study along with corresponding the P-values.
Statistically, significant differences in the mean amplitude of the PPG signals was found
in the RIF and the LIF during ice water immersion.
Sensor Wavelength Comparison Statistical significance P-value
Ear canal
Red
Baseline vs Ice No
=0.928
Ice vs Recovery No
Recovery vs Baseline No
Infrared
Baseline vs Ice No
=0.997
Ice vs Recovery No
Recovery vs Baseline No
Right index finger
Red
Baseline vs Ice Yes
=0.019
Ice vs Recovery No
Recovery vs Baseline Yes
Infrared
Baseline vs Ice Yes
=0.007
Ice vs Recovery No
Recovery vs Baseline Yes
Left index finger
Red
Baseline vs Ice Yes
<0.001
Ice vs Recovery Yes
Recovery vs Baseline No
Infrared
Baseline vs Ice Yes
<0.001
Ice vs Recovery Yes
Recovery vs Baseline No
10.3.2 Variations in amplitude of DC PPG signals
Figure 10.14 shows the variation in infrared DC PPG waveform acquired from the EC, the
RIF and the LIF, along with simultaneously acquired temperature signals from the right
and the left hand of a volunteer. It can be noticed that the amplitude of the ear canal
DC PPG signal is larger than that of the right and the left index fingers during baseline.
This is because the absorption of light by tissue and other non-pulsatile absorbers is much
higher in the finger than the ear canal, which is a bony structure covered only with a few
millimetres of tissue.
During the ice water immersion, the amplitude of the DC PPG signals in the RIF has
increased with temperature. This is expected as the profound vasoconstriction resulting
from the ice water immersion causes a significant reduction in the arterial and venous blood
fractions in the measurement site. Hence, there will be a reduction in light absorption.
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(a) EC DC PPG signal 
(b) RIF DC PPG signal 
(c) LIF DC PPG signal 
(d) RIF Temperature 
(e) LIF Temperature 
Figure 10.14: The infrared DC PPG signals recorded from (a) the ear canal (EC), (b)
the right index finger (RIF) and (c) the left index finger (LIF) of a volunteer, along with
the temperature reading from (d) the right index finger and (e) the left index finger.
Other contributing factors for this increase in DC amplitude include the constriction of
muscles and the thickening of the dermis layer due to sympathetic response. Similar to
the RIF, the LIF has shown an increase in the amplitude of the DC PPG signals, although
there is no noticeable change in left-hand temperature. After the ice water immersion,
the RIF DC PPG amplitude has either remained constant or has further increased in a
few volunteers. In contrast, the LIF DC amplitude has reduced and returned to a value
equivalent to the baseline. The ear canal DC PPG signal amplitude, on the other hand,
has remained relatively constant throughout the experiment.
The changes in the mean DC red and infrared PPG signals acquired from the EC, the RIF
and the LIF during all three stages of the experiments are plotted with the help of a Box
and Whiskers plot in Figure 10.15.
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(b) Infrared DC amplitude
Figure 10.15: Box and whiskers plot demonstrating the change in mean amplitude of
(a) red and (b) infrared DC PPG signals obtained from all three sensors before, during
and after the cold pressor test.
10.3.3 Changes in arterial oxygen saturation values
Arterial oxygen saturation (SpO2) values were calculated from the AC and DC fractions of
the PPG signals acquired from the ear canal and the finger sensors for the entire duration
of the study using Equation 10.3. To demonstrate the effect of compromised peripheral
perfusion on the estimation of arterial oxygen saturation, a mean value of the estimated
SpO2 was calculated for the baseline, ice water immersion, and the recovery periods of
each volunteer. The mean SpO2 values calculated from the EC, the RIF and the LIF
of all volunteers, during all three stages of the experiment are graphically displayed in
Figure 10.16, with the help of a box plot. The mean range of SpO2 values calculated from
all three sensors during baseline was 102 – 97%, this is expected since all volunteers were
healthy and well perfused. Hence, it can be said that there is a good agreement between
all three sensors during baseline.
Table 10.6 shows the mean of the mean SpO2 values calculated during all three stages of
the experiment from all three sensors. Although SpO2 is a global variable and would not
change in healthy volunteers from one site to another, a decrease in the mean SpO2 was
189
Chapter 10 - Investigation of photoplethysmograms and arterial oxygen saturation values
































Figure 10.16: Demonstrates the change in mean SpO2 estimated by the ear canal, the
right index finger and the left index finger pulse oximeters during all three stages of the
experiment.
Table 10.6: Mean SpO2 values calculated from the EC, RIF and LIF PPG sensors
during baseline, ice water immersion and recovery periods of the experiment.
Location
Baseline
SpO2 (%) ± SD
Ice water immersion
SpO2 (%) ± SD
Recovery
SpO2 (%) ± SD
Ear canal 100.2 ± 1.5 99.3 ± 2.3 100.2 ± 2.2
Right index finger 97.4 ± 1.2 94.0 ± 5.7 97.2 ± 2.1
Left index finger 97.8 ± 1.6 94.6 ± 5.1 96.7 ± 2.1
observed during ice water immersion in the right and left index fingers. In contrast with
the finger sensors, the SpO2 calculated from the ear canal remained relatively constant.
Although the mean SpO2 values calculated from the right and left index finger have de-
creased during the ice water immersion, the sensors have truly only failed to estimate SpO2
accurately in a few healthy volunteers. This is evident from the large standard deviation
and the interquartile range of SpO2 values (Figure 10.16) measured from RIF during the
ice water immersion. In the rest of the volunteers, the estimated SpO2s were accurate and
close to the baseline reading. Hence to discriminate between cases where the finger sensor
has failed to estimate SpO2 with the others, the mean percentage drop in SpO2 between
baseline and ice water immersion was calculated. A drop in SpO2 value greater than 5%
during the ice water immersion was considered to be a failure.
The percentage drop in SpO2 during ice water immersion in all the volunteers is given in
Table 10.7. The right index finger pulse oximeter failed to estimate accurate SpO2 in 5
healthy volunteers while the left index finger pulse oximeter failed to estimate SpO2 in
4 healthy volunteers. Compared to the finger sensors, the ear canal pulse oximeter only
failed in one volunteer. These results show that the SpO2 measurements made from the
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Ear canal Right index finger Left index finger
< 1% 8 1 4
1% – 5% 6 9 7
> 5% 1 5 4
periphery are to an extent dependent on the thermal state that, it really weakens the
capacity of the pulse oximeter to provide accurate readings. While a central site such as
the ear canal can increase the reliability of the pulse oximeter readings.
10.3.4 Variations in cardiac function
While demonstrating the dependence of pulse oximeters on the presence of a strong pe-
ripheral pulse to estimate SpO2 accurately, the cardiovascular reactivity and the heart’s
function to induced stress stimuli were also studied. The sudden change in temperature
due to the immersion of the right hand in ice triggers the activation of the sympathetic
nervous system which reacts by changing the distensibility of blood vessels. Along with
the initiation of vasoconstriction, the autonomic nervous system triggers the cardiac accel-
erator nerves which release norepinephrine. This interaction results in an increase in heart
rate and the contractility of the heart to compensate for the sudden change in temperature
(heat loss). These responses combine to an increase in blood pressure (BP).
These variations in the hearts function during the cold pressor test were captured by
calculating the changes in heart rate, R-to-R interval and the R-wave amplitude from the
QRS complex of the ECG signal acquired from each volunteer. The amplitude of the
R-wave was measured as it corresponds to the voltage conducted with every contraction
of ventricles. Figure 10.17 shows the changes in the beat-to-beat interval, heart rate, and
peak-to-peak (R-wave) amplitude estimated from the ECG signal acquired from one of the
volunteers. It can be observed from the figure that, as soon as the right hand is immersed
in ice water, there is an increase in heart rate and the amplitude of the R-wave and the
time between two consecutive R-peaks decreases. During the recovery period, as the hand
rewarms, the heart rate and the amplitude of the QRS complex of the ECG signal dropped
back to a value similar to the baseline. Similar effects were seen in all the volunteers.
Figure 10.18 shows the mean heart rate, R-R interval and the pk-pk amplitude calculated
for all the volunteers during all three stages of the experiment. The heart rate has on an
average increased by 8 ± 2 (SEM) BPM amongst the volunteers during ice water immer-
sion. The R-R interval has on an average decreased by 73.4 ± 17.8 (SEM) milliseconds
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(a) ECG signal 
(b) Beat-to-beat interval
(c) Heart rate 
(d) Peak-to-peak amplitude 
(e) Temperature 
Figure 10.17: The changes in the (a) ECG signal, (b) R-R interval, (c) heart rate, (d)
peak-to-peak amplitude (e) temperature of a volunteer during the CPT.














































Figure 10.18: The mean heart rate, R-R interval and the pk-pk amplitude calculated
for all the volunteers during baseline, ice water immersion and the recovery periods of the
experiment.
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during the ice water immersion amongst all the volunteers. The R-wave amplitude has on
an average increased by 156 ± 110 mV (SEM) during this period.
10.3.5 Pulse Transit Time (PTT)
As mentioned earlier, the immersion of right hand in the ice water leads to an increase
in heart rate and a decrease in the blood vessel diameter. These reactions combine to an
increase in the velocity of the pulse propagating through arteries and the blood pressure.
Conversely, after the ice water immersion, the dilation of blood vessels to rewarm the hand
causes a decrease in pulse wave velocity (PWV) and blood pressure (BP). The velocity
of a pulse propagating through the arteries is given as the pulse propagation distance
divided by the pulse transit time. Therefore, the PTT is indirectly proportional to the
PWV and the BP. Thus, by calculating the PTT from the PPG signals acquired from
all three different locations, and monitoring the changes in the measured time during all
three phases of the experiment, the extent of vasoconstriction and local change in PWV
at each site can be indirectly measured. Similarly, the extent of vasodilation after the ice
immersion can also be demonstrated.
Hence, PTT at each location was calculated using the ECG signal and the infrared PPG
signals acquired from the respective areas. Three volunteers were exempted from the PTT
analysis as the PPG signals acquired from these volunteers during ice water immersion
were indistinguishable from noise. The mean PTT measured from the EC, the RIF and the
LIF PPG signals during all three stages of the experiment are shown in Figure 10.19 using
a box-plot. The mean of the mean PTT measurements made across all the volunteers is
given in Table 10.8.
The mean baseline PTT measured from the EC is smaller than the PTT measured from
the LIF and the RIF. This is expected since the ear is closer to the heart than the finger.
The mean PTT measured from the EC, the RIF and the LIF has dropped during the ice
water immersion. This indirectly indicates a general rise in PWV and BP in the body.
However, the percentage drop in PTT varied across all three locations. The PTT in the
Table 10.8: Depicts the mean of the mean PTT measurements from the EC, the RIF
and the LIF during baseline, ice immersion and recovery periods of the experiment.
Location
Pulse Transit Time (ms ± SD)
Baseline Ice immersion Recovery
Ear canal 135.8 ± 21.88 126.7 ± 21.56 142.7 ± 21.8
Right index finger 176.81 ± 22.7 159.98 ± 29.3 184.4 ± 24.2
Left index finger 206.9 ± 34.2 193.53 ± 35.8 257.69 ± 39.6
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Figure 10.19: Box-plots showing the changes in PTT measured from the ear canal (EC),
the right index finger (RIF) and the left index finger (LIF).
EC and the LIF has dropped by 3% and 7% while the RIF PTT has dropped significantly
by 12%. These differences in the drop of PTT across the three locations indicates the
disparity in the strengths of local vasoconstriction in the respective areas. During the
recovery period, the mean PTT measured from the EC and the RIF has approximately
returned to the baseline value, whereas the LIF PTT exceeded baseline values. This is
due to the profound vasodilation resulted from the activation of the thermoregulatory
mechanism. The percentage increase in mean PTT during the recovery period, when
compared to baseline, was 4% in the EC, 2% in the RIF and 22% in the LIF. These
observations demonstrate the ear canal is much more resistant to local changes in BP
compared to the peripheral sites.
10.4 Summary
Following the laboratory testing of the novel RECAP probe, it was evaluated in 15 healthy
volunteers undergoing a cold pressor test. The main aim of the study was to test the per-
formance and reliability of the ear canal sensor in conditions of poor peripheral perfusion,
as opposed to the traditional finger sensor. During the study, red and infrared PPG signals
were acquired from the ear canal, the right index finger and the left index finger. Along
with the PPG signals, skin temperature measurements were made from the dorsal surface
of both left and right hands of the volunteer. The ECG signal was also recorded from all
the volunteers. The study started with a 2 min baseline recording followed by a 30 sec
right-hand immersion in ice cold water and a recovery period. The recording was stopped
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when the right hand was rewarmed to a minimum temperature of 24◦C. Data recorded
during all these stages was analysed oﬄine to extract various parameters such as pk-pk
amplitude, SpO2, heart rate, R-R interval, and PTT.
The PPG signals acquired from the volunteers show that measurable, good quality red and
infrared PPG signals can be obtained from the human auditory canal. However, the ear
canal PPG signals were found to be morphologically different to the finger PPG signals
(Figure 10.9). PPG pulse features such as the dicrotic notch in the diastolic phase, arrive
earlier in ear canal signals when compared to the finger PPG signals. The modulation of
the raw PPG signals due to respiration was also more pronounced in the EC PPGs than
the RIF and the LIF PPGs.
During the ice water immersion, the amplitude of the AC PPG signals acquired from the
RIF decreased significantly with temperature. Similarly, the LIF AC PPG signals have
also decreased significantly although no change was observed in skin temperature of the left
hand. The EC AC PPG signals, on the contrary, remained relatively constant throughout
the experiment. The infrared RIF PPG signals have decreased by 21.5 mV/◦C during
the ice water immersion. To check for any statistically significant differences between
the amplitude of AC PPG signals measured during baseline, ice water immersion and the
recovery periods of the experiment, one-way analysis of variance test was performed on the
measured data. A statistically significant difference was found when the mean amplitude
of the RIF and LIF (red and infrared) PPG signals from baseline were compared with ice
water immersion. Statistically significant difference was also found when RIF PPG signals
from baseline were compared with the recovery period, indicating that the amplitude of
PPG signals from the right hand had not recovered back to baseline within the monitoring
period. Meanwhile, no significant difference was found in the amplitude of the EC PPG
signals among any of the three stages in the experiment.
The mean amplitude of the DC PPG signal in the RIF increased with a decrease in
temperature of the right hand. A similar effect was observed in the LIF, although the
temperature of the left hand remained constant. The increase in the DC amplitude is due
to the reduced light absorption resulting from a significant reduction in arterial and venous
blood fractions at the measurement site. The DC amplitude of the EC PPG signals, on
the other hand, have remained relatively constant throughout the experiment. The AC
and the DC fraction of the PPG signals acquired from all three locations were then used to
calculate the SpO2 for all three stages of the experiment. During baseline, the mean SpO2
calculated from all three uncalibrated sensors was between 102 – 97%, this is expected since
all volunteers were healthy and well perfused. During ice water immersion, a drop in the
estimated SpO2 was seen in the finger pulse oximeters. A drop in SpO2 value greater than
5% was considered to be a failure. Therefore, the right index finger pulse oximeter had
failed to estimate accurate SpO2 in 5 healthy volunteers while the left index finger pulse
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oximeter failed to estimate SpO2 in 4 healthy volunteers. Compared to the finger sensors,
the ear canal pulse oximeter only failed in one volunteer. These results demonstrate the
dependence of the pulse oximeters on the thermal state of the measurement site. Hence,
a central site such as the ear canal will increase the accuracy and reliability of the pulse
oximeters.
The cardiovascular reactivity to an induced stress stimulus was also studied through this
experiment. The variations in the heart’s function were captured by calculating the
changes in the heart rate, R–R interval, and the R-wave amplitude of the ECG signal
during all three stages of the experiment. During the ice water immersion, the sudden
change in temperature caused an increase in the heart rate and R-wave amplitude of the
ECG signal in almost all the volunteers. Since the R-R interval is inversely proportional
to the heart rate, the measured R–R interval decreased in all the volunteers. These results
demonstrate the effect of the autonomic nervous system on the heart. The resistivity of
the ear canal to local changes in BP or PWV was also demonstrated by measuring the
PTT to all three locations during all three stages of the experiment. The mean PTT
measured across all the volunteers during the ice immersion dropped by 3% in the EC, 7%
in the LIF, and by 12% in the RIF. During the recovery period, the PTT increased back
to baseline in the EC, while the RIF PTT increased by 2% and LIF PTT had increased by
22%. These results demonstrate the capability of the ear canal as a location for reliable
monitoring of PPGs and SpO2 in conditions of compromised peripheral perfusion.
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— The skin vessels of the human
hand constrict so effectively that
the ratio of maximum-to-minimum
blood flow can be 60 to 1, whereas
the same ratio in the body shell is
about 6 to 1
Thompson, Pulse oximetry, 1977
11
Investigation of ear canal pulse oximetry in
conditions of artificially induced vasoconstriction
This chapter investigates in vivo the capability of the ear canal in producing high quality
PPGs and reliable SpO2 values in conditions of global hypothermia (whole body exposed
to a cold environment). This investigation aims to create a more realistic environment
compared with the more local hypothermia induced on the arm during the cold pressor
test discussed in the previous chapter
In this chapter whole body cold exposure was used as it results in heat loss from all portions
of the body and stimulates more natural responses a patient would experience in conditions
leading up to hypothermia. Therefore, a study was carried out in 15 healthy volunteers
who were exposed to room temperatures of 10◦C. During this investigation, PPG signals
were acquired from the ear canal and the finger using the custom built probes discussed
in earlier chapters, and from the ear lobe using a commercial earlobe sensor. Comparisons
were then made amongst all three sensors with respect to the amplitude of the PPG signals
and SpO2 values estimated. The degree of autonomic control over arteriolar vessels of the
finger and the ear canal was also studied using the acquired PPG signals.
This chapter briefly describes the aims and objectives of the study followed by details of the
procedure and methodology for the investigation. The various methods of data analysis are
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then described in the chapter. Finally, the results obtained and their statistical significance
is discussed.
11.1 Aims and objectives
• To validate the hypothesis that the ear canal remains sufficiently perfused in con-
ditions leading to hypothermia, and good quality PPG signals can be obtained in
those circumstances.
• To investigate the differences in SpO2 measured from the finger and the ear canal in
conditions of profound peripheral vasoconstriction.
• To illustrate the differences in the influence of sympathetic nerve activity on the
peripheral and core circulation through low-frequency spectral analysis.
11.2 Methods and Materials
11.2.1 Measurement setup
The measurement setup described in Chapter 10 was adapted to acquire, display and store
PPG, ECG, temperature, and NIRS signals in this investigation. The block diagram of
the system is shown in Figure 11.1. The system consists of the following.
11.2.1.1 PPG and ECG monitor
PPG signals were acquired from three different locations during the course of this study.
The custom built ear canal and finger PPG sensors were used to acquire red and infrared
PPG signals from the ear canal and the finger. The configuration of these sensors and the
materials used to manufacture these sensors are described in Chapter 7. Along with these
sensors a commercial ear clip sensor (LNCS TC-I, Reusable Tip-Clip Ear Sensor, Masimo
corp., CA, USA) was used to acquire PPG signals from the earlobe. The motivation of
using a earlobe sensor was used to demonstrate that the ear canal is better perfused than
the earlobe in conditions of whole body vasoconstriction. Raw red and infrared PPG
signals from all three sensors were acquired using two PPG processing systems (described
in Chapter 8). The acquisition system was also used to acquire the ECG signal, which
acted as the timing reference for the acquired PPG signals.
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Figure 11.1: Block diagram showing the measurement setup used during the cold ex-
posure test. PPG, ECG, temperature, NIRS and LDF signals were acquired using the
setup.
11.2.1.2 NIRS and other monitors
A commercial NIRS monitor (NIRO 200NX, Hamamatsu Photonics, Shizuoka, Japan) was
adopted to record changes in the Normalised Tissue Haemoglobin Index (nTHI) (which is
a measure of changes in tissue blood volume) from both the peripheral and central sites.
The NIRO 200NX adopted Spatially Resolved Spectroscopy and modified Beer-Lambert
law to calculate changes in haemoglobin concentrations and blood volume. See Section 3.6
for more information on the principles and operation of NIRS. The NIRS sensors used to
estimate these parameters consisted of 3 LEDs at specific emission wavelengths of 735,
810 and 850 nm, and two photodiodes with a small separation distance between each
other. A separation distance of 4 cm between light emitters and detectors was used in this
study to maximise the light penetration depth. nTHI was measured to study the effect of
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cold stress on the blood volume in the measurement sites. nTHI was measured from the
forearm (peripheral) and the forehead (central) of the volunteer.
A laser Doppler flowmeter (moorVMS-LDF2, Moor Instruments, Devon, U.K.) was used
to measure peripheral skin temperature. Along with the NIRS and the LDF systems a
commercial non-invasive blood pressure (NIBP) monitor was used to measure the systolic
and diastolic blood pressure (HEM-907, Omron Healthcare, Hoofddorp, The Netherlands).
A tympanic thermometer (ThermoScan-5 IRT4520, Braun GmbH, Frankfurt, Germany)
was used to measure the core temperature from the ear canal of the volunteer.
11.2.1.3 Data acquisition
The PPG signals from the ear canal, the finger and the earlobe were digitised and recorded
along with the ECG signal using two PCIe-6321 NI DAQ cards ((National Instrument
Corporation, Austin, Texas)). An NI USB-6212–bus powered USB DAQ card was used to
record the nTHI signals from the NIRS and the skin temperature signal from the LDF. The
simultaneous recording of signals and control of the systems was through a VI implemented
in LabVIEW. The VI described in Chapter 9 was modified to include the acquisition and
control of all three DAQ cards. All the signals were recorded at a sampling frequency of
1 kHz. The blood pressure reading and core temperatures were recorded manually in an
Excel sheet during the study.
11.2.2 Subjects
With the approval of the Senate Research Ethics Committee of the City University London,
fifteen healthy volunteers (6 – ♀ and 9 – ♂) aged between 19 and 45 (mean age ± SD –
28 ± 5 years) were recruited for this study. Based on the medical history and a general
medical examination, subjects with cardiovascular, pulmonary, or metabolic diseases were
excluded from the study. The general medical examination included a measure of heart
rate, blood pressure and core body temperature. All the subjects were normotensive (mean
BP ± SD – 116/70 ± 14/11), normothermic (mean core temp ± SD – 36.52 ± 0.33) and
none was taking any medication. The subjects were informed of the details of the study
and signed informed consent was sought from all the volunteers before the experiment.
All the subjects were asked to refrain from ingesting beverages containing caffeine and
alcohol and were asked not to exercise or smoke for at least two hours preceding the test.
To maximise the effect of cold temperatures on the cardiovascular system, all the subjects
were asked to wear just one layer of clothing during the experiment.
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11.2.3 Measurement protocol
The trials were carried out in the Biomedical Engineering Research Laboratory, at City
University London. Upon arrival, all the volunteers were seated in a room maintained
at 24 ± 1◦C for a minimum of 10 min to ensure haemodynamic stabilisation. During the
study, the subjects were made to sit in a comfortable chair, with both hands resting on
armrests arranged to a height approximately equivalent to their heart’s position. Once
the volunteer was comfortable, heart rate (HR), blood pressure and core temperature
were measured. If the volunteer was found to be normotensive and normothermic then,
the study was continued.
The following sensors were then attached to the volunteer–
• The finger PPG probe was placed on the second digit of the left hand (Figure 11.2).
The RECAP sensor was placed 9 mm inside the left ear canal, and the ear clip sensor
was attached to the right earlobe of the volunteer
• The NIRS sensors were placed on the left forearm and the left side of the forehead.
The sensors were kept in place using a double-sided clear medical adhesive tape
• The LDF sensor was placed just below the thumb on the dorsal surface of the left
hand and it was attached to the skin by means of a ring-shaped double-sided adhesive
• The red, yellow and green leads of the ECG cable were connected to the Ag-AgCl
easitab ECG electrodes (SKINTACT, F-WA00) placed directly on the chest (the
right and the left side) and on the left hip.
Once all the sensors were in place, the investigation protocol (Figure 11.3) started with
the acquisition of baseline measurements from the volunteer for at least two minutes. The
volunteers were then moved to the adjacent temperature-controlled room maintained at
Figure 11.2: Photograph of the measurement set-up showing the forehead NIRS sensor
and the ear canal PPG sensor on the left, and the finger PPG probe on the index finger,
NIRS sensor on the forearm and LDF sensor on the back of the hand on the right.
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(24oC ± 1oC) (24oC ± 1oC)  (10oC ± 1oC) 
2 minute
Baseline
10 minute cold exposure 10 minute recovery 
Figure 11.3: Diagram showing the measurement protocol of the investigation.
10 ± 1◦C for 10 minutes. After the cold exposure, the volunteers were moved back to
normal room temperatures (24◦C), where monitoring continued for another 10 minutes.
PPG, ECG, NIRS and temperature data was continuously recorded during all three phases
of the experiment. The core temperature was measured from the right ear of the volunteer
once every minute for the entire duration of the study (22 minutes). Blood pressure was
measured once at the start of the study, and then at the end of the cold exposure and the
recovery period. The NIRS system was zero-set between each phase of the experiment to
highlight just the changes in the measurements and avoid any motion artefacts from being
recorded.
11.2.4 Data analysis
The raw PPG, ECG, NIRS and temperature data recorded during the study was extracted
separately for oﬄine analysis. Prior to any signal processing, the acquired signals were
resampled from 1000 Hz to 100 Hz. This was to restrict the bandwidth of the signals and
remove unwanted noise. This process is described in detail in Chapter 10.
Normalised Pulse Amplitude (NPA) – The red and infrared PPG signals acquired from
all three locations were first divided into AC and DC components using bandpass and
lowpass filters implemented in LabChart–8.0 (ADInstruments, Sydney, Australia). The
lower and upper cut-off frequencies of the bandpass filter (AC signal) were 0.5 Hz and
15 Hz respectively. The cut-off frequency of the lowpass filter (DC signal) was 15 Hz.
Further details on the filters used are provided in Section 10.2.4. The AC component of
the PPG signals was then divided by the DC component to normalise the PPG signals
(Figure 11.4).
A peak detection algorithm was used to detect the peaks and valleys of all the normalised
PPG signals. From the detected peaks, the normalised pulse amplitude (NPA) was calcu-
lated. The mean NPA estimated from the red and infrared PPG signals acquired from all
three locations was then averaged for every two minutes of the study. NPA was estimated
by the above procedure for all the subjects and was then averaged for the entire group.
The mean NPA of all the subjects during the cold exposure (every 2 min) and the recov-
ery (every 2 min) was analysed for their statistical significance compared to the baseline
period. A non-parametric statistical test (ANOVA on ranks) was performed on the data.
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(b) Normalised pulse signal
(a) Raw PPG signal 
Figure 11.4: Shows (a) the raw PPG signal and (b) the normalised PPG signal. The
blue trace in sub-plot ‘a’ shows the DC component. Normalised pulse signal is the ratio
of AC and DC components of the PPG signal.
A P-value < 0.05 was considered to be statistically significant. Statistical analysis was
performed using SigmaPlot-12.0 (SPSS Inc, Chicago, USA).
The NPA of the infrared PPG signals was then compared with the nTHI measured by the
NIRS device since the nTHI and NPA both reflect changes in blood volume in the mea-
surement areas. However, the comparisons were made keeping in mind the key difference
between the two techniques. That is the light penetration depth, and hence, the informa-
tion the variables provide. nTHI from NIRS is calculated from deeper layers of tissue and
is a reflection of the arterial, venous and capillary blood volume. On the other hand, NPA
of a PPG signal reflects just the changes in arterial blood volume. Hence, NIRS is probably
superior to photoplethysmography in measuring changes in blood volume. Nonetheless,
the changes in arterial blood volume during the cold exposure will reflect in both NPA
and nTHI. Therefore, the trends can be compared. Hence, the nTHI measured from the
forehead were compared with NPA from the ear canal and the nTHI from forearm was
compared with the NPA from the finger.
SpO2 analysis – The effect of cold exposure on the quality of the peripheral pulse and on
the estimated SpO2 by the pulse oximeter was demonstrated by calculating SpO2 values
from the acquired PPG signals. SpO2 measurements were made from all three locations to
highlight the superiority of the RECAP probe over other two probes. SpO2 was calculated
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in a three-seconds rolling window using the below equation.
SpO2 = 110− 25×ROS (11.1)
ROS –the ratio of ratios is the ratio of the red and infrared NPA. The SpO2 estimated from
each volunteer was averaged for every two minutes of the study. The SpO2 estimated from
each volunteer during the first 2 min (i.e., baseline) was then compared with every 2 min
(2–10) of the cold exposure and the recovery. Further, the change in SpO2 as a response
to the cold exposure was calculated, and the number of instances where the SpO2 value
has dropped below 90% was considered as a failure. The number of instances each sensor
has failed during the cold exposure was then calculated and compared.
Sympathetic and parasympathetic activity– Exposure to cold temperatures commonly leads
to a drop in the skin temperature due to heat loss. This effect triggers the activation of
the sympathetic nervous system which causes a change in the arterial distensibility and
cardiac function to counter the heat loss. However, the peripheral vasculature is known to
more sensitive or is more affected by the sympathetic activation than the core vasculature.
Hence, the degree of sympathetic control over blood vessels in the finger and the ear
canal was studied through low-frequency spectral analysis of the PPG signals acquired
from the respective areas. The infrared PPG signal acquired from the finger and the ear
canal were imported and preprocessed for analysis in MATLAB (The Math Works Inc.,
Massachusetts, USA). The acquired signals were bandpass filtered, with a linear-phase
FIR filter. The lower and upper cut-off frequencies of the filter were 0.035 and 0.5 Hz
respectively. The signals were filtered to eliminate all other components apart from the
sympathetic and the parasympathetic components, which are known to be between 0.04
Hz and 0.4 Hz [275].
The filtered signals were then divided into three segments, each containing information
from one stage of the study, i.e., the baseline, the cold exposure and the recovery. The
power spectrum of all three segments was then obtained using the ‘pwelch’ function in
Matlab. From the power spectrum, the power of the low-frequency components (LF)
(between 0.04 – 0.15 Hz) and the high-frequency (HF) components (in the range 0.15 –
0.4 Hz) was computed. The power of LF components corresponds to both sympathetic
and parasympathetic activity while the power of HF components corresponds to only
parasympathetic activation. Hence, the ratio of LF to HF (LF/HF) components was
calculated to quantify the changes in the sympathetic activity, as in [276]. The LF to
HF ratio measured from the finger and the ear canal were then compared during all three
stages of the experiment.
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11.3 Results
Baseline – Good quality, easily recognisable PPG signals with large amplitudes were
recorded from the finger, the ear canal and the earlobe in all the volunteers during baseline.
Figure 11.5 depicts typical AC red and infrared PPG signals acquired from the finger, the
ear canal, and the earlobe of a volunteer for a period of 15 seconds. The figure also depicts
the ECG signal acquired from the volunteer during the same period. As can be seen from
Figure 11.5, the PPG signals from all locations are synchronous with the R-wave peak
of the ECG signal. The PPG signals acquired from the ear canal of the volunteer were
smaller in magnitude than the finger and the earlobe probes. This is expected since the
finger and earlobe contain more vascular tissue than the ear canal. As mentioned earlier in
Chapter 10, the morphology of the PPG signals acquired from the ear canal were distinct
from the finger and the earlobe PPG signals. A close-up of the PPG signals acquired
from all three locations is presented in Figure 11.6. The earlobe PPG signal resembled

























Figure 11.5: The red (green trace) and infrared (blue trace) PPG signals acquired from
the finger, the ear canal and the earlobe, and the ECG signal acquired from one of the
volunteers for a duration of 15 sec.
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Figure 11.6: A close-up of the PPG signals acquired the finger, the ear canal and the
ear lobe showing the differences in the morphology of the PPG signals.
mean (±SD) skin and core temperature of the volunteer during the baseline was 27.43
± 0.02◦C and 36.7 ± 0.1◦C respectively. The blood pressure of the volunteer before the
baseline recording was 110/60.
Cold exposure – Figure 11.7 shows the infrared PPG signals acquired from the finger,
the earlobe and the ear canal along with the peripheral (skin) and the core temperature
measured from one of the volunteers for the entire duration of the study (22 min). From the
figure, the amplitude of the PPG signals acquired from the finger has reduced significantly
with time during cold exposure. This is expected due to the profound vasoconstriction
resulting from exposure to low temperatures. The skin temperature of the volunteer has
dropped to 20.2◦C by the end of the cold exposure. Similarly, the earlobe PPG signals have
also reduced in amplitude during the cold exposure. However, the magnitude of reduction
was much lower compared to the finger. On the other hand, the amplitude of the PPG
signals from the ear canal has remained relatively constant throughout the cold exposure.
The maximum drop in the core temperature of the volunteer during the cold stimulus
was 0.9◦C, which is below the ±1◦C error of the digital tympanic thermometer. This
conceivably explains the uncompromised blood flow to the ear canal and, therefore, the
unwavering PPG signals obtained from the ear canal. The blood pressure of the volunteer
has increased to 119/71 by the end of the cold exposure.
Recovery – The amplitude of the PPG signals acquired from all three locations has re-
covered with an increase in skin temperature over the recovery period. However, the
amplitude of finger PPG signals did not return to the initial baseline value within the 10
min recovery period. The ear lobe PPG signals have recovered to the steady state baseline
value in the first few minutes and remained unchanged. The ear canal PPG signals, on
206
Chapter 11 - Investigation of ear canal pulse oximetry in conditions of artificially
induced vasoconstriction









































Figure 11.7: Infrared AC PPG signals acquired from (a) the finger, (b) the earlobe and
(c) the ear canal of volunteer number 11 and the simultaneously acquired (d) core and (e)
skin temperature signal for the entire duration of the study. The Y-axis on the left shows
the amplitude of the PPG signals while the Y-axis on the right shows the temperature.
the contrary, have increased in amplitude as soon as the volunteer was removed from the
air-conditioned room, and have remained relatively constant for the rest of the monitoring
period. The skin and the core temperature of the volunteer by the end of the recovery
period were 24.1◦C and 36.8◦C respectively. The blood pressure has recovered back to
111/60 by the end of the study. To analyse these changes further, and to take into ac-
count the changes in the DC portions of the PPG signals, NPA (AC/DC) of the PPG
signals was measured.
11.3.1 Normalised Pulse Amplitude (NPA)
Figure 11.8 shows the NPA of the infrared PPG signals acquired from one of the randomly
selected volunteers; the NPA measured here is averaged using a 5 sec rolling window.
From the figure, it is evident that the NPA measured from the ear canal does not change
during the cold exposure. While, the NPA from the finger and the earlobe have reduced
significantly.
Similar to this volunteer, the NPA of the red and infrared PPG signals acquired from
all three locations was measured and was averaged for every two minutes of the study in
all the volunteers. The distribution of this data is graphically displayed here using the
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Figure 11.8: NPA of the infrared PPG signals acquired from the finger (blue trace), the
earlobe (red trace) and the ear canal (green trace) of a randomly selected volunteer using
a five-second rolling window.
Box and Whiskers plots in Figure 11.9, Figure 11.10, and Figure 11.11. The following
observations can be made from these figures:
• The sudden exposure to cold temperatures during the experiment caused an instan-
taneous and significant drop in the mean NPA of red and infrared finger PPG signals
in all volunteers. This is evident through the significant reduction in the interquartile
range, the mean and the median at the 4th minute in Figure 11.9 when compared to
the first two minutes
• The NPA of the finger PPG signals had further reduced with time across the volun-
teer group at a steady rate till the end of the cold exposure. The mean percentage
drop in the NPA of red and infrared finger PPG signals by the end of the cold
exposure was 80.1% and 86.3% respectively. The magnitude of this change in the
mean NPA of finger PPG signals demonstrates the sensitivity of the arterial vessels
in the periphery to the vasoconstrictor stimuli. The mean skin temperature of the
volunteers has dropped to 19.5 ± 0.49◦C (±SEM) by the end of the cold exposure
from 29.9 ± 0.42◦C during baseline.
• During the recovery period, the NPA of the finger PPG signals slowly increased with
time. However, the NPA did not rise to a value close to the baseline, although a
steady state was achieved between the 20th and 22nd min. The percentage difference
between the mean NPA measured by the end of the study to the baseline was 47.2%
(red) and 54.5% (infrared)
• The NPA of red and infrared PPG signals from the earlobe reduced during the cold
exposure. This is clearly visible in Figure 11.10, as the interquartile range, the
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(a) Infrared PPG Signals 










(b) Red PPG signals
Baseline Cold exposure Recovery
Baseline Cold exposure Recovery
Figure 11.9: NPA of the (a) infrared and (b) red finger PPG signals acquired from
15 volunteers during all three stages of the experiment. Each box shows the mean NPA
measured across a two minute period in all the volunteers. The red line in each box shows
the median value of the data, the ✩ shows the mean, and + shows the outliers.
mean and the median have deviated down the y-axis with time. Nonetheless, the
variability (i.e., the interquartile range) of the data has more or less remained the
same during the cold exposure. The mean percentage drop in the NPA of earlobe
PPG signals by the end of the cold exposure was 20% (red) and 26% (infrared). By
the end of the study, the NPA of the red and infrared PPG signals from the earlobe
has approximately returned to the baseline.
• In contrast with both the finger and the earlobe, the NPA measured from the ear
canal did not change during the cold exposure. Again, this is clearly visible in
Figure 11.11. The interquartile range, the mean and the median have all remained
relatively constant throughout the experiment. The % drop in the mean NPA of
red and infrared PPG signals from the ear canal during cold exposure was 0.2%
and 13.7% respectively. The mean core temperature of the volunteers has remained
unchanged (baseline: 36.6 ± 0.07◦C, cold: 36.0 ± 0.11◦C).
To quantify the changes in the mean NPA of the red and infrared PPG signals measured
from all three locations for every two minutes of the study, statistical tests were carried
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(b) Red PPG signals
Baseline Cold exposure Recovery
Baseline Cold exposure Recovery
Figure 11.10: NPA of the (a) infrared and (b) red earlobe PPG signals acquired from
15 volunteers during all three stages of the experiment. Each box shows the mean NPA
measured across a two minute period in all the volunteers. The red line in each box shows
the median value of the data, the ✩ shows the mean, and + shows the outliers.
out. Before commencing statistical analysis, a normality test was performed on the data
using the Kolmogorov-Smirnov test with Lilliefors’ correction, as in Section 10.3.1.2. The
P-value set in the test was 0.05. As not all the data was found to be normally distributed,
it was decided that for further analysis a non-parametric test will be used. The test
used was Kruskal-Wallis One Way Analysis of Variance on Ranks. A comparison between
two groups of data was recognised as significantly different if the computed P-value by
Kruskal-Wallis test was < 0.05.
As shown in Figure 11.12, the mean NPA of all the subjects during baseline (every 2 min)
was compared with every 2 min mean of the cold exposure and the recovery periods for
statistical significance (i.e., baseline vs 4→ 22 min, 10 comparisons per PPG signal). The
summary of the results of the Kruskal-Wallis test is presented in Table 11.1. Statistically
significant (p < 0.05) differences were found between all the groups when NPA of red
and infrared finger PPG signals was compared during the study. This suggests that the
NPA of red and infrared PPG signals has reduced significantly during the cold exposure
and never recovered back to the baseline value in the monitoring period. The H-value of
the red and infrared PPG signals were also large compared to the other locations. No
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(a) Infrared PPG Signals










(b) Red PPG Signals
Baseline Cold exposure Recovery
Baseline Cold exposure Recovery
Figure 11.11: NPA of the (a) infrared and (b) red ear canal PPG signals acquired from
15 volunteers during all three stages of the experiment. Each box shows the mean NPA
measured across a two minute period in all the volunteers. The red line in each box shows
the median value of the data, the ✩ shows the mean, and + shows the outliers.
significant difference was found between any of the groups when the NPA of the red and
infrared PPG signals from earlobe were compared. Similar to the earlobe, no significant
difference was found between any of the groups in the ear canal. However, by comparing
the P-values and the H-values, it could be said that the ear canal offers better quality
PPG signals during the cold exposure than the earlobe.
Baseline Cold exposure Recovery
2 4 6 8 10 12 14 16 18 20 220
1 2 3 4 5 6 7 8 9 10
Time (min)
Comparisons
Figure 11.12: Statistical analysis was carried out to measure the significant difference
between the mean NPA during baseline and every two minute mean of NPA during the
cold exposure and recovery periods (10 comparisons).
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Table 11.1: Summary of the statistical test results obtained from the Kruskal-Wallis
test performed on the NPA of red and infrared PPG signals acquired from the finger,
the ear canal and the earlobe of the volunteers. A P- value <0.05 indicates a statistically





Red Infrared Red Infrared
Finger = 0.002 < 0.001 28.05 35.67 Yes
Earlobe = 0.926 = 0.654 4.37 7.74 No
Ear canal = 0.993 = 0.847 2.38 5.61 No
11.3.2 NPA vs nTHI
The custom built finger and ear canal PPG sensors were so far used to measure changes in
arterial blood volume from the respective areas during the cold exposure. In this analysis,
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Figure 11.13: A comparison of (a) the finger NPA signal with the nTHI signal measured
from the forearm, and (b) the ear canal NPA signal with the forehead nTHI signal.
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Figure 11.14: (a) A comparison of the mean nTHI measured from the forehead with
the NPA measured from the ear canal. The y-error bars indicate the standard error of
mean (±SEM). (b) A comparison of the mean nTHI measured from the forearm with the
NPA measured from the finger.
the blood volume changes (nTHI) from a commercial NIRS system, to verify indirectly the
results and to validate the performance of the developed sensors. Comparisons were made
at both central and peripheral sites (i.e., the finger NPA vs. the forearm nTHI and the
ear canal NPA vs. the forehead nTHI). It should be noted that the PPG and NIRS sensor
locations are not exactly the same, and it is assumed that the finger and forearm reflect
changes in peripheral blood volume, and the ear canal and the forehead reflect changes
in central blood volume. NIRS sensors could not be used in the same locations as they
require large separation distance between the emitters and the detector (4 cm).
Figure 11.13(a) shows the changes in normalised finger PPG signal, along with forearm
nTHI acquired from a randomly selected volunteer for a duration of 22 min. From the
figure, it is evident that as the NPA of the finger is reduced with time during the cold
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exposure (between 2-12 min), the nTHI of the forearm has also reduced, indicating a
decline in the blood volume, particularly the arterial blood volume. Figure 11.13(b) shows
the changes in normalised ear canal PPG signal and the nTHI of the same volunteer
measured from the ear canal and the forehead. From the plot, it is clear that the NPA of
the ear canal PPG signal stays relatively constant during the cold exposure, indicating a
constant blood flow to the area. The same could be said about the nTHI measured from
the forehead, although a very small rise is observed during the start of the cold exposure.
To verify if a similar response can be observed in all the volunteers, the mean nTHI was
calculated for every 2 min of the study. The mean of the mean nTHI (±SEM) across
the entire group was then compared with the mean of the mean NPA. The mean nTHI
(±SEM) and the NPA (±SEM) measured across the volunteer group from the forehead
and the ear canal are shown in Figure 11.14(a). The same parameters estimated from the
finger and the forearm are shown in Figure 11.14(b).
From these figures, it is evident that the NPA and the nTHI measured from the finger and
the forearm decrease rapidly during the cold exposure due to profound vasoconstriction. In
contrast with the periphery, the NPA and nTHI measured from the ear canal and forehead
remain relatively constant. However, minor differences can be observed between the NPA
and nTHI in these regions. This is probably due to the anatomical differences between the
forehead and the ear canal. The nTHI measured from the forehead is a direct indicator
of changes in cerebral blood volume, whereas the NPA measured from the ear canal does
not signify the same. Additionally, nTHI is an indicator of changes in total blood volume,
while NPA is an indicator of changes only in arterial blood volume. Nonetheless, it is
reasonable to say that the ear canal is recognisably defiant to profound vasoconstriction
resulting from the cold exposure.
11.3.3 Arterial oxygen saturation (SpO2)
To show the effect of the cold exposure on the acquired PPG signals and subsequently
the effect on the SpO2 estimated by the pulse oximeter, arterial oxygen saturation values
were calculated from all three sensors for the entire duration of the study. SpO2 was
calculated using Equation 11.1 in a three-second rolling window, the ROS in the equation
is the ratio of the red and infrared NPA. Figure 11.15 shows the NPA of red and infrared
ear canal PPG signals acquired from a volunteer and the SpO2 estimated from the signals.
The SpO2 estimated from all three sensors in each volunteer was averaged for every two
minutes of the study. The mean SpO2 estimated from the first two minutes of the study
(i.e. baseline) was then compared with the every two minute mean of the cold exposure
and recovery periods.
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(a) Boxplot of the mean finger SpO2












Baseline Cold exposure Recovery
(b) Boxplot of the mean ear canal SpO2












Baseline Cold exposure Recovery
(c) Boxplot of the mean earlobe SpO2
Figure 11.16: Box and whiskers plots demonstrating the change in mean SpO2 measured
for every two minutes of the study in (a) the finger and (b) the ear canal and (c) the
earlobe. SpO2 estimated from the finger have dropped significantly towards the end of
the study when compared to the ear canal and the earlobe. The red line in each box
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The mean SpO2 values calculated for every two minutes of the study in all the volunteers
is displayed in Figure 11.16 with the help of boxplots. The SpO2 values estimated from
all three uncalibrated probes during baseline were in the healthy adult oxygen saturation
range (94% – 100%). The mean of the mean SpO2 (±SEM) calculated for the entire group
during baseline was 95 ± 0.45% in the finger, 98 ± 0.7% in the ear canal and 99 ± 0.6%
in the earlobe.
During the cold exposure, the mean of the mean SpO2 (represented by ✩ in Fig-
ure 11.16(a)) estimated from the finger probe had dropped with time, particularly in
the last 4 minutes of the cold exposure. The increase in variability (interquartile range)
of the data with time and the relatively stable median, however, indicate that the SpO2
might have dropped significantly only in a few volunteers. Nonetheless, these low SpO2
values would normally indicate hypoxia or even death in clinical circumstances, and hence
are inaccurate. The mean of the mean SpO2, the interquartile range and the median
of the SpO2 values calculated from the RECAP probe have remained relatively constant
throughout the cold exposure, with the exception of one outlier towards the end of the
stimulus (Figure 11.16(b)). The mean of the mean SpO2 estimated from the earlobe probe
reduced by the end of the cold stimuli. However, with the exception of the two or three
outliers, the values generally are in the limits (Figure 11.16(c)). This is confirmed by the
rather constant median and interquartile range.
During the recovery period, the mean of the mean SpO2 estimated from the finger has
recovered with time. Similarly, the mean of the mean earlobe SpO2 has improved with
time. However, SpO2 estimated from the earlobe of two volunteers has remained signif-
icantly low in the first few minutes of the recovery period. The ear canal SpO2, on the
other hand, has remained relatively constant with the exception of the one outlier.
Since blood oxygenation is a global variable which does not change in healthy volunteers
from site to site, the differences observed in mean SpO2 amongst the sensors was further
investigated. To differentiate the volunteers in whom any of the pulse oximeters had
Table 11.2: Summary of the pulse oximeter failure during the cold exposure and the
recovery period in 15 volunteers
No. of volunteers with SpO2 < 90%
Sensor
Cold exposure Recovery
4 6 8 10 12 14 16 18 20 22
Finger 4 2 3 4 5 4 3 3 2 2
Ear canal 0 0 1 1 1 1 1 0 0 0
Earlobe 0 0 2 1 2 3 2 2 2 1
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failed (i.e., inaccurate SpO2) from the others, the percentage drop in SpO2 for every 2
min of the study was calculated in each volunteer. The number of instances in which the
SpO2 estimated from a particular probe had dropped to a value <90% was calculated and
considered as a failure. Table 11.2 shows the number of volunteers in whom the estimated
SpO2 has dropped to a value <90% during the cold exposure and the recovery period.
From the table, the finger probe produced erroneous SpO2 readings in four volunteers as
soon as they were exposed to cold air, and by the end of the cold stimulus, 5 volunteers
had SpO2 below the 90% mark. The ear canal pulse oximeter, on the other hand, had
failed in one volunteer towards the end of the cold exposure. Similarly, the earlobe pulse
oximeter has failed to estimate accurate SpO2 in 3 volunteers.
The high failure rate in the finger sensor was not due the reduction in blood oxygenation
but is merely due to the quality of the signals acquired. As observed in Figure 11.9, the
mean NPA of the red and infrared PPG signals dropped significantly towards the end
of the cold exposure. In some volunteers, the amplitude of the PPG signals diminished
so significantly that the peak detection algorithms could not distinguish between noise
and PPG signal peaks. Hence in these volunteers, the amplitude of the noise is being
measured instead of the PPG signal. Since the amplitude of noise in both the red and
infrared channels is approximately similar, the absorbance ratio (ROS) will drive towards




















Figure 11.17: Depicts the red finger PPG signal (green trace) and the ECG signal (blue
trace) acquired from a volunteer towards the end of the cold exposure, along with the
peaks detected (red trace) by the peak detection algorithm. The amplitude of the red
finger PPG signals was sometimes so small that the peak detection algorithm could not
distinguish between the heart beat peaks and the noise peaks.
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Figure 11.18: Red PPG signals acquired form the fingers of the volunteers in whom
accurate estimation of SpO2 was not possible during the cold exposure. The PPG signal
is indistinguishable from noise in these cases.
PPG signal acquired from a volunteer during the cold exposure is shown in Figure 11.17,
along with the peaks detected by the algorithm and the ECG signal. The quality of the red
finger PPG signals acquired from the five volunteers in whom accurate SpO2 estimation
was not possible is shown in Figure 11.18.
From the results acquired in this study so far, it is fair to say that the SpO2 measurements
made from the finger are susceptible to poor peripheral perfusion and are heavily dependent
on the thermal state of the site. This limitation really weakens the ability of the pulse
oximeters in conditions when they are most needed. The newly developed RECAP probe
on the other side offers reliable SpO2 measurements even under the influence of the cold
temperatures or profound vasoconstriction.
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11.3.4 Sympathetic and parasympathetic activity
When the human body is exposed to low ambient temperatures (as in the case of this
experiment), the thermoregulatory mechanism of the body initiates the activation of the
sympathetic nervous system to counter the heat loss and maintain homeothermy. This
activation causes a change in peripheral blood flow through the intense constriction of
cutaneous blood vessels and a marked increase in the heart rate and the blood pressure.
The degree of the sympathetic control over blood vessels is, however, known to be more





























2 4 6 8 10 12
(c) Cold exposure
Time (min)





















(a) Raw PPG signals 
Figure 11.19: An example of the sympathetic activity estimation; (a) The raw PPG
signals acquired from the ear canal (blue trace) and the finger (green trace) were first
bandpass filtered and then divided into three segments, each containing data from (b)
baseline, (c) cold exposure and (d) recovery; The power spectrum of the corresponding
signals was then acquired (e), (f) and (g).
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prominent in the periphery than the core vasculature. Hence, the significant drop in
finger PPG amplitude compared to the earlobe or ear canal PPG signals. To quantify the
differences in the degree of sympathetic nerve activation between the periphery and the
core and supplement the above statement, low-frequency spectral analysis was performed
on the raw PPG signals acquired from the finger and the ear canal. Two volunteers
were exempt from this analysis, as the raw PPG signals acquired from these volunteers
contained some noise.
The power spectrum of the ear canal (blue trace) and the finger (green trace) PPG signals
acquired from a volunteer during (c) baseline, (d) cold exposure and (e) recovery periods
is shown in Figure 11.19, along with (a) the raw and (b) the filtered PPG signals. Note
that the power spectrum acquired at each stage was normalised to the component with the
maximum power to facilitate easy comparison between the two locations. Therefore, the
power of the highest component in each sub-plot is at 1. During baseline, the component
with the maximum peak in both the finger and the ear canal was the LF component.
During the cold exposure, the component with the maximum peak in the finger was the
LF component, whereas in the ear canal it was the HF component. Hence, the ratio of LF
to HF will be very high in the finger compared to the ear canal, suggesting a higher degree
of sympathetic activity. The LF/HF ratio of the finger has increased to 86.4 during the
cold exposure from 19.2 at the baseline. While the ear canal LF/HF ratio has decreased to
1.38 during the cold exposure from 1.62 at baseline. These results indicate the differences
in the degree of sympathetic activation between the two locations. The LF/HF power ratio
estimated from the finger and the ear canal PPG signals during baseline, cold exposure
and recovery are graphically displayed in Figure 11.20.
Statistical tests were performed on the data to check if the changes occurring in the LF/HP
(a)





























Figure 11.20: Box plot showing the changes in LF/HF ratio during the cold exposure
in (a) finger and (b) the ear canal.
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Table 11.3: Statistical test results obtained from non-parametric analysis performed on
the LF/HF ratio measured from the finger and the ear canal PPGs.
Location Comparison Statistical significance P-value
Finger
Baseline vs Cold Yes
0.002Cold vs Recovery No
Recovery vs Baseline Yes
Ear canal
Baseline vs Cold No
0.781Cold vs Recovery No
Recovery vs Baseline No
ratio are significantly different between any of the two stages in the study. Before the
statistical analysis, the normality of the data was tested using the Kolmogorov-Smirnov
test with Lilliefors’ correction. As most of the data included in the study were not nor-
mally distributed, a non-parametric test (Kruskal-Wallis One Way Analysis of Variance
on Ranks) was used for statistical analysis. A comparison between data acquired from two
different stages of the experiment was recognised as significantly different if the computed
P-value by Kruskal-Wallis test was < 0.05. To isolate the group or groups that differ from
the others, all pairwise multiple comparison procedures (Student-Newman-Keuls Method)
was used. The results of the statistical tests together with the corresponding P-value are
shown in Table 11.3. A significant difference was found when the LF/HF power ratio
computed from the finger was compared between baseline and the cold exposure, while no
significant differences were found in the ear canal LF/HF ratio in any of the comparisons.
These results prove that the sympathetic control of the blood vessels in the periphery is
significantly higher than the core regions.
11.4 Summary
The newly developed ear canal PPG probe, the finger PPG probes, and a commercial
ear clip pulse oximetry sensor were used along with the acquisition system in an in-vivo
study investigating the effect of whole body the cold exposure on the quality of the PPG
signals acquired from both the periphery (the finger and earlobe) and the core (the ear
canal). The study aimed to prove the hypothesis that the ear canal remains sufficiently
perfused and accurate SpO2 estimation will be possible in conditions of compromised
peripheral perfusion where the finger sensor will commonly fail due to the diminishing
peripheral pulse. The study was carried out in 15 healthy volunteers with no history of
cardiovascular disease. During the study, all volunteers were exposed to 10 minutes of low
ambient temperatures (10◦C). The red and infrared PPG signals acquired from all three
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sensors during the study were analysed and compared with respect to their normalised
amplitude (AC/DC) and the SpO2 estimated. The measured parameters were averaged
for every two minutes of the study, and the baseline 2-minute mean was compared with
every two minutes mean of the cold exposure and recovery periods. The PPG signals
between the ear canal and the finger were also analysed for their sympathetic modulation.
The PPG signals acquired from all the volunteers were generally of good quality. The
morphology of the AC PPG signals acquired from the ear canal were different to the finger
and the earlobe PPG signals. The morphological differences between the finger and the ear
canal signals were expected due to the large distance between the heart to the finger than
to the ear canal. However, the differences in the earlobe and the ear canal PPG signals were
not expected. Especially since the earlobe is very close to the ear canal. The morphological
difference between these sites is possibly due to the dissimilarity in the vasculature. The
earlobe is supplied by the auricular branches (capillaries) of the superficial temporal artery
while the ear canal gets rich blood supply from the deep auricular artery, a branch of the
internal maxillary artery.
The NPA of the finger PPG signals has reduced significantly as soon as the volunteers were
exposed to cold. The drop in NPA of red and infrared PPG signals was > 80% by the end
of the cold exposure. The NPA of the earlobe PPG signals has also dropped considerably,
but not as significantly as the finger. The mean drop in the NPA of earlobe PPGs was
20% and 26% at red and infrared wavelengths. On the contrary to both these sensors, the
ear canal PPG signals remained relatively unchanged. During the recovery period, the
NPA measured from both the finger and the earlobe sensors has increased with time. The
earlobe NPA was close to the baseline value by the end of the recovery period. However,
the NPA of the finger PPGs has not recovered to the baseline value by the end of the 10 min
recovery period. The finger NPA was approximately 45% lower than the baseline value by
the end of the study. The statistical tests carried out to measure the differences between
the groups (baseline vs. every 2 min mean) have shown that a statistically significant
difference (P-value: red– 0.002, infrared– <0.001) exists between the NPA of the finger
PPG signals measured during baseline and the NPA of finger measured during the cold
exposure. Similar results were found when finger NPA from baseline was compared with
the recovery period. On the other hand, no significant difference was found between the
groups when NPA of the earlobe (P-value: red– 0.926, infrared– 0.654) and the ear canal
was compared (P-value: red– 0.993, infrared– 0.847).
The NPA of infrared PPG signals acquired from the ear canal and the finger during the
study were compared with the nTHI measurements acquired from the forehead and the
forearm to indirectly validate the acquired results. The results show that the NPA from
the finger follows the nTHI during the study in both locations. This indicates that the
arterial blood volume in the finger reduces significantly during the cold exposure while the
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ear canal remains relatively constant. However, minor differences were observed between
nTHI from the forehead and NPA from the ear canal. This could be due to the anatomical
differences between sites and the penetration depth of the NIRS system.
The mean SpO2 estimated from all three sensors during baseline was between 95% and
99%, i.e., in the healthy oxygen saturation range. During the cold exposure, the mean
SpO2 measured from the finger probe has dropped significantly in the last 4 minutes. The
sensor has failed (SpO2 < 90%) to estimate accurate SpO2 in 5 volunteers by the end of
the cold exposure (a 33.3% failure rate). The SpO2 estimated from the earlobe sensor has
failed in 20% of the volunteers. Compared to both these sensors the SpO2 estimated from
the ear canal has only failed in 1 volunteer. The failure in SpO2 of the finger sensor or the
ear lobe sensor is not due to the drop in oxygen saturation but is due to the quality of the
PPG signals acquired.
The degree of sympathetic control over peripheral and core vasculature was quantified
through low-frequency spectral analysis. The frequency spectrum of the infrared finger
and the ear canal PPG signals was acquired, and the power of the LF and HF component
was calculated. The ratio of LF to HF power was then calculated and compared between
the sites. The results show that the LF/HF ratio in the finger has increased significantly
(p= 0.002) during the cold exposure. While the ear canal LF/HF ratio has stayed relatively
constant compared to the finger (p=0.781).
From these results, it is reasonable to conclude that the ear canal is a superior site com-
pared to the finger and the ear lobe in providing good quality PPG signals and accurate
SpO2 in condition of compromised perfusion.
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nology is indistinguishable from
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Arthur C Clarke, Hazards of




Continuous assessment of arterial oxygenation (SpO2) by pulse oximetry has become
widespread during anaesthesia, in the peri-operative period, and in the critically ill. It
is now an ASA standard for intraoperative monitoring during all anaesthetics. However,
commercial pulse oximeter probes placed on the finger may fail to provide a valid read-
ing in conditions of poor peripheral perfusion caused by hypotension, hypothermia, and
vasoconstriction. Hence, this project aimed to develop an ear canal pulse oximeter, on
the hypothesis that this central site will remain sufficiently perfused in order to enable
accurate and reliable measurements of SpO2 in conditions of poor peripheral perfusion.
A novel earphone shaped optoelectronic reflectance ear canal photoplethysmography probe
(RECAP II), small enough to fit inside the ear canal was successfully developed (Chap-
ter 7) to acquired red (658 nm) and infrared (870 nm) PPG signals from the posterior
surface of the outer ear canal. Two optically identical peripheral PPG sensors were also
developed to obtain PPG signals from the fingers or toes, and hence allow for quantitative
and qualitative analysis of the PPG signals obtained at both the periphery and the ear
canal. To pre-process and acquire the ear canal and the finger PPG signals, a novel dual-
wavelength PPG processing system was developed (ZenPPG). A modular design approach
was implemented in the system’s design, whereby the electronic circuitry in the system
was divided into multiple modules, which were connected by a system bus. Through this
modular approach, various functions in the system were kept independent of each other,
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allowing for easy debugging and incremental improvement. The developed system com-
prised of two identical PPG processing channels and an ECG processing channel. The
PPG instrumentation system was developed to operate in conjunction with a virtual ac-
quisition and control instrument designed in LabVIEW. The virtual instrument allowed
for the continuous acquisition and display of all signals from the instrumentation system
and consisted of various filters and algorithms to reduce the bandwidth of the acquired
signals and estimate parameters such as SpO2 and heart rate.
During the design and developmental phase of the technology mentioned above, two in vivo
investigations, a participant survey and several other performance verification experiments
were conducted in the laboratory to aid the design of the ear canal PPG sensor, and to
evaluate and optimise the performance of the ZenPPG system. Firstly, an in-vivo study
was carried out in 7 healthy volunteers to investigate the quality of PPG signals that can
be obtained from different depths of the ear canal (i.e., outer ear canal, inner ear canal).
Two RECAP-I probes with different dimensions (10 mm and 15 mm in length and 7 and 8
mm in diameter) were used in this investigation. The results of this investigation showed
that good quality red and infrared PPG signals can be acquired from both locations in the
ear canal. However, two key differences were observed between the sites: (1) the amplitude
of the PPG signals acquired from the outer ear canal were found to be marginally smaller
than those acquired from deep inside the ear canal (infrared: P = 0.07, red: P = 0.26), (2)
the PPG signals acquired from the deeper auditory canal are slightly noisy and contained
high respiratory modulation. The noisy PPG signals in the deeper region of the ear canal
were however expected since the Eustachian tube induces respiratory and jaw movements
to the middle ear and deeper regions of the outer ear. These initial measurements have
given the necessary confidence for the further development of the sensor and have shown
the feasibility of the ear canal as a monitoring site for PPGs and blood oxygen saturation.
The volunteers participating in this study were asked to fill in a survey that was designed
to aid the further development of the sensor technology. From the participants’ responses,
it was determined that (1) the size of the designed probe needs to be minimized, as some
of the volunteers have expressed discomfort during prolonged usage; (2) thermal safety
tests need to be carried out to establish if the light emitted by the LEDs could result in
any undesirable thermal effects, especially as a couple of the volunteers have complained
about warm sensation after prolonged use. Taking these observations into consideration,
it was decided that the outer ear canal is used as the optimal site for monitoring PPG
signals in future investigations.
Prior to any further development of the sensor, another in-vivo study was carried out in
the same set of volunteers to determine the surface along the circumference of the ear
canal from which the acquired PPG signals will be of the best possible quality. This
investigation was focused only on the outer region of the ear canal. Anterior (top), ventral
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(right), posterior (bottom) and dorsal (left) surfaces of the outer ear canal were investigated
during this study. The PPG signals acquired from all four surfaces of the ear canal
were of good quality. However, the posterior surface of the outer ear canal was found to
be the best possible surface for the acquisition of high amplitude and undistorted PPG
signals. Statistically, significant differences were found when the amplitude of PPG signals
acquired from the anterior and posterior surfaces of the ear canal (Red: P= 0.008, infrared:
P= 0.006) were compared. From these findings, it was decided that the posterior surface
of the outer ear canal will be used as the location for PPG signal monitoring in the ear
canal.
The above encouraging results have prompted the development of the second prototype
probe (RECAP–II) with smaller dimensions. Preceding the design and development of the
RECAP–I probe, a thermal safety test was carried out on the first prototype to determine
the effect of the thermal radiation emitted by the LEDs on the surrounding tissue. The
LEDs have reached a maximum temperature of 28.7◦C in the first 15 min of on-time
(i.e. a 3.2◦C raise from baseline) and then stayed relatively constant for the rest of the
test period. The minimum temperature at which the human skin might receive a shallow
burn is at 44◦C. Since the maximum temperature of the probe is well below the shallow
burn range, it was concluded that there was no risk of thermal injury from the optical
components used. Additionally, the size of the probe does not affect the amount of heat
generated by the LEDs. Hence, the same optical components were used in the design of
the second prototype. The RECAP–II probe was designed to look like a small earphone.
The prototype probe was successfully tested in 3 volunteers. The amplitude of the infrared
PPG signals recorded from the probe was between 200 and 400 mV. However, the smaller
dimensions of the probe meant a higher susceptibility to motion artefacts in users with large
ears, due to the loose fit. To provide more effective fixing and comfort, an interchangeable
ear hook and an ear fin were incorporated into the probes design.
Similar to the prototype probes, the performance of each module in the ZenPPG system
was thoroughly tested. Several simulations and experiments were conducted to fine-tune
the current source, the transimpedance amplifier, the sample and hold amplifier and the
analogue filters. As a result, a high SNR of 101.31 dB was achieved. The low power
consumption (1.07 W) of the system also meant that it could be used continuously for
more than 2 hours when powered by batteries.
Following these experimental investigations and the finalisation of the developed technol-
ogy, sufficient confidence was acquired to commence a systematic in vivo evaluation of
the ear canal probe in conditions of comprised peripheral perfusion for the first time. The
City University Senate Research Ethics Committee has given the approval to conduct PPG
measurements in 15 healthy volunteers undergoing a cold pressor test (CPT) (30 sec right
hand into an ice bath). Red and infrared PPG signals were acquired from the ear canal
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(EC), the right index finger (RIF) and the left index finger (LIF) of the volunteers during
the study. Oﬄine analysis was conducted on all acquired signals to examine the variations
in the amplitude of AC and DC PPG signals. The results show that good quality red and
infrared PPG signals can be obtained from the human auditory canal and the periphery
using the custom built sensors. The ear canal PPG signals were found to be morpholog-
ically different to the finger PPG signals (Figure 10.9). PPG pulse features such as the
dicrotic notch in the diastolic phase, arrive earlier in ear canal signals when compared to
the finger PPG signals. The ear canal PPG signals bear a high resemblance to the arterial
pressure pulse recorded from the aortic arch. These physiological features were suppressed
in the finger PPG signals due to the increased vascular compliance of peripheral blood ves-
sels. The ear canal PPG signals also contained pronounced respiratory modulations when
compared to the left and right index finger PPGs. Hence, by further decomposing the
ear canal PPG signal, valuable clinical information regarding the cardiovascular function
might be extracted.
During the CPT, the amplitude of the AC PPG signals from the RIF have reduced sig-
nificantly (P < 0.05), which is expected due to the profound vasoconstriction resulting
from immersion of the right hand into ice water. However, the amplitude of the LIF has
also reduced significantly, although the skin temperature of the left hand has remained
constant. The effect of the right-hand immersion on the amplitude of the LIF PPGs is
probably due to the activation of the sympathetic nervous system. The sudden change in
temperature of the right-hand forces the thermoregulatory centre to stimulate the sym-
pathetic nervous system, in order to maintain homoeostasis. This leads to an increase in
vessel wall stiffness of peripheral blood vessels, which in turn causes the blood pressure
and heart rate to increase (as seen in Figure 10.18). Hence, during ice water immersion
most of the peripheral body parts are affected, as it has in this case with the left finger.
On the contrary to the periphery, the amplitude of the AC ear canal PPG signals has
remained relatively constant. These findings show that with induction of vasoconstrictive
stimulus in the right hand, other peripheral parts such as the left hand are prominently
affected while central areas such as the ear canal remain reasonably immune. During
the recovery period, the amplitude of the AC PPG signals increased with temperature.
No significant differences were found between the amplitude of the LIF PPGs during the
baseline and the recovery periods (From Table 10.5). However, significant differences were
found in the RIF, when the baseline and recovery periods were compared. This indicates
that the amplitude of the RIF PPG signals has not increased to a greater extent by the
end of the study, although the temperature of the right hand has increased to a minimum
temperature of 24◦C in all the volunteers.
The baseline mean SpO2 estimated from the ear canal pulse oximeter was in good agree-
ment with both the finger pulse oximeters. During the cold pressor test, the mean SpO2
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from both the finger pulse oximeters dropped considerably. However, SpO2 is a global
variable, and would not change from site to site in healthy volunteers. Therefore, the drop
in SpO2 of pulse oximeters is purely due to the reduction in amplitude and quality of
PPG signals, resulting from vasoconstriction of peripheral blood vessels. A drop in SpO2
higher than 5% was found in 34% of the volunteers in the RIF pulse oximeter while 27%
of the volunteers experienced a similar drop in the LIF pulse oximeter. Compared to the
finger pulse oximeters, the ear canal pulse oximeter has only failed in one volunteer. These
results show the durability of the ear canal for SpO2 monitoring.
One of the shortcomings of this study was the duration of applied stimulus. The short
duration of cold immersion has not allowed for low-frequency spectral analysis which could
have helped determine the extent of the sympathetic activity in each location. Nonethe-
less, the extent of vasoconstriction at each site during the ice immersion was indirectly
quantified by calculating the PTT from the PPG signals acquired from the respective
locations. The mean PTT measured during baseline from the EC was smaller than the
RIF and LIF PTT, this was expected since the distance from the heart to the ear canal
is smaller than that of the finger. However, this proves that the ear canal offers a faster
desaturation response time than the periphery. The mean PTT measured from the EC,
the RIF and the LIF has dropped during the ice water immersion. This indirectly indicates
a general rise in blood pressure. However, the percentage drop in PTT varied across all
three locations. The PTT in the EC and the LIF has dropped by 3% and 7% while the
RIF PTT has dropped significantly by 12%. These differences in the drop of PTT across
the three locations indicates the disparity in the strengths of local vasoconstriction in the
respective areas. From all these findings it was concluded that the ear canal is a reliable
site for monitoring PPGs and SpO2 in conditions of compromised peripheral perfusion.
Since the ear canal was successfully shown to be an adequate site for monitoring PPGs
and estimating SpO2 in conditions of locally induced hypothermia, the next practical step
was to test the sensors performance in a more realistic hypothermic situation (i.e., in
patients or volunteers experiencing a mild form of hypothermia). Hence with the consent
of City University Senate Research Ethics Committee, a study was carried in 15 healthy
volunteers undergoing whole body cold exposure. The volunteers participating in this
study were exposed to ambient temperature of about 10◦C for 10 min, as the blood flow to
the periphery is known to be minimal (less than 1 ml/min) at this temperature [277, 278].
Red and infrared PPG signals were acquired from the finger, the earlobe and the ear canal
of the volunteer during the study. The PPG signals acquired from all the volunteers were
generally of very good quality. The morphology of the AC PPG signals acquired from
the ear canal were different to the finger and the earlobe PPG signals. The differences
between the finger and the ear canal signals are expected due to the reasons mentioned
earlier, however, the PPGs acquired from the ear lobe bore more resemblance to the finger
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PPGs than the ear canal PPGs although being closer to the ear canal. This is perhaps due
to the differences in the vasculature of the tissue in the respective areas. The earlobe is
supplied by a capillary network originating from the superficial temporal artery while the
ear canal is supplied mainly by the arterioles originating from the deep auricular artery
and the internal maxillary artery.
During the cold exposure, the changes in NPA of the PPG signals has varied across all three
locations. The NPA of the red and infrared PPG signals from the finger was significantly
reduced as soon as the volunteer was exposed to cold temperature and has further decreased
with time. By the end of the cold exposure, a mean drop in NPA of red and infrared finger
PPGs greater than 70% was found in two thirds of the volunteers. Statistically, significant
differences were found in the mean NPA of the red and infrared finger PPG signals (P-
value: red– 0.002, infrared– < 0.001) when the baseline measurement was compared with
every 2 min mean of cold exposure. The NPA of the earlobe PPGs was also affected,
however, the magnitude of change was much smaller compared to the finger. A mean drop
in NPA of earlobe PPGs greater than 70% was found only in one volunteer. No significant
difference was found (P-value: red– 0.926, infrared– 0.654) between any of the groups when
the mean NPA of baseline PPGs was compared with those acquired during cold exposure
(every 2 min mean). In contrast with the finger and the earlobe, the NPA of the ear canal
PPGs has remained relatively constant throughout the study, and none of the volunteers
had a drop in NPA > 70%. The mean drop in the red and infrared NPA of the ear canal
PPGs was only 0.2% and 13% respectively. Similar to the earlobe, no significant difference
was found (P-value: red– 0.993, infrared– 0.847) between any of the groups when the NPA
of the ear canal PPGs from baseline was compared with cold exposure. However, judging
from the P-value, the variations in ear canal PPGs were much smaller than the ear lobe
PPGs. During the recovery period, the NPA of the PPG signals measured from all three
locations has increased with time. However, the NPA of the finger PPGs was significantly
(P< 0.05) lower than the baseline value by the end of the study.
The disparities in NPA of PPG signals acquired from the finger, the earlobe and the ear
canal (or, in other words, the variations in the effect of cold exposure on the blood supply)
are due to the thermal adaptation of the body. When the human body is exposed to cold,
the efferent sympathetic nerves descending from the posterior hypothalamus (the body’s
thermostat) produce intense constriction of the skin resistance vessels and closure of the
arteriovenous anastomoses. This innervation reduces the heat transfer from the body’s
core to the body’s surface and subsequently the heat loss to the environment but at the
expense of further cooling the extremities [278, 279]. Hence, appendages such as the finger,
which are part of the peripheral circulation are more affected by the cold than the central
areas such as the ear canal. The differences between the NPA of the ear canal and the
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earlobe PPGs is explained by the dissimilarity in the vasculature of respective areas and
the passive cooling of the skin surrounding the auricle and lobule during cold exposure.
To verify the measurements made from the custom built probes, the NPA changes mea-
sured from the finger and the ear canal probes were compared with the nTHI measurements
from the forearm and the forehead. The NPA measured from the finger PPGs and the
nTHI measured from the forearm followed the same trend throughout the measurement
period. Both the parameters decrease rapidly during cold exposure due to profound vaso-
constriction. Similarly, the NPA from the ear canal PPGs and the nTHI from the forehead
followed the same trend. However, the parameters stayed relatively constant throughout
the study in this region. However, minor differences were observed between the parame-
ters measured in this region (see Figure 11.14). This is expected due to the anatomical
differences between the forehead and the ear canal and the fundamental differences in the
information provided by the parameters. nTHI is an indicator of changes in total blood
volume while NPA is an indicator of changes only in arterial blood volume. These results
show that the ear canal is recognisably resistant to profound vasoconstriction resulting
from cold exposure.
To demonstrate the effect of the cold exposure on the SpO2 estimated by the pulse oxime-
ters, mean SpO2 values were calculated from the PPGs acquired from all three probes,
for every two minutes of the study. During baseline, the SpO2 estimated from all three
probes were in the healthy adult oxygen saturation range (94% – 100%). During the cold
exposure, the mean of the mean SpO2 measured from the finger has dropped significantly
with time, particularly in the last 4 minutes of the cold exposure (see Figure 11.16). The
mean of the mean SpO2 calculated from the ear canal probe and the earlobe probe has
remained relatively constant throughout the study, with the exception of three outliers.
The failure rate of each probe was quantified by calculating the number of volunteers in
whom the estimated SpO2 had dropped to a value < 90%. The finger probe produced
erroneous SpO2 readings in a maximum of 5 volunteers during the cold exposure. The
earlobe pulse oximeter has failed to estimate accurate SpO2 in a maximum of 3 volunteers
during the course of the study. The ear canal pulse oximeter, on the other hand, had failed
only in one volunteer.
The high failure rate in the finger sensor does not actually mean a reduction in the blood
oxygenation of the volunteers. The failure of the pulse oximeter in these healthy volunteers
is due to the quality of the signals acquired. When the body is exposed to ambient
temperatures of 10◦C, the blood flow through the hand is minimal (less than 1ml/min).
Hence, the recorded AC PPG signals are very low in amplitude. In some cases, the
amplitude diminishes so significantly that the peak detection algorithms cannot distinguish
between noise and PPG signal peaks. In these instances, the amplitude being measured
is of the noise. Since the amplitude of noise in both the red and infrared channels is
230
Chapter 12 - Discussion and conclusions
approximately similar, the absorbance ratio (ROS) will drive towards 1, resulting in a
SpO2 close to 85%.
As mentioned earlier, the activation of the sympathetic nervous system by the thermoreg-
ulatory mechanism leads to a profound vasoconstriction. This innervation is, however,
more prominent in the periphery than the core vasculature. In fact, the skin vessels of the
human hand constrict so effectively that the ratio of maximum-to-minimum blood flow in
the hand can be 60 to 1 whereas the same ratio in the body’s core is about 6 to 1 [280].
Hence, to quantify the differences in the degree of sympathetic nerve activation between
the periphery and the core during the cold exposure, the low-frequency spectral analysis
was performed on the raw PPG signals acquired from the finger and the ear canal. The
ratio of LF to HF power was calculated during this analysis and was compared at different
stages of the study. A significant difference (P= 0.002) was found when the LF/HF power
ratio computed from the finger was compared between baseline and the cold exposure
while no significant differences were found in the ear canal LF/HF ratio (P= 0.781).
In summary, a new and clinically useful ear canal pulse oximetry system was successfully
designed and developed. The system allowed for the first time the detailed investigation
of PPG signals acquirable from the ear canal. The observations from both the in vivo
investigations support the hypothesis that the ear canal can be used as an adequate site
for monitoring blood oxygen saturation in conditions of poor peripheral perfusion where
conventional pulse oximetry fails. However, more trials need to be conducted in more
healthy volunteers and patients in order to assess this hypothesis.
The proposed future work is focused on conducting additional in vivo investigations in
patients undergoing elective general and cardiothoracic surgery (ASA II-IV). As compro-
mised peripheral perfusion is most likely to occur in this patient group. The goal of the
further efforts is to develop a smaller, more robust and smart ear canal probe with added
features such as core temperature measure. If developed, such a probe would have the
potential to be the only technology capable of measuring heart rate, SpO2, respiration
rate, and core temperature. More emphasis will be made in future developments of the
novel ZenPPG processing system. Work will be carried out in three different streams,
(1) in making the system a multi-wavelength and multi-channel analogue system, (2) in
developing a digital front end with adaptive DC correction, and adaptive LED intensity
control, and (3) in implementing a high resolution ADC within the system, which would
make the ZenPPG independent from LabVIEW DAQ cards. Finally, as the current sys-
tem is un-calibrated, efforts will be made to calibrate the developed technology against




The schematic diagrams of the core module, the power supply module, the current source
module, the transimpedance amplifier module and the vital sign module are depicted here.
The 3D models showing the architecture of the ZenPPG system, and the microcontroller
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Figure A.5: Schematic diagram of the vital sign monitoring module
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Mechanical diagrams
Figure A.6: 3D rendering showing the exploded view of the ZenPPG system along with the front and back panels
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MCU control code
#include <avr / io . h>
#include <util / delay . h>
#dene MUX PORTB
#dene CMUX PORTD
// const unsigned char MUX 0 = PB0;
// const unsigned char MUX 1 = PB1;
// const unsigned char MUX _INH = PB2;
const uint 8_t IR = 0;
const uint 8_t RED = 1;
inline void init () {
 DDRB = _BV( DDB2) | _ BV( DDB1) | _ BV( DDB0) ;
 DDRD = _BV( DDD1) | _ BV( DDD0) ;
}
inline void muxSel ( uint 8_t n ) {
 uint 8_t tmp = MUX;
 tmp &= 0b11111100 ;
 tmp | = n & 0b00000011 ;
 MUX = tmp;
}
inline void muxOn () {
 MUX &= 0b11111011 ;
}
inline void muxO () {
 MUX | = 0b00000100 ;
}
inline void ledOn ( uint 8_t n ) {
 uint 8_t tmp = CMUX;
 tmp &= 0b11111100 ;
 tmp | = n & 0b00000011 ;
 CMUX = tmp;
}
inline void ledMuxSel ( uint 8_t n ) {
 ledOn ( n) ;
 muxSel ( n) ;
}
inline static void qdelay ( uint 8_t n ) {
 for ( int i =0; i <n; i ++) {
  _delay _us ( 125 ) ;
 }
}
inline static void ledMuxTrack () {
 qdelay ( 1) ;
 muxOn() ;
 qdelay ( 2) ;
 muxO () ;
 qdelay ( 1) ;
}
int main ( void ) {
    init () ;
    while ( 1) {
  ledMuxSel ( RED) ;
  ledMuxTrack () ;
  ledMuxSel ( IR ) ;
  ledMuxTrack () ;  
  }
}      
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